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Summary 
PKC and PKCζ are members of the atypical protein kinase C family and play a 
key role in regulating cell polarity. PKC also acts as an oncogene and high levels of PKC 
protein in cancerous tissue is linked to a poor patient prognosis. Identifying substrates of 
PKC is important to understand how PKC controls cell polarity and is acting as an 
oncogene. This work describes the localisation of PKC and PKCζ, with PKC and PKCζ 
localising to the tight junctions and centrosomes during mitosis. The autophosphorylation 
and activation of PKC and PKCζ also increases during mitosis. This suggests that 
substrates of PKC could be localised to the centrosomes and tight junctions. A kinase 
assay was developed to elucidate novel PKC phosphorylation targets. The polarity and 
centrosomal phosphorylation candidates; Pals-1, Dlg, GSK3β and LGN  were tested, 
however, none of these were found to be in vitro PKC phosphorylation targets, suggesting 
that PKC does not function by phosphorylating these proteins. Interestingly, Dlg was 
found to increase the autophosphorylation of PKC indicating that it activates PKC. 
Previous studies have shown that PKC may also be involved in the Hippo pathway, which 
controls cell proliferation and cell death. PKC activation inhibits the Hippo pathway as a 
result of the mislocalisation of the Hippo protein. This work has demonstrated that the 
transcriptional co-activator proteins Yap and Taz, which function downstream of the Hippo 
pathway, are phosphorylated by PKC in vitro. In addition, overexpression of Yap and 
PKC in MDCK cells causes the nuclear accumulation of Yap, indicating that 
phosphorylation of Yap by PKC promotes its nuclear entry and possibly transcription of 
its target genes. Therefore, these results identify a new way in which PKC regulates the 
Hippo pathway and suggests the direct regulation of the Hippo pathway could be involved 
in the promotion of tumorigenesis by PKC. 
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Chapter 1 
1. Introduction 
1.1 Atypical Protein Kinase C Family 
The atypical Protein Kinase C proteins (aPKC) are members of the protein kinase C 
family, a group of serine/threonine kinases that phosphorylate a wide range of target 
proteins (Newton, 1995). The eleven member family is comprised of three groups; 
conventional, novel and atypical protein kinase C. aPKC differs from the conventional and 
novel forms in that it is not calcium or diacylglycerol sensitive. There are two aPKC 
proteins; PKC/λ and PKCζ. PKC and PKCλ are orthologues, PKCλ is the mouse name 
for human PKC. PKC/λ and PKCζ have  72% total amino acid homology and 86% 
homology within the kinase domain (Akimoto et al., 1994). PKCζ was first cloned in 1992 
(Nakanishi and Exton, 1992) and PKC/λ in 1993 (Akimoto et al., 1994; Selbie et al., 
1993). There are also two other aPKC family members; PKCζII and PKMζ. PKCζII has no 
kinase activity but can interact with the catalytic domain of PKC/ζ and with Par-6, 
possibly acting as a dominant negative, preventing the interaction between PKC/ζ and 
Par-6 and inhibiting PKC/ζ function (Parkinson et al., 2004). RNAi of PKCζII in HCII 
mouse mammary epithelial cells promotes tight junction formation indicating that PKCζII 
inhibits tight junction development. PKMζ is the catalytic domain of PKCζ, it has no 
regulatory domain and is therefore constitutively active (Hernandez et al., 2003) and is 
only found in the brain. This study will focus on PKC and PKCζ. 
Human PKCι 596aa 
Serine/Threonine Kinase Regulatory domain 
Zn 
Finger 
Human PKCζ 592aa 
Serine/Threonine Kinase Regulatory domain 
Zn 
Finger 
Figure 1.1 A schematic diagram showing the domains of human PKC and PKCζ 
PKC/ζ have four main domains; a regulatory domain that contains a PB1 domain, a 
pseudosubstrate domain, a zinc-finger domain and a kinase domain that phosphorylates 
target proteins. 
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1.1.1 The Par-aPKC Complex 
Figure 1.2 The Par-aPKC complex. 
PKC/ζ binds Par-3 and Par-6. CRIB - Cdc42/Rac interacting domain; PDZ - postsynaptic 
density 95, discs large, zonula occludens-1; CR - conserved region. Adapted from Ohno, 
(2001). 
PKC/ζ form a conserved complex with Par-6 and Par-3, which is termed the Par-
PKC complex (Ohno, 2001). PKC/ζ binds to Par-6 through the PB1 domain of Par-6 and 
the regulatory domain of PKC/ζ (Etienne-Manneville and Hall, 2003b). Par-3 binds to the 
kinase domain of PKC/ζ and Par-6 and Par-3 interact with each other through their PDZ 
domains to complete the complex (figure 1.2). 
Par-6 and PKC/ζ normally colocalise within cells, however Par-3 only joins this 
complex when the cells polarise and this association has been reported to be transient 
(Totong et al., 2007). Par-3 seems to act as a scaffolding protein that enlists the Par-6-PKC 
complex to the apical domain of polarised cells and to areas of tight junction assembly 
(Denning, 2007). There are other proteins that have been reported to associate with this 
complex such as lambda-interacting protein (LIP), Rac1 (Jaken and Parker, 2000), 
members of the 14-3-3 family, Cdc42 (Suzuki and Ohno, 2006) and junctional adhesion 
molecule (JAM) (Ohno, 2001). These proteins may serve to bring the substrates of PKC/ζ 
into close proximity and will be discussed in more detail later. 
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1.1.2 Differences between PKC and PKCζ 
The phenotypes of the knock-out PKC (lethal) and PKCζ (viable), which will be 
discussed later, indicate that they may have functional differences despite their high 
homology. However, this has not been well studied, especially in the context of cell 
polarity. Many of the antibodies used bind to both isoforms and dominant negatives 
usually inhibit both isoforms making the effects of dominant negatives and localisation 
difficult to distinguish between the two. This has led to some groups referring to aPKC 
rather than the individual isoform. In contrast knockouts are specific for each isoform and 
show different phenotypes. Other known differences between the two proteins include the 
LIP, which is a PKC specific activator that does not bind PKCζ (Diaz-Meco et al., 1996b). 
During mouse embryonic development PKC/λ mRNA is expressed abundantly throughout 
the embryo. However, PKCζ expression is lower throughout development and is found in 
fewer tissues. At later stages of development (embryonic day 16.5) PKC and PKCζ both 
show high level of mRNA and protein expression in epithelial tissues such as the intestine, 
kidney and lung (Kovac et al., 2007). This may indicate that in a polarised epithelial tissue 
the functions of PKC and PKCζ are redundant. In this report PKC/ζ will be used when it 
is not clear which isoform is being researched and PKC or PKCζ when it is specific. 
1.2 Cell Polarity 
PKC/ζ are known regulators of cell polarity (Suzuki and Ohno, 2006). Cell 
polarity can be defined as the asymmetric distribution of constituents within a single cell 
that produces an asymmetry of cellular functions. Epithelial cells are one example of 
polarised cells, they have apical and basolateral domains and each domain carries out 
different functions. The domains are separated by tight junctions (Farquhar and Palade, 
1963) (figure 1.3), which block diffusion across the epithelial sheet and between the apical 
and basal membrane domains. Tight junctions are composed of the transmembrane 
proteins; claudin, occludin, JAM and membrane associated proteins; ZO-1, ZO-2 and 
cingulin. Occludin and claudin are required to maintain the transepithelial electrical 
resistance (TER) of the cell. They also function as cell-cell adhesion molecules. ZO-1 and 
ZO-2 are scaffolding proteins that have PDZ, SH3 and an inactive guanylate kinase 
domain that target other proteins to the tight junctions and bind to actin. Cingulin may also 
be a scaffolding protein responsible for actin organisation at the tight junction (Balda and 
Matter, 1998; Mitic and Anderson, 1998). Below the tight junctions are adherens junctions, 
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which are cadherin-based cell-cell adhesion sites composed of cadherin, β-catenin, α-
catenin, vinculin, α-actinin, ZO-1, actin, nectin and LIN-7, with other proteins localising in 
the area that may be connected to the adherens junction (Nagafuchi, 2001). Adherens 
junctions are responsible for cell-cell adhesion. Desmosomes are composed of the 
desmosomal cadherins; desmogliens and desmocollins to which the proteins plakoglobin, 
plakophilin and desmoplakin associate (Green and Jones, 1996). Hemidesmosomes are 
composed of α and β-integrins, laminin-5, BP180 and plactin. The desmosomes and 
hemidesmosomes provide a cell surface attachment site to bind intermediate filaments to 
help maintain tissue integrity. 
Figure 1.3 A Polarised Epithelial Cell. (courtesy of V. Sherwood) 
Polarised epithelial cells have apical and basal domains which are separated by tight 
junctions. Below the tight junctions are adherens junctions and desmosomes, which 
provide sites of cell-cell adhesion. Connecting an epithelial sheet to the basal lamina are 
hemidesmosomes. 
Another example of cell polarity occurs in developing embryonic cells, which are 
often polarised and cell fate determinants are asymmetrically distributed, so that during 
asymmetric division, each daughter cell receives a different set of cell fate determinants 
(Knoblich, 2008). This generates cell fate diversity, allowing a complex multicellular 
organism to arise from a single cell. Other examples of polarised cells are migrating cells, 
neurones and cells involved in wound healing. Cell polarity is often disrupted in cancer; 
cells lose polarity and this contributes to tumour formation, which is covered in section 
1.7, so cell polarity is important for a diverse range of biological processes and cancer 
progression. 
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1.3 The Control of Epithelial Cell Polarity. 
There are four main polarity complexes that are required to maintain polarity: the 
apical PKC/ζ/Par-3/Par-6 complex, the apical Crumbs/Pals-1/PATJ complex, the 
basolateral Lethal giant larvae (Lgl)/Discs Large (Dlg)/Scribbles group and the lateral 
Yurt, Coracle, Neurexin IV and Na+, K+-ATPase group, as well as the basolateral protein 
Par-1. These complexes are evolutionarily conserved (Hurd et al., 2003; Izumi et al., 1998; 
Joberty et al., 2000; Laprise et al., 2009; Lin et al., 2000; Plant et al., 2003; Yamanaka et 
al., 2003) and are required to establish and maintain epithelial polarity. 
1.4 The Par-aPKC complex 
The Par-aPKC complex, as discussed above, is an apical complex that consists of 
PKC/ζ, Par-6 and Par-3. The three proteins colocalise at tight junctions (Izumi et al., 
1998; Suzuki et al., 2001). 
1.4.1 Function of PKC/ζ 
In C. elegans, the homologue of PKC/ζ is called PKC-3. The one cell C. elegans 
embryo is highly polarised and PKC-3 localises to the anterior of the embryo with Par-3 
and Par-6 (St Johnston and Ahringer, 2010). The Par-PKC complex is required to establish 
polarity once the C. elegans egg has been fertilised and enters the first mitotic division 
(Cowan and Hyman, 2007) and loss of these proteins results in a loss of polarity. 
Drosophila PKC/ζ (DaPKC) zygotic null mutants are normal at the embryonic 
stage, due to maternal DaPKC contribution, but the mutants are lethal at the larval stage 
(Rolls et al., 2003). The mutants have abnormal neuroblast polarity, indicated by 
mislocalised Lgl and Par-6. The DaPKC mutants also have defects in epithelial cell 
polarity and a loss of monolayer morphology. Expression of DaPKC mutants that cannot 
bind Par-6 or lack kinase activity cause a loss of apico-basal polarity in the embryonic 
ectoderm and neuroblasts, however the follicular epithelium is grossly normal (Kim et al., 
2009). This indicates that the kinase activity of DaPKC is required for many epithelia but 
may be dispensable in some Drosophila epithelial cell types. 
PKC is called heart and soul (has) in Zebrafish. Embryonic has mutants affect the 
morphogenesis of embryonic polarised epithelia. The adherens junctions are not 
maintained in has mutants, resulting in multiple lumens in the intestine and disorganised 
retina (Horne-Badovinac et al., 2001). In the developing Xenopus embryo, dominant 
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negative PKC/ζ causes a loss of apical identity. There is an expansion of the basolateral 
domain into the apical domain, as indicated by staining for the basolateral markers, β-1 
integrin and occludin. There is also a loss of tight junctions, as indicated by a loss of 
cingulin staining (Chalmers et al., 2005). During Xenopus gastrulation it has been shown 
that XGAP is phosphorylated by PKC/ζ, which allows XGAP to bind Par-5. XGAP 
controls convergent extension in Xenopus by cooperating with Par proteins to control cell 
polarity (Hyodo-Miura et al., 2006). 
Aberrant localisation of PKC/ζ in the chick neuroepithelium results in a disruption 
of neuronal polarity (Ghosh et al., 2008). Expression of myristoylated PKC/ζ localises to 
the entire cell membrane and causes adherens junctions disruption and a loss of 
neuroepithelial architecture. Inhibition of PKC/ζ using an inhibitor prevents neurones 
from gaining polarity (Shi et al., 2003). 
PKCζ deficient mice are viable and grossly normal. They have small changes in the 
spleen and β-cell maturation is slow, NFκB activation is also slowed, indicating that PKCζ 
is involved in the immune system (Leitges et al., 2001). This may indicate that PKCζ has 
no role in polarity or that it is functionally redundant and can be replaced with PKC/λ in 
polarity. PKC/λ knock-out mice are embryonic lethal, they die at embryonic day 9 and are 
highly morphologically abnormal (Soloff et al., 2004). The embryos appear to have no 
morphological organisation at all, which is consistent with a role for PKC/λ in cell 
polarity. A conditional knock-out of PKC/λ in photoreceptors within the mouse retina 
results in a lack of cell polarisation, but does not affect receptor differentiation (Koike et 
al., 2005). When PKC/λ is conditionally knocked-out in the mouse neocortex there is a 
loss of adherens junctions and polarity (Imai et al., 2006). There is a disruption of 
neuroepithelial tissue architecture and the mice die within one month and display 
hydrocephalus. In a PKC/λ conditional knock-out in the mouse lens, there is reduced 
proliferation during development caused by premature withdrawal from the cell cycle 
(Sugiyama et al., 2009). The lens cells also go through epithelial-mesenchyme transition 
(EMT), therefore, in the lens PKC/λ is required for proliferation and to suppress EMT. In 
summary PKCλ knock-out in different tissues causes a general loss of cell polarity which 
supports a role for PKC/λ in cell polarity. 
PKC/ζ are also involved in tight junction regulation in mammalian cell lines. Par-3 
binds to the tight junction protein JAM, tethering the Par-PKC complex to the tight 
junction (Ebnet et al., 2004). PKC/ζ is the last tight junction protein to be recruited to the 
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tight junction; however, the kinase activity of PKC/ζ is required for junctional maturation 
as in the mouse mammary epithelial MTD1-A cells, expression of a dominant negative 
PKCλ prevents junctional maturation (Suzuki et al., 2002). ZO-2 is also phosphorylated by 
PKC/ζ and associates with PKC/ζ in vivo (Avila-Flores et al., 2001). This 
phosphorylation occurs during tight junction assembly; however, the purpose of this 
phosphorylation remains unclear as no studies were carried out with a non-
phosphorylatable ZO-2. PKC/ζ phosphorylates claudin-4 during tight junction formation 
and prevention of this phosphorylation using a claudin-4 mutant that cannot be 
phosphorylated prevents tight junction formation (Aono and Hirai, 2008). A dominant 
negative mutant of PKC/ζ interferes with tight junction development in MDCK cells, 
where it has been shown that there is mislocalisation of Par-3, ZO-1, occludin and claudin-
1 (Suzuki et al., 2001). In 3D MDCK cysts, dominant negative PKC/ζ results in multiple 
lumen cysts (Horikoshi et al., 2009). Therefore, PKC/ζ is essential for tight junction 
development. 
All of these reports from diverse systems ranging from C. elegans to mammals 
indicate that PKC/ζ has a crucial role in cell polarity and the establishment and/or 
maintenance of epithelial cell junctions. 
1.4.2 Regulation of PKC/ζ 
One mode of PKC/ζ activation is through Par-6 and Cdc42. Par-6 links Cdc42 to 
PKC/ζ, by binding to Cdc42 through its CRIB domain and binding the regulatory domain 
of PKC/ζ. The binding of Par-6 to the regulatory domain of PKC/ζ is inhibitory, but the 
binding of Cdc42 to Par-6 relieves the inhibition of Par-6 on PKC/ζ (Qiu et al., 2000; 
Yamanaka et al., 2001) allowing PKC/ζ to autophosphorylate (Akimoto et al., 1994). Loss 
of Cdc42 phenocopies mutations in Par-6 and PKC/ζ in the Drosophila notum (Georgiou 
et al., 2008). Cdc42 also targets the Par-PKC complex to the apical cortex (Martin-
Belmonte et al., 2007). The association of Cdc42 with the Par-aPKC complex and 
therefore the activation of PKC/ζ is thought to be mediated by ceramide which binds 
directly to the complex (Krishnamurthy et al., 2007). Ceramide depletion results in no 
association of Cdc42 and the Par-PKC complex and therefore no PKC/ζ activation, 
however, this has only been shown in mouse embroid bodies. A Cdc42 activator and 
therefore activator of PKC/ζ is Tuba, a guanine nucleotide exchange factor (GEF) specific 
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for Cdc42 (Qin et al., 2010). Cdc42 is apically enriched in MDCK cysts; however, this 
enrichment is abolished upon Tuba depletion, as is PKC/ζ autophosphorylation and 
therefore activation. So Tuba activates Cdc42 which in turn activates PKC/ζ through Par-
6. 
Another PKC specific activator is LIP which binds to the zinc-finger region of 
PKC/λ, but not PKCζ and activates PKC/λ in vivo (Diaz-Meco et al., 1996b), however, 
this method of PKC/ζ activation has not been linked to polarity. Dap160 (related to 
mammalian Intersectin) is also an activator of PKC/ζ was been found in Drosophila 
neuroblasts. Dap160 colocalises with DaPKC at the apical cortex in vivo. In vitro Dap160 
interacts with DaPKC and stimulates the activity of DaPKC (Chabu and Doe, 2008). 
Dap160 mutant neuroblasts have ectopic DaPKC localisation and abnormal polarity, 
indicating that DaPKC is not active. This work needs to be repeated in mammalian 
epithelial cells to discover whether this is also a PKC/ζ regulation method in mammals 
(via Intersectin) or is specific to Drosophila. 
Par-4 is a PKC/ζ inhibitor; it binds to the zinc finger and regulatory domain of 
PKC/ζ and inhibits its activity in vivo. Overexpression of Par-4 induces apoptosis in NIH-
3T3 cells, through inhibition of PKC/ζ (Diaz-Meco et al., 1996a), therefore PKC/ζ is 
involved in cell survival which is supported by its role in cancer formation (see section 
1.11.). Protein phosphatase 2A (PP2A) is another negative regulator of PKC/ζ. PP2A is a 
serine/threonine phosphatase that interacts with tight junctions and colocalises with PKC/ζ 
in MDCK cells (Nunbhakdi-Craig et al., 2002). PP2A regulates tight junction assembly by 
dephosphorylating tight junction proteins phosphorylated by PKC/ζ such as ZO-2 and 
occludin. 
1.4.3 Par-3 
In the C. elegans embryo, Par-3 localises to the anterior cortex and is required for 
cell polarity (Etemad-Moghadam et al., 1995), Par-3 mutants display disrupted actin 
distribution and a lack of asymmetric division. In Drosophila, Par-3 is termed Bazooka. 
Drosophila mutants for Bazooka fail to establish cell polarity after cellularisation (Muller 
and Wieschaus, 1996). In Drosophila neuroblasts, Bazooka is also required for cell 
polarity. Bazooka binds to Inscuteable and aids the rotation of the mitotic spindle and the 
subsequent localisation of cell fate determinants (Wodarz et al., 1999). In Bazooka mutant 
neuroblasts, there is no apical-basal polarity and random spindle orientation. In border cells 
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of the Drosophila ovary, Bazooka loss results in impaired migration (Pinheiro and Montell, 
2004). 
The mammalian Par-3 was first identified as a binding partner of B-type ephrins 
(Lin et al., 1999). There are three splice variants of Par-3 of 180kD, 150kD and 100kD. 
The 180kD and 150kD splice variants are widely expressed during development, however 
the 100kD variant is limited to the heart and kidney and does not contain a PKC/ζ binding 
domain. The 100kD Par-3 strongly binds to Par-6 in vivo and is phosphorylated by PKC/ζ 
in vitro, despite not having a PKC/ζ binding domain (Lin et al., 2000). The other splica 
variants are also phosphorylated by PKC/ζ. Nagai-Tamai and colleagues demonstrated 
that it is serine 827 (S827) of Par-3 that is phosphorylated by PKC/ζ in vivo in MDCK 
cells and that this phosphorylation of Par-3 reduces the affinity of PKC/ζ for Par-3 
(Nagai-Tamai et al., 2002). They also showed that expression of a S827 to alanine mutant 
of Par-3 caused defective polarity and tight junctions after a calcium switch, indicating that 
Par-3 phosphorylation by PKC/ζ is necessary for polarity establishment. Overexpression 
of Par-3 (but not Par-3 lacking the PKC binding region) promotes tight junction formation 
(Hirose et al., 2002). However, in MDCK cells RNAi of Par-3, followed by a calcium 
switch does not block tight junction formation, it only slows it down (Chen and Macara, 
2005), indicating that Par-3 is not totally necessary for tight junction formation. Par-3 
knock-down in 3D MDCK cysts results in impaired apical development and intercellular 
lumen formation (Horikoshi et al., 2009). The polarity is partly established in single cells, 
but not as a group of cells. This is also seen with the knock-down of PKC/ζ, therefore the 
Par-3-PKC/ζ interaction is required for proper lumen formation. In mice, Par-3 knock-
down is embryonic lethal and the embryos display disrupted epithelia (Hirose et al., 2006). 
In Drosophila, Par-1 phosphorylates Par-3 causing it to interact with 14-3-3 
proteins and restricts Par-3 to the apical domain, but this does not allow Par-3 to bind the 
Par-aPKC complex (Benton and St Johnston, 2003). However, in mice it has been shown 
that protein phosphatase 1α dephosphorylates Par-3 bound to 14-3-3, allowing Par-3 to 
bind the Par-aPKC complex (Traweger et al., 2008). Unfortunately these two events have 
not been shown in the same species. 
1.4.4 Par-6 
In C. elegans, Par-6 is required for embryonic polarity and loss of Par-6 
phenocopies the loss of Par-3 including defective polarity and asymmetric division (Watts 
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et al., 1996). In Drosophila neuroblasts, Par-6 localises apically and is required for Par-
3/Bazooka localisation (Petronczki and Knoblich, 2001). In Par-6 mutant neuroblasts 
asymmetric divisions are misorientated and cell fate determinants are mislocalised. In 
Drosophila Par-6 mutant epithelia, apico-basal polarity is lost. As with Par-3, Par-6 is also 
required for border cell migration in the Drosophila ovary and RNAi of Par-6 results in 
impaired cell migration (Pinheiro and Montell, 2004). There are three human homologues 
of Par-6; α, β and γ. They all have PDZ and CRIB domains and all interact with Cdc42 and 
PKC/ζ in vivo (Noda et al., 2001). Par-6 phosphorylation by PKC/ζ could not be detected 
in an in vitro kinase assay (Lin et al., 2000), so it is likely that it is not phosphorylated by 
PKC/ζ. Par-6 localises to the apical domain of epithelial cells with PKC/ζ. Par-6 in 
Drosophila is required to localise Patj apically (Hutterer et al., 2004). The amino terminal 
domain of Par-6 binds the regulatory domain of PKC/ζ and inhibits PKC/ζ unless Cdc42 
binds to Par-6 (Yamanaka et al., 2001). Overexpression of mutant Par-6 in MDCK cells, 
followed by a calcium switch, suppresses TER development and the accumulation of the 
tight junction markers ZO-1, claudin and occludin at the tight junctions is incorrect. This is 
similar to the effects seen with PKC/ζ kinase null in MDCK cells (Suzuki et al., 2001) and 
supports the role of Par-6 in PKC/ζ activation. 
1.5 The Scribble, Lgl, Dlg Complex 
Scribble, Lgl and Dlg are all tumour suppressor genes in Drosophila that act in a 
common pathway (Wodarz, 2000). In Drosophila the phenotypes of each mutant are 
indistinguishable. The mutants have abnormal cell polarity, loss of zonula adherens 
junctions and exhibit tissue overgrowth; therefore they are required for cell polarity and 
correct tissue architecture. Single zygotic mutants of any of the genes are viable until late 
larval stages, when tissue overgrowth begins. However, double zygotic mutants for any of 
the genes are embryonic lethal (Bilder et al., 2000). This indicates that the genes cooperate 
to generate cell polarity and regulate proliferation. 
1.5.1 Lgl 
Drosophila Lgl has been shown to be phosphorylated by PKC/ζ in an in vitro 
kinase assay and little phosphorylation of Lgl is seen in S2 cells depleted of PKC/ζ 
(Betschinger et al., 2003). It was demonstrated that phosphorylation of Lgl by PKC/ζ 
releases Lgl from the Par-PKC/ζ complex, it was speculated that this phosphorylation of 
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Lgl by PKC/ζ inactivates Lgl at the apical end of Drosophila neuroblasts. Lgl is also 
required to be active at the basal end of the neuroblasts to recruit the cell fate determinant 
Miranda (Peng et al., 2000) which is only found at the basal end of the cells. So PKC/ζ 
inactivates Lgl at the apical end of the cell preventing Lgl activation and Miranda 
recruitment. 
In Xenopus, Lgl is inhibited by PKC/ζ (Chalmers et al., 2005). The two proteins 
mutually inhibit each other, overexpression of either protein results in the mislocalisation 
of the other. Each protein can also rescue the effects of the overexpression of the other. 
There are two mammalian homologues of Drosophila Lgl; Lgl1 and Lgl2. The 
expression pattern of Lgl1 in the mouse embryo is broad whereas Lgl2 is only found in the 
liver, kidney and stomach. Lgl1 knockout mice show defects in the brain, with tissue 
overgrowth and a loss of cell polarity (Klezovitch et al., 2004). In MDCK cells Lgl1 and 
Lgl2 localise to the lateral membrane as cells become polarised (Musch et al., 2002). Lgl 
binds Par-6 and PKC/ζ transiently as polarity is being established, it competes with Par-3 
for incorporation into the complex. Lgl is phosphorylated by PKC/ζ in vivo and this 
causes Lgl to dissociate from the Par-6/PKC complex and Par-3 to bind to the complex 
(Yamanaka et al., 2003). The phosphorylation by PKC/ζ inhibits Lgl function in the apical 
domain. In fibroblast scratch assays, Lgl localises with PKC/ζ at the leading edge and is 
phosphorylated. If the five serines phosphorylated by PKC/ζ are mutated to alanines there 
is a 19% decrease in fibroblast polarisation, so phosphorylation of Lgl by PKC/ζ is 
important for cell polarity (Plant et al., 2003). Little is known about how Lgl functions, but 
Lgl binds the t-snare, syntaxin 4, indicating a possible role in the regulation of basolateral 
exocytosis (Musch et al., 2002). 
Lgl may act as a tumour suppressor in humans. In colorectal cancer, Lgl is lost in 
75% of cases and the less Lgl present the more metastatic the cancer (Schimanski et al., 
2005). However, the authors do not speculate on what is causing the loss of Lgl in 
colorectal cancer or what role the loss of Lgl plays in tumour progression. 
1.5.2 Scribble 
Human Scribble (hScrib) was first discovered in 2003 as the functional homologue 
of Drosophila Scribble (Dow et al., 2003). It was shown that the human gene can rescue 
the mutant Scribble phenotype in Drosophila. This indicates that as Scribble acts as a 
tumour suppressor in Drosophila, it is possible it has the same role in mammalian cells. 
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hScrib is a LRR and PDZ domain (LAP) protein with sixteen leucine rich repeats (LRR); 
LAP proteins interact with transmembrane proteins via the LRRs tethering them to the 
membrane (Nagasaka et al., 2006). GFP tagged hScrib colocalises with the adherens 
junction marker E-cadherin in MDCK cells, however, it does not colocalise with ZO-1, 
indicating it is on the lateral membrane below the tight junctions. Scribble restricts the Par-
aPKC complex to the apical membrane (Tanentzapf and Tepass, 2003). shRNA 
knockdown of scribble results in no loss of apico-basal cell polarity, except when the cells 
are subjected to a calcium switch, when the cells take longer to regain their polarity. 
Scribble stabilises the link between α-catenin and E-cadherin to allow adhesive junctions 
to form (Qin et al., 2005). hScrib has also been linked to the cell cycle, it negatively 
regulates cell cycle progression inhibiting cell proliferation, therefore it may be a tumour 
suppressor in humans (Nagasaka et al., 2006). 
Loss of scribble also affects cell migration and cell adhesion; cells migrate more, 
but they lose their cell-cell adhesion (Qin et al., 2005). This was also demonstrated in 
scratch assays using migrating astrocytes (Osmani et al., 2006). In cells depleted of 
Scribble there is a lack of cell polarisation and microtubule disorganisation; when Scribble 
is overexpressed multiple protrusions occur. They also showed that Scribble is found at the 
leading edge of migrating astrocytes and that it controls Cdc42 recruitment to the leading 
edge and therefore, PKC activation. 
Murdoch and colleagues demonstrated that a truncated form of Scribble is found in 
the mouse circletail mutant embryos which have massive neural tube defects (Murdoch et 
al., 2003). There is a failure in neural tube closure, which occurs in the human diseases, 
spina bifida and anencephaly. This indicates that hScrib may be involved in these human 
diseases too. 
Loss of Scribble in mice mammary glands results in tumours and Scribble is 
involved in cell death regulation and in the maintenance of cell architecture (Zhan et al., 
2008). In human breast cancer samples hScrib is absent in 55% of ductal carcinomas and 
81% of lobular carcinomas (Navarro et al., 2005). This indicates that hScrib is important in 
preventing some types of mammary carcinoma. hScrib is also targeted by the high-risk 
human papillomavirus (HPV) E6 proteins (Nakagawa and Huibregtse, 2000). HPV has 
been linked to 90% of uterine carcinomas. The E6 proteins target hScrib for degradation 
and in MDCK cells, this results in the breakdown of tight junctions damaging the integrity 
of the tight junctions as seen by a loss of ZO-1 staining. As loss of Scribble in Drosphila 
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leads to tissue overgrowth, the loss of hScrib in response to HPV infection could result in 
tumorigenesis. 
1.5.3 Dlg 
Dlg is a member of the membrane-associated guanylate kinase homologues 
(MAGUK) (Woods and Bryant, 1994). Dlg has three PDZ domains and an SH3 domain 
which act as sites of protein-protein interaction. Dlg also has a region which is similar to a 
guanylate kinase domain, but it has a three amino acid deletion making it kinase inactive. 
Dlg localises to the septate junctions in Drosophila and mutation of Dlg results in a loss of 
cell polarity and septate junction in imaginal discs. Loss of Dlg also redistributes two 
proteins of the band 4.1 family, coracle and expanded, from the septate junctions and 
apical membrane respectively, to the cytoplasm (Woods et al., 1996). 
There are five alternatively spliced isoforms of human Dlg (hDlg), 1 to 5. Isoforms; 
1, 2, 3 and 5 are found in many tissues, only 1 and 4 are found in the brain and liver, only 1 
and 3 at sites of cell-cell contact and only 1 and 2 in the nucleus (McLaughlin et al., 2002). 
hDlg was first characterised in 1994 and was shown to localise to cell-cell contact regions 
in polarised MCF-7 cells (Lue et al., 1994). Muller and colleagues also showed that rat Dlg 
localised to cell-cell contacts in T84 cells and demonstrated that when cells were not in 
contact, Dlg did not localise to the membrane (Muller et al., 1995). A truncated form of 
Dlg1 in mice, missing the SH3 and guanylate kinase domains, causes growth retardation 
and craniofacial abnormalities. The mice also die perinatally, which is probably due to an 
inability to feed (Caruana and Bernstein, 2001). This indicates that these domains are 
important for the function of Dlg. However, the authors make no mention of cell polarity 
within the Dlg mutants, so it is unknown whether the polarity was affected in these 
mutants. 
In HEK293 cells, Dlg1 localisation alters through the cell cycle. In G1 phase it is 
membrane bound; as cells go through the cell cycle the staining becomes much more 
cytoplasmic. At metaphase, Dlg1 is found on the mitotic spindle and on the midbody 
during cytokinesis. Phosphorylation by CDK1 and CDK2 alters the localisation of Dlg1, 
specifically targeting it into the nucleus (Narayan et al., 2009). Non-phosphorylatable Dlg 
is excluded from the nucleus. Overexpression of Dlg1 in 3T3 fibroblasts inhibits cell cycle 
progression by impairing G1-S-phase progression (Ishidate et al., 2000). 
Dlg is a target for some human viral oncoproteins including 9ORF1, HTLV-1 Tax 
and HPV-18 E6 oncoprotein (Lee et al., 1997). It was shown that the oncoproteins bind the 
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same region of Dlg that binds adenomatous polyposis coli (APC). APC is mutated in many 
colorectal tumours and is involved in Wnt signalling. Dlg forms a complex with APC and 
this complex may block cell cycle progression (Matsumine et al., 1996). By binding Dlg 
the oncoproteins may disrupt the Dlg-APC complex leading to unregulated cell 
proliferation (Lee et al., 1997). hDlg is also degraded in HPV-positive cervical tumours. In 
normal epithelial cells hDlg is stabilised at cell-cell contact regions with APC, resulting in 
no proliferation. Any hDlg not found at the sites of cell-cell contact is degraded, the cells 
become polarised and Dlg is stabilised. Therefore, if Dlg is degraded and misregulated and 
not at cell-cell contacts with APC, proliferation can occur, possibly adding to the tumour 
growth (Mantovani et al., 2001). This idea is supported by the fact that loss of Dlg in 
Drosophila leads to massive tissue overgrowth. 
In astrocytes, the cortical recruitment of Dlg to the leading edge of scratch assays is 
prevented by inhibiting PKCζ; therefore PKCζ controls the recruitment of Dlg to the 
leading edge (Etienne-Manneville et al., 2005). The authors go on to show that the Dlg-
APC interaction at the leading edge is required for microtubule polarisation, centrosome 
reorientation and cell migration. 
The interactions of PKC/ζ with the Scribble, Lgl, Dlg complex are depicted in 
figure 1.4. 
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Figure 1.4 PKC/ζ and the Scribble, Lgl, Dlg complex 
A schematic diagram depicting the interactions between PKC/ζ and the Scribble, Lgl, Dlg complex 
25 
1.6 The Crumbs/Pals-1/Patj Complex 
The third polarity complex is composed of Crumbs3, Pals-1 and Patj (Lemmers et 
al., 2002; Makarova et al., 2003; Roh et al., 2002). 
1.6.1 Crumbs 
Crumbs is A Type 1 membrane protein with a short cytoplasmic tail (Wodarz et al., 
1995). In Drosophila epithelial cells, Crumbs is localised to the entire apical membrane 
and concentrates at the zonula adherens (Tepass, 1996; Wodarz et al., 1995). Crumbs 
overexpression results in the expansion of the apical domain and loss of Crumbs leads to a 
loss of cell polarity and a failure of zonula adherens junction formation (Grawe et al., 
1996; Tepass, 1996). In Drosophila, DaPKC binds crumbs at the apical membrane. The 
authors showed that the human PKCζ phosphorylates a GST-Crumbs fusion protein at 
threonines 6 and 9 (Sotillos et al., 2004). However this has not been shown in mammalian 
cells or in vivo in Drosophila. Overexpression of a non-phosphorylatable form of Crumbs, 
in the Drosophila wing, results in loss of Crumbs and Patj from the apical membrane and 
aberrant Scribble localisation indicating that phosphorylation by DaPKC is important for 
cell polarity. 
There are three mammalian crumbs genes. CRB1 was the first to be discovered as a 
mutated gene in retinitis pigmentosa group 12 (RP12), a retinal degeneration disease (den 
Hollander et al., 1999). Crumbs1 is expressed in the brain and retina, not epithelial cells 
(den Hollander et al., 2002). Crumbs2 and Crumbs3 were identified shortly after Crumbs1, 
they have 67% and 54% homology with Drosophila Crumbs (Lemmers et al., 2002). 
Crumbs3 mRNA is expressed in a wide variety of epithelial tissues, skeletal muscle and 
the brain, but not in other tissues (Lemmers et al., 2004). Crumbs3 localises to the apical 
membrane in epithelial cells. Overexpression of Crumbs3 in MDCK cells does not alter 
cell polarity on its own, but when the cells are subjected to a calcium switch there is a 
delay in tight junction establishment in cells overexpressing Crumbs3 (Lemmers et al., 
2004). Crumbs3 also localises to the leading edge of migrating cells (Shin et al., 2005). 
Crumbs3 is downregulated in tumour derived cell lines (TDCLs) from nude mice 
injected with immortal baby mouse kidney epithelial cells (Karp et al., 2008). These cell 
lines grow beyond contact inhibition resulting in a multilayered phenotype instead of the 
monolayer seen in cell lines from tissue not derived from tumours, also tight junctions are 
lost. Re-expression of Crumbs3 in the TDCLs restores the wild type phenotype; therefore, 
Crumbs3 is responsible for the multilayered, loss of junction phenotype. This indicates that 
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Crumbs plays an important role in maintaining polarity and loss of Crumbs may contribute 
to tumour progression. 
1.6.2 Patj 
Patj is the mammalian homolog of the Drosophila protein Discs lost. Discs lost 
localises at the apical membrane with Crumbs (Bhat et al., 1999). In Drosophila epithelia, 
Discs lost is vital for polarity and loss of Discs lost leads to a loss of the apical localisation 
of Crumbs and a loss of polarity. 
Patj contains eight PDZ domains and localises to the tight junctions and apical 
domain in epithelial cells and binds Crumbs and Pals-1 (Lemmers et al., 2002). During 
monolayer MDCK cell polarisation, Patj is targeted to the apical domain and then the tight 
junction later on in polarisation. In Patj knockdown cells subjected to a calcium switch, 
there is a delay in tight junction formation. In Patj knockdown MDCK cells grown in 3D 
culture, no central lumen forms unlike in control cells, so Patj plays an important role in 
the cell polarity of MDCK cells (Shin et al., 2005). Patj targets Pals-1 to the tight junctions 
(Roh et al., 2002). It has been shown that Patj is required for the apical localisation of 
Crumbs and Pals-1 and the lateral localisation of occludin and ZO-3, hence Michel and 
colleagues hypothesised that Patj may act as a determinant between the apical and lateral 
border (Michel et al., 2005). 
In migrating MDCKII cells, Patj localises to the leading edge and is required for 
wound healing (Shin et al., 2007). PKC/ζ and Par-3 also localise to the leading edge of 
migrating MDCKII cells and in the absence of Patj they are mislocalised, so Patj may be 
needed for the recruitment of the Par-aPKC complex to the leading edge. 
Patj, like Scribble and Dlg, is a target of the HPV E6 proteins. The E6 proteins 
cause Patj degradation (Storrs and Silverstein, 2007), as Patj is involved in epithelial cell 
polarity and regulates tight junction formation (Shin et al., 2005), the degradation of Patj 
may aid the progression of HPV mediated cervical cancer. 
1.6.3 Pals-1 
Pals-1 is the mammalian homologue of the Drosophila protein Stardust. Stardust 
binds to the cytoplasmic tail of Crumbs (Bachmann et al., 2001) and is required for 
epithelial polarity in Drosophila embryos and loss of Stardust has a phenotype similar to 
loss of Crumbs (Tepass and Knust, 1993), Stardust mutants also have abberant Crumbs 
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localisation, indicating that Stardust may localise Crumbs. However, Stardust is 
downstream of Crumbs and is activated by Crumbs. Interestingly, although Stardust and 
Crumbs are required for Drosophila epithelial polarity, they are not required for neuroblast 
polarity (Hong et al., 2001). 
In mammalian epithelial cells, Pals-1 is targeted to the tight junction via its L27 
domain that binds Patj (Roh et al., 2002). Pals-1 also binds the C-terminal region of 
Crumbs3 (Makarova et al., 2003) and the PDZ domain of Par-6 (Hurd et al., 2003). The 
binding of Par-6 to Pals-1 is inhibitory to the binding of Patj to Pals-1 (Wang et al., 2004), 
which may inhibit the function of Pals-1, or the activation of the Crumbs complex. 
Partial siRNA knockdown of Pals-1, followed by a calcium switch in MDCKII 
cells results in a delay in tight junction formation, a loss of Patj expression and a loss of 
PKC/ζ at the tight junctions. In 3D culture Pals-1 siRNA results in a disrupted polarity 
and a failure to form a central lumen (Straight et al., 2004). Total siRNA of Pals-1 in 
MDCKII cells, followed by a calcium switch, results in no reformation of tight junctions 
and a lack of E-cadherin at adherens junctions. The E-cadherin is found intracellularly and 
not trafficked to the cell surface, so Pals-1 is required for the targeting or the fusion of E-
cadherin containing vesicles to the membrane (Wang et al., 2007) and for the 
establishment of polarity. 
The interactions of PKC/ζ with the Crumbs, Pals-1, Patj complex are depicted in 
figure 1.5. 
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Figure 1.5 PKC/ζ and the Crumbs, Pals-1, Patj complex 
A schematic diagram depicting the interactions between PKC/ζ and the Crumbs, Pals-1, Patj complex 
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1.7 The Yurt, Coracle, Neurexin IV and Na+, K+-ATPase Group 
A new polarity complex that has recently been identified is the Yurt, Coracle, 
Neurexin IV and Na+, K+-ATPase group (Laprise et al., 2009). As a whole, the group 
promotes the basolateral identity of epithelial cells. 
Yurt is a FERM (F for 4.1 protein, E for ezrin, R for radixin and M for moesin) 
domain containing protein. FERM domains are thought to link cytoplasmic proteins to the 
plasma membrane (Chishti et al., 1998). Drosophila Yurt mutants have an enlarged apical 
membrane and Crumbs is mislocalised indicating that Yurt is required for Crumbs 
localisation. In Drosophila, Yurt colocalises transiently with Crumbs at the adherens 
junctions and does not expand any further apically than this. There are also low levels of 
Yurt found at the basolateral membrane of epithelial cells. So only a small portion of Yurt 
localises apically with Crumbs. In the developing Drosophila embryo, Yurt only interacts 
with Crumbs later in development; the authors suggest that this change in interaction may 
be mediated by the phosphorylation of Yurt. They also suggest that Yurt may play a role in 
suppressing Crumbs to maintain apical-basal polarity (Laprise et al., 2006). Likewise, it 
has been shown that Yurt negatively regulates Crumbs function. However, Crumbs is 
responsible for recruiting Yurt to the apical membrane as loss of Crumbs results in Yurt 
localising totally to the basolateral membrane (Laprise et al., 2009). 
The situation in vertebrates is not as clear as in Drosophila. In Zebrafish Yurt (also 
called mosaic eyes) localises apically with Crumbs (Hsu et al., 2006) which it does not in 
Drosophila. In Zebrafish, morpholino knockdown of Yurt phenocopies Crumbs 
knockdown and the mutants are lethal 5-6 days post fertilisation. It has also been shown by 
the same authors that Yurt forms a complex with Crumbs and PKC/ζ in Zebrafish in vivo. 
Although the localisation data for Drosophila and Zebrafish do not entirely match, the data 
indicates that Yurt is critical for epithelial cell polarity. 
Yurt and Crumbs also interact in mammals. There are two mammalian Yurt 
orthologs, EHM2 and EPB41L5 (renamed YMO1). Yurt localises to the lateral membrane 
in mammalian cells. Immunoprecipitation experiments in HEK293 cells indicate that 
Crumbs and Yurt interact and point mutants revealed that the FERM binding domain of 
Crumbs and the FERM domain of Yurt is essential for this interaction (Laprise et al., 
2006). Similar interactions between Crumbs and EHM2 have been seen in the mouse 
retina. RNAi of YMO1 and EHM2 in MDCK cells results in a loss of the lateral membrane 
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and an increase in the apical and basal membrane. The authors conclude that Yurt is 
required for basolateral identity in mammals (Laprise et al., 2009). 
More recently, Yurt has been shown to act with Coracle. Coracle is a member of 
the Protein 4.1 superfamily (Lamb et al., 1998). Coracle forms part of the Drosophila 
septate junction and Coracle null mutants are embryonic lethal. The reason for this is 
probably due to the role of Coracle in transepithelial barrier maintenance being lost. 
Yurt/Coracle double mutants in Drosophila show cell apicalisation (Laprise et al., 2009), 
similar to that seen in PKC/ζ overexpression in Xenopus (Chalmers et al., 2005). Coracle 
also functions in a second pathway with Neurexin IV and Na+, K+-ATPase, which are also 
components of the Drosophila septate junction. This pathway is independent of Yurt as 
double mutants for Yurt and Neurexin IV or Na+, K+-ATPase enhance the Yurt phenotype. 
The two complexes have similar functions but do not operate in the same pathway. 
The Yurt, Coracle, Neurexin IV and Na+, K+-ATPase pathways are an exciting new 
development in the understanding of how cell polarity is established and maintained in 
epithelial cells. Further work is now required to determine if these proteins interact with 
any other polarity proteins. One avenue to explore is Yurt phosphorylation as Yurt shows 
varying levels of phosphorylation in Drosophila (Laprise et al., 2006). It is possible that 
PKC/ζ or Par-1 could phosphorylate Yurt leading to the promotion or suppression of 
Crumbs interaction. 
The interactions of PKC/ζ with the Yurt, Coracle, Neurexin IV and Na+, K+-
ATPase pathways are depicted in figure 1.6. 
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Figure 1.6 PKC/ζ and the Yurt, Coracle, Neurexin IV and Na+, K+-ATPase pathways 
A schematic diagram depicting the interactions between PKC/ζ and the Yurt, Coracle, Neurexin IV and Na+, K+-ATPase pathways 
32 
1.8 Par-1 
Par-1 is a serine/threonine kinase that was first identified in C. elegans (Guo and 
Kemphues, 1995). Par-1 is crucial for the establishment of asymmetry during the first cell 
cycle in C. elegans and its kinase activity is required. 
In Drosophila, Par-1 is also a crucial player in cell polarity. Par-1 serves to inhibit 
the Par-PKC/ζ complex by phosphorylating Bazooka/Par-3 (Benton and St Johnston, 
2003), loss of Par-1 results in ectopic lateral localisation of the Par-PKC/ζ complex. 
Phosphorylation of Par-3 by Par-1 causes Par-3 to bind to 14-3-3 proteins, preventing it 
from binding to PKC/ζ. The phosphorylation of Par-3 by Par-1 therefore prevents ectopic 
localisation and activation of the Par-PKC/ζ complex and limits the apical domain. Par-1 
has also been linked to microtubule organisation in Drosophila (Cox et al., 2001; 
Doerflinger et al., 2003). 
In mammalian cells, Par-1 is a regulator of cell polarity and apical surface 
formation (Cohen and Musch, 2003). During the development of polarity in MDCK cells 
overexpression of kinase null Par-1 is deleterious to polarity formation and apical surface 
formation. In 3D MDCK cell cultures, Par-1 knock-down prevents apical lumen formation 
(Cohen et al., 2004) and it is suggested that this is due to a role of Par-1 in microtubule and 
cytoskeletal organisation. Par-1 has also been described in tumour suppression (Elbert et 
al., 2006) and is thought to antagonise the Wnt signalling inducer Dishevelled, preventing 
cell transformation. 
Par-1 has also been shown to be a substrate of PKC/ζ (Hurov et al., 2004). The 
phosphorylation of Par-1 regulates the kinase activity of Par-1, with the phosphorylation 
reducing the kinase activity. The phosphorylation also regulates the subcellular localisation 
of Par-1. Phosphorylation of Par-1 causes Par-1 to move into the cytoplasm and 
intracellular compartments, away from the membrane. If a non-phosphorylatable version of 
Par-1 is overexpressed in HeLa cells with PKCζ, the Par-1 remains at the membrane. This 
gives another level of complexity to the control of cell polarity, in which PKC/ζ can 
inactivate Par-1, but equally Par-1 can inhibit the formation of the Par-PKC/ζ complex. 
The interactions between PKC/ζ and Par-1 are depicted in figure 1.7. 
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Figure 1.7 PKC/ζ and Par-1 
A schematic diagram depicting the interactions between PKC/ζ and Par-1 
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1.9 Polarity Summary 
There are four main polarity complexes that are required to maintain polarity: the 
apical PKC/ζ/Par-3/Par-6 and Crumbs/Pals-1/Patj complex, the basolateral 
Lgl/Dlg/Scribbles group and the Yurt, Coracle, Neurexin IV and Na+, K+-ATPase group, 
as well as the basolateral protein Par-1. 
The Par-PKC/ζ complex is a crucial player in cell polarity, possibly interacting 
with nearly every polarity complex, as shown in figure 1.8. The Par-PKC/ζ complex 
inhibits the Lgl/Scribble/Dlg group as a whole, although how or if PKC/ζ directly inhibits 
Scribble or Dlg has yet to be investigated. In turn the Lgl/Scribble/Dlg group inhibits the 
effects of the Par-PKC/ζ complex. Par-1 phosphorylates Par-3, inhibiting the formation of 
the Par-PKC/ζ complex basal to the tight junctions. 
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Figure 1.8 Epithelial Cell Polarity and PKC/ζ Targets 
A schematic diagram depicting all of the interactions between PKC/ζ and the polarity proteins 
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In turn PKC/ζ phosphorylates Par-1, inhibiting it’s kinase activity and causing it to 
delocalise from the membrane, restricting it to the basal domain. 
PKC/ζ can also phosphorylate Crumbs in Drosophila, but the purpose of this 
phosphorylation, or whether it occurs in mammalian cells has yet to be elucidated. 
Par-6 can bind to Pals-1, preventing its association with Patj and therefore, possibly the 
activation and localisation of the Crumbs complex. 
The Yurt, Coracle, Neurexin IV and Na+, K+-ATPase group also plays a key role in 
polarity and Yurt has been shown to interact with Crumbs, inhibiting its function. Yurt 
itself is phosphorylated, but the kinase responsible has yet to be found. It is possible that 
the kinase is PKC/ζ or Par-1. 
Overall lots is known about the establishment and maintenance of polarity, 
particularly in Drosophila, further work is required to see if what has been found in 
Drosophila occurs in mammals and to further understand all of the mechanisms regulating 
cell polarity. The Par-PKC/ζ complex clearly plays a key role in cell polarity and its 
polarity substrates needs to be investigated further. 
1.10 PKC/ζ and Cell Fate 
PKC/ζ has been linked to polarity and asymmetric division. PKC/ζ itself can also 
act as a cell fate determinant in Drosophila neuroblasts (Lee et al., 2006). Overexpression 
of PKC/ζ targeted to the membrane, results in neuroblast self renewal, rather than the 
production of one differentiating daughter cell and one neuroblasts upon cell division. In 
agreement with this, loss of PKC/ζ causes a decrease in neuroblast number. 
One aspect of asymmetric division is the restriction of cell fate determinants to 
specific areas of the cell. PKC/ζ phosphorylates the cell fate determinant Miranda. This 
phosphorylation leads to basolateral restriction in Drosophila neuroblasts and therefore 
alters the fate of one daughter cell (Atwood and Prehoda, 2009). PKC/ζ also 
phosphorylates the cell fate determinant Numb (Smith et al., 2007). This phosphorylation 
restricts Numb to the basolateral membrane of sensory organ precursor cells in Drosophila 
and in mammalian cells, where Numb is restricted to the basolateral membrane and a non-
phosphorylatable version of Numb localises throughout the cell cortex. 
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1.11 PKC/ζ and Cancer 
Epithelial tissue transformation involves the loss of cell polarity and alteration in 
the expression of polarity regulators is thought to be responsible (Dow and Humbert, 2007; 
Huang and Muthuswamy, 2010). The loss of apical-basal polarity can result in EMT which 
increases invasiveness and is a hallmark of malignant tumours (Thiery, 2002). 
1.11.1 Evidence for PKC Oncogenesis 
PKC is an oncogene in non-small cell lung cancer (NSCLC). There is 
overexpression of PKC, mRNA and protein, but not PKCζ in NSCLC and the expression 
of PKC is associated with poor patient survival (Regala et al., 2005b). PKC/ζ is needed 
for the chemotaxis of NSCLC cells, as inhibition or downregulation of PKC/ζ results in 
less chemotaxis of the NSCLC cell line A549 (Liu et al., 2009). Aurothioglucose (ATG) 
and Aurothiomalate (ATM) are inhibitors of PKC-Par-6 interactions. They stop PKC-
Rac1 signalling and inhibit tumour growth in nude mice (Stallings-Mann et al., 2006) and 
inhibit anchorage-independent growth of lung cancer cells (Regala et al., 2008). These 
drugs are therefore potential treatments for NSCLC and ATM is currently in Phase1 
clinical trails (Fields and Regala, 2007). 
PKC is upregulated in human prostate cancer. The mRNA for PKC is more highly 
expressed in cancer tissue samples than controls. Also the higher the PKC expression, the 
higher the prostate specific antigen failure, a marker used in prostate cancer diagnosis, 
which is associated with patient death (Ishiguro et al., 2009). However, the exact 
mechanism by which PKC promotes prostate cancer cell growth remains unclear as IL-6 
signalling, IKKβ phosphorylation and NFκB activation and the phosphorylation of Cdk7 
and Cdk2 leading to cell cycle progression have all been implicated (Ishiguro et al., 2009; 
Win and Acevedo-Duncan, 2008; Win and Acevedo-Duncan, 2009). Further work is 
required to elucidate the exact mechanism(s) of PKC during prostate cancer initiation and 
progression. 
PKC is upregulated in ovarian cancer and its upregulation is linked to poor 
prognosis (Eder et al., 2005; Zhang et al., 2006). The apical localisation of active PKC is 
lost in ovarian cancer, with active PKC accumulating in the cytoplasm, indicating a loss of 
apical-basal polarity (Grifoni et al., 2007). Therefore, PKC is important in ovarian cancer 
and could be a therapeutic target. 
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PKC/ζ is upregulated and mislocalised to the cytoplasm in human breast cancer 
cells and this is linked to the pathological type of the cancer. The more PKC/ζ, the more 
severe the cancer (Kojima et al., 2008). In human breast cancer cells in culture, a PKCζ 
pseudosubstrate blocks the chemotaxis of the cells (Sun et al., 2005). Therefore, PKC/ζ 
may be an effective therapeutic target in breast cancer, especially in preventing metastasis. 
Upregulation of PKC also occurs in human gastric and oesophageal cancers and is 
associated with metastasis and poor prognosis (Takagawa et al., 2010; Yang et al., 2008). 
PKC mRNA is also elevated in human colon carcinomas (Murray et al., 2004). In bile 
duct and pancreatic carcinoma, high PKC expression correlates with poor patient survival 
and metastasis (Li et al., 2008; Scotti et al., 2010). PKC expression is also high and 
correlates with increased cyclin E expression in hepatocellular carcinoma (Wang et al., 
2009). In normal brain tissue, PKC staining is weak. However, in human glioma cells 
PKC levels are elevated and may play a role in glioma cell proliferation (Patel et al., 
2008). 
PKC/ζ and Par-6 regulate cell death in 3D MDCK cell cysts. Inhibition or siRNA 
of PKC leads to an increase in apoptosis. The effect of PKC-Par-6 on apoptosis is 
mediated through the phosphorylation of GSK3β by PKC. When PKC is lost, GSK3β is 
not phosphorylated and active, and causes caspase dependent cell death (Kim et al., 2007). 
1.11.2 Mechanisms of PKC Oncogenesis 
PKC is thought to be a human oncogene (Regala et al., 2005b). Loss of polarity 
could be involved in oncogenesis as loss of polarity is associated with cancer progression. 
PKC is required for Ras-mediated oncogenic signalling and PKC and PKCζ can be 
activated by Ras, through the binding of Ras to the regulatory domain of PKC (Diaz-
Meco et al., 1994). This activation then activates two pathways involving PKC, the NFκB 
and Rac1 pathways (Fields and Regala, 2007; Lu et al., 2001). NFκB activation by PKC 
increases cell survival via cellular inhibitors of apoptosis (cIAPs) and B-cell lymphoma 
extra large (Bcl-XL). Rac1 links PKC to the Pak1-MEK-ERK pathway, increasing tumour 
growth (Fields et al., 2007). PKC-Rac1 signalling is crucial for NSCLC tumorigenicity in 
vivo (Regala et al., 2005a). So PKC links oncogenic Ras to its downstream effectors. 
Steroid receptor coactivator-3 (Src-3) is overexpressed in many cancers. PKC/ζ 
phosphorylates Src-3 protecting it from proteosome-mediated degradation resulting in 
39 
increased cell growth and proliferation (Garabedian and Logan, 2008; Yi et al., 2008). 
PKC is also required for the migration and invasion of Src transformed 3T3 cells in 
culture (Rodriguez et al., 2009). 
PKC regulation by Bcr-Abl, an oncogenic fusion protein, via transcriptional 
activation has also been described. In chronic myelogenous leukaemia, PKC is required 
for the Bcr-Abl mediated resistance to Taxol-induced apoptosis. The PKC upregulation 
causes NFκB activation and cell survival (Gustafson et al., 2004). Abl also phosphorylates 
PKC leading to PKC activation (Grunicke et al., 2003). The authors suggest that this 
phosphorylation covalently modifies PKC, causing constitutive activation, but the 
mechanism surrounding the modification remains unclear. 
PKC also phosphorylates Bad in NSCLC, preventing its interaction with Bcl-XL. 
This stops Bad acting as a proapoptotic kinase, leading to cell survival (Jin et al., 2005). 
1.12 Other Roles of PKC/ζ 
In addition to cell polarity and tumour progression PKC/ζ has been linked to a 
number of other cellular processes. 
1.12.1 Insulin Signalling 
PKC/λ is involved in glucose induced insulin secretion in mice. A pancreatic 
PKCλ knockout has abnormal glucose tolerance when glucose load is increased 
(Hashimoto et al., 2005). More insulin is released basally but less in response to glucose, 
leading to an impaired glucose tolerance. The effects of PKCλ come from modulation of 
gene expression, the mRNA for Glut2 and HNF3β is decreased in PKCλ knockout 
pancreatic β-cells. Glut2 is a glucose transporter. HNF3β is a transcription factor 
responsible for the transcription of sulfonylurea receptor 1 (Sur1) and Kir6.2. Sur1 senses 
intercellular ATP concentrations and aids potassium channel opening, Kir6.2 aids 
potassium channel opening. 
It has also been shown that insulin sensitivity is increased in PKCλ liver specific 
knockout mice (Matsumoto et al., 2003). The concentration of insulin in plasma is reduced 
in the knockout mice in response to glucose and more glucose is absorbed. There is also a 
marked reduction in mRNA levels for SREBP-1, a transcription factor that regulates the 
gene expression of triglyceride synthesis genes and fatty acid synthase. Consequently there 
is a decrease in the hepatic lipid content in PKCλ liver-specific knockout mice. The authors 
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propose that the increase in insulin sensitivity is due to an inhibition of the TNFα-PKCλ-
IKKβ-NFκB pathway as inhibition of IKKβ increases insulin sensitivity. 
Muscle-specific knockout of PKCλ results in an obesity and diabetes phenotype 
and glucose transport is impaired (Farese et al., 2007). PKC/ζ is also involved in insulin 
signalling and phosphorylates insulin receptor substrate 1 (IRS-1) and Akt1 providing 
negative feedback in insulin signalling and may be linked to insulin resistance (Weyrich et 
al., 2007). The glucose transporter GLUT4 does not get translocated to the membrane, 
therefore, PKCλ is involved in the glucose response in response to insulin in skeletal 
muscle. In PKCλ knockout adipocytes in culture, insulin-stimulated glucose transport is 
impaired (Bandyopadhyay et al., 2004), which is measured by deoxyglucose uptake. This 
affect can be rescued by the expression of wild-type PKCλ. The authors suggest that 
insulin activates PKCλ, increasing glucose uptake. 
PKCζ has also been shown to phosphorylate the IRS-1 in hepatotoma Fao cells (Liu 
et al., 2001). PKC/λ was not investigated. The phosphorylation of IRS-1 by PKCζ causes 
IRS-1 to dissociate from the insulin receptor. This causes the insulin signal to be 
terminated indicating that PKCζ is involved in a nedative feedback loop. PKCζ can 
transmit and terminate the insulin signal. Overall these studies indicate that PKC/ζ plays a 
crucial role in insulin signalling that may be separate to its role in polarity. 
1.12.2 Endocytosis 
The Par-PKC/ζ complex may have a role in endocytic trafficking. Specifically, in 
cells treated with a dominant negative Par-6 or Cdc42, uptake of MHC1 occurs normally, 
but its recycling is impaired, so Par-6/Cdc42 and by implication the Par-PKC/ζ complex is 
responsible for the recycling of clathrin independent cargo (Balklava et al., 2007). In 
contrast, the uptake of clathrin-dependent cargo is impaired in dominant negative Par-6 or 
Cdc42 treated cells. Transferrin uptake is reduced by 30% in these cells. However, the 
mechanism by which the Par-PKC/ζ complex controls endocytosis has not been 
completely elucidated. 
One method could be that the Par-PKC/ζ complex controls endocytosis via 
actomysin contractility as in C. elegans actomysin contractility is stimulated by Par-3 and 
Cdc42 (Wissler and Labouesse, 2007). Another method of endocytic control could be 
mediated by the known PKC/ζ phosphorylation target Numb (Nishimura and Kaibuchi, 
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2007). Expression of phosphomimetic Numb inhibits integrin endocytosis in cell migration 
in HeLa cells. 
Overall these reports indicate that the Par-PKC/ζ complex may play a crucial role 
in endocytosis that needs to be investigated further. 
1.12.3 RNA Transciption 
Nucleolin is phosphorylated by PKC/ζ in vivo (Zhou et al., 1997). Nucleolin is 
involved in chromatin organisation, DNA transcription and ribosome assembly. The 
authors suggest that a possible role for PKC/ζ phosphorylation of nucleolin is to modulate 
nucleolin-RNA interactions. 
1.13 Summary 
PKC/ζ plays a role in a diverse range of cellular functions including; polarity, 
tumour formation, cell fate, endocytosis and insulin signalling. Due to these wide effects 
and the increase of PKC in cancer, the function of PKC needs to be investigated further. 
The aim of this thesis is to discover novel PKC phosphorylation substrates with 
the goal of understanding the effects of PKC in cancer. 
1.14 Aims 
The central aim of this thesis is to discover novel phosphorylation targets of PKC 
and begin to understand the effects that phosphorylation by PKC has on these novel 
targets. This will hopefully aid our understanding of how PKC mediates its effects within 
a normal cell setting and within a cancerous one. 
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Chapter 2 
2.1 Materials 
All chemicals were obtained from Sigma unless otherwise stated. 
Buffer/Solution Components 
2.5% cysteine 2.5g/100mls  dH2O, ~7 pellets NaOH, adjust to pH 7.8-8.1 
10% Blocking 
Buffer 
500ml PBS, 50g milk powder (dried skimmed milk with non 
milk fat), 500μl Tween 20 
4x Sample Buffer 
10ml 
2.5ml 1M Tris pH 6.8, 4.0ml 20% SDS, 400μl 100% glycerol, 
0.008g bromophenol blue 
10x Electrophoresis 
Buffer 
2M glycine, 0.25M Tris, 1% SDS 
10x MMR 2M NaCl, 0.04M KCl, 20mM MgCl2.6H2O, 4omM 
CaCl2.2H2O, 2mM EDTA disodium salt, 1M Hepes 
Bacterial Protease 
Inhibitors 
Protease inhibitors were dissolved in DMSO and H2O 
according to the manufacturer’s instructions. 
Benzocaine 480mls ethanol, 20mls water, 50g benzocaine (10%) 
Blotting Buffer 1L 750ml distilled water, 200ml MeOH, 10x electrophoresis 
buffer 
Coomassie Stain 60% dH2O, 30% Methanol, 10% Acetic Acid (Fisher), 0.2% 
Coomassie brilliant blue (Fluka). 
Destain 60% dH2O, 30% Methanol, 10% Acetic Acid (Fisher) 
Freezing media FCS containing 10% DMSO 
Injection Buffer 1% Ficoll in 1x MMR 
IP Buffer 50mM Tris, 0.15M NaCl, 1% triton, 0.5% sodium deoxycholic 
acid, 0.1% SDS, 1mM EDTA 
Kinase Assay Buffer 4mM MOPS, 4mM MgCl2, 1 mM EGTA, 0.4mM EDTA, 
50M DTT, pH 7.2 
LB Agar 1L LB Broth, 15g Agar 
LB Broth 1L 10g Tryptone, 5g Yeast extract, 10g NaCl 
Mowiol Mowiol (Calbiochem) was reconstituted according to the 
manufacturer’s instructions. 
PBS 1 PBS tablet (Oxoid) per 100ml dH2O 
PBS Lysis Buffer 20ml PBS, 1ml Bacterial protease inhibitors, 1% Triton 
PBST PBS, 0.1% Tween 20 
PBS with protease 
inhibitors 
20ml PBS, 1ml Bacterial protease inhibitors 
TBST 0.1M KCl, 0.02M Tris base, 0.1% Tween 20 to pH 7.4 
Table 2.1 Solution Composition 
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Construct Linearisation Enzyme 
GFP Not1 
PKC Not1 
Lgl-GFP Not1 
Par-1-GFP Sal1 
Table 2.2 Constructs and Linearisation Enzymes 
Antibody Specificity Species Supplier Dilution (unless 
otherwise stated) 
GFP Goat Abcam 1:20,000 
GFP Rabbit Abcam 1:10,000 
Phosphoserine Mouse Sigma 1:10,000 
Phosphothreonine Rabbit Abcam 1:250 
C20 PKC Rabbit Santa cruz 1:200 
Phospho-PKC Rabbit Santa cruz 1:200 
PKC Mouse BD Transduction 1:500 
PKC Mouse Santa Cruz 1:5000 
α-Tubulin Mouse Sigma 1:5000 
Phospho Par-1 Rabbit Abcam 1:500 
GST Mouse Sigma 1:1000 
Goat IgG Invitrogen 1:40,000 
Mouse IgG Sigma 1:5000 
Rabbit IgG Sigma 1:10,000 
Table 2.3 Antibodies used in Western Blotting and Immunoprecipitation 
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Name Species Tag Vector Resistance Origin 
GFP pCSGFP3 Ampicillin 
LgL X Laevis GFP pCSGFP Ampicillin 
PKC X Laevis pCS2 Ampicillin 
PKC A120E Human His pCDNA3.1 Ampicillin 
P. Salas (Wald et al., 
2008) 
Scribble Human GFP pEGFP-C1 Kanamycin I. Macara (Qin et al., 2005) 
Pals1 Mouse YFP pEYFP-C1 Kanamycin 
B. Margolis (Kamberov et 
al., 2000) 
Pals1 Mouse GST pDest15 Ampicillin 
Dlg Rat HA pCDNA3 Ampicillin 
L. Banks (Massimi et al., 
2006) 
Dlg Rat GST pDest15 Ampicillin 
Par-1b Human GST pGEX Ampicillin 
H. Piwinica-Worms (Hurov 
et al., 2004) 
mLgl Mouse GST pGEX Ampicillin 
T. Pawson (Plant et al., 
2003) 
Patj Human Myc pIRES Ampicillin 
A Le Bivic (Lemmers et al., 
2002) 
Yap Medaka His pSV281 Kanamycin S. Bagby (unpublished) 
Taz Medaka His pSV281 Kanamycin S. Bagby (unpublished) 
Yap Human Flag pCS2+ Ampicillin 
M. Furutani-Seiki 
(unpublished) 
LGN Mouse GST pGEX Ampicillin V. Slepak (Nair et al., 2005) 
GSK3β Human GST pGEX-6P-2 Ampicillin 
HK Paudel (Sun et al., 
2002) 
Table 2.4 Plasmids 
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Primer Sequence 
Dlg TOPO 
Forward 
CACC ATG AGC GGG GCA GGG CGG CGG ACA 
Dlg TOPO 
Reverse 
TAA TTT TTC TTT TGC TGG GAC CCA GAT GT 
Scribbles TOPO 
Forward 
CACC ATG CTC AAG TGC ATC CCG 
Scribbles TOPO 
Reverse 
GGA GGG CAC AGG GCC CAG GCC 
Patj TOPO 
Forward 
CAC CAT GCC TGA AAA TCC TGC 
Patj TOPO 
Reverse 
TTA CCG TTT CCC AAC GAT GC 
Pals-1 TOPO 
Forward 
CAC CAT GAC AAC ATC ATA TAT GAA TGG 
Pals-1 TOPO 
Reverse 
TCA CCT TAG CCA GGT GGA TGG 
Yap S54A 
Forward 
CATGAGGATGAGGAAGCTGCCGGACGCATTCTTCAAGCC 
CCCGGAGCCCAAGTC 
Yap S54A 
Reverse 
GACTTGGGCTCCGGGGGCTTGAAGAATGCGTCCGGCAGC 
TTCCTCATCCTCATG 
Taz S45A 
Forward 
CATGAGGATGAGGAAGCTGCCGGACGCATTCTTCAAGCC 
CCCGGAGCCCAAGTC 
Taz S45A 
Reverse 
GACTTGGGCTCCGGGGGCTTGAAGAATGCGTCCGGCAGC 
TTCCTCATCCTCATG 
Dlg S472A 
Forward 
CTT CAT CGT GGC GCA ACG GGA CTT GGT TTC 
Dlg S472A 
Reverse 
GAA ACC AAG TCC CGT TGC GCC ACG ATG AAG 
Dlg Sequencing 
primer 
GCC TTA AAG AAT ACA TCT G 
GST Sequencing 
Primer 
GGG CTG GCA AGC CAC GTT TGG TG 
Table 2.5 Primers used for TOPO® Cloning, SDM and Sequencing 
Construct Annealing Temperature 
°C 
Extension Time 
(minutes) 
Patj 52.3 4.5 
Scribble 59.0 5 
Pals-1 52.3 2 
Dlg 57.4 2.7 
Table 2.6 PCR Conditions 
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Gene Species Accession Number 
Lgl Mouse NM_145438 
Scribble Human NM_182706 
Pals-1 Mouse AF_199008 
Dlg Rat NM_021265 
Par1b Human NM_017490 
Patj Human NM_176877 
GSK3β Human NM_002093 
Yap Medaka 
Taz Medaka 
Yap Human NM_001130145 
Taz Human NM_000116 
Table 2.7 Accession Numbers for Genes used for the Phosphorylation Prediction 
Tools 
Cell Type Media 
MDCK DMEM (Lonza), 10% FCS, 2mM L-glutamine (Cambrex), 
pen/strep (100U/ml penicillin, 100g/ml streptomycin - Cambrex) 
Caco-2 DMEM, 20% FCS, 2mM L-glutamine, 1x Non-essential amino 
acids, pen/strep 
A549 DMEM, 10% FCS, 2mM L-Glutamine, pen/strep 
HeLa DMEM, 10% FCS, 2mM L-glutamine, pen/strep 
OVCAR-3 RPMI-1640, 20% FCS, 0.01mg/ml bovine insulin, pen/strep 
Table 2.8 Tissue Culture Media for Different Cell Types 
Antibody 
Specificity 
Species Supplier Cat. No. Starting 
Dilution 
Dilution 
(unless 
otherwise 
stated) 
C20 PKC Rabbit Santa cruz SC-21C 200μg/ml 1:100 
Phospho-PKC Rabbit Santa cruz SC-12894-R 200μg/ml 1:150 
PKC Mouse BD Transduction 610176 250μg/ml 1:100 
PKC Mouse Santa Cruz SC-17781 200μg/ml 1:100 
-tubulin Mouse Abcam Ab-11316 28mg/ml 1:1000 
Pericentrin Rabbit Covance PRB-432C 0.2mg/ml 1:500 
ZO-1 Mouse Zymed 339100 0.5μg/μl 1:25 
α-tubulin Rat Abcam Ab-6160 1mg/ml 1:100 
Flag Tag Mouse Sigma F-1804 1mg/ml 1:300 
Anti-Rabbit 488 Invitrogen A11008 2mg/ml 1:500 
Anti-Rabbit 568 Invitrogen A11011 2mg/ml 1:300 
Anti-Mouse 488 Invitrogen A11001 2mg/ml 1:500 
Anti-Mouse 568 Invitrogen A11004 2mg/ml 1:500 
Anti-Rat 488 Molecular probes A11006 2mg/ml 1:300 
Table 2.9 Antibodies used in Immunofluorescence 
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2.2 Methods 
2.2.1 RNA Manufacture 
The plasmid DNA template was linearised using the appropriate enzyme in the 
correct buffer according to the guidelines set out by Roche (see table 2.2 for the list of 
enzymes). RNA was made using this template and the mMessage Machine kit according to 
the manufacturer’s instructions (Ambion). This kit utilises an RNA polymerase (Sp6 or 
T7) to make the RNA. RNA was quantified using a Genequant machine (GE Healthcare) 
and also run out on a 1% agarose gel in a Mupid-EXu electrophoresis tank, to check the 
integrity of the RNA. 
2.2.2 Fertilisation of Xenopus laevis Eggs 
Male X. laevis (Xenopus) were killed by a schedule 1 method using benzocaine. 
Testes were harvested from the freshly killed male and used immediately, or stored for up 
to 5 days in L-15 medium (Sigma) at 4°C. Female Xenopus were injected with 50units of 
Pregnant Mare Serum Gonadotrophin (PMSG - Intervet®) 3 days prior to egg collection 
and with 500units of chorionic gonadotrophin (hCG - Intervet®) 12 hours prior to egg 
collection. The female Xenopus were put into 1x MMR (Marcs Modified Ringers) to 
maintain the ability of the laid eggs to be fertilised and eggs were collected from this 
medium. The collected eggs were washed once with 0.1x MMR and fertilised with the 
harvested testes, in this procedure, a small piece of the testes, approximately 5mm wide 
was cut from a testis. It was placed into the dish containing the Xenopus eggs and then torn 
apart and wiped over the eggs. This was to release all of the sperm allowing fertilisation. 
The fertilised eggs were dejellied approximately 40mins post fertilisation, 2.5% (w/v) 
cysteine was added to the fertilised eggs and left for 2-3mins until the jelly could be seen 
to have been removed. The eggs were then washed 4 times with 0.1x MMR. 
2.2.3 Microinjection of RNA and Protein Extraction 
Glass capillary tubes (0.53” width, Drummond Scientific) were pulled using a 
Sutter P-97 needle puller. RNA microinjection was carried out using a Drummond micro-
injector, RNA volume and concentration as stated. Embryos were injected into one cell at 
the 2-cell stage and then incubated at 14°C overnight until they reached approximately 
stage 9. Embryos were staged by cell number or as described previously (Nieuwkoop and 
Faber, 1967). The embryos were examined using a Leica M26 (Deerfieled, Illinois) and 
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any dead embryos removed. The remaining embryos were snap frozen, in batches of 50, on 
dry ice. 
The frozen embryos were resuspended in 500µl of 1xPBS, then 500µl of Freon 
1,1,2-trichlorotrifluoroethane (Riedel-de Haën) was added and the mixture vortexed. The 
mix was then centrifuged at 13.2K rpm at 4°C for 10 minutes and the supernatant retained. 
The supernatant was either used immediately in a Western blot or immunoprecipitation or 
was stored at 4°C for 2-3days or at -20°C for longer than 3 days. 
2.2.4 Immunoprecipitation 
Dried Protein-A sepharose beads (Amersham) were prepared by immersion in 
dH2O followed by two washes in dH2O and then three washes in IP buffer by low speed 
centrifugation. The beads were centrifuged, the supernatant removed and discarded. Fresh 
buffer was then added and the centrifugation repeated. A pre-clearing reaction was set up 
comprising of 10µl lamb’s serum, 50µl beads and the Freon extracted embryo mixture. A 
coupling reaction was also set up which comprised of 50µl beads, 500µl IP buffer and the 
primary anti-GFP antibody as stated. Both reactions were incubated at 4°C with rotation 
for 2hours. After the incubation time for both preparations the coupling reaction was 
washed three times with IP buffer by low speed centrifugation and resuspension, to remove 
any unbound antibody. The pre-clearing reaction was centrifuged and the supernatant 
added to the washed coupling beads. This preparation was incubated overnight at 4°C with 
rotation. Following the overnight incubation the beads were washed with PBS using low 
speed centrifugation. See table 2.3 for the antibodies used. 
2.2.5 SDS-PAGE and Western Blotting 
The Western blotting apparatus was a Bio-Rad Mini-protean II. The SDS-PAGE 
gels were 10% gels, unless otherwise stated. Prior to loading 4X sample buffer was added 
to the protein sample and boiled for 5 minutes. Approximately 40µg of protein was added 
to each well. On each gel a protein ladder (Fermentas) was run in one lane. The gels were 
run in electrophoresis buffer at 100V until the protein had reached the separating gel and 
then at 150V until the proteins were separated sufficiently, as determined by the separation 
of the bands on the protein ladder. 
The gel was equilibrated in blotting buffer along with nitrocellulose membrane 
(Whatman), filter paper and fibre pads. The blotting cassette was assembled and bubbles 
removed by rolling with a glass tube. The blot was run at 100V for 1 hour. The 
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nitrocellulose membrane was then removed and Ponceau (Sigma) stained to show the 
transferred protein. The nitrocellulose membrane was rocked in 10% blocking buffer for 1 
hour at room temperature, followed by the primary antibody diluted in 10% blocking 
buffer and rocked overnight at 4°C. The membrane was washed in 2% blocking buffer in 
PBS 5 times. The secondary antibody was then added, diluted in 2% blocking buffer in 
PBS, and rocked for 2 hours at room temperature. The membrane was then washed 5 times 
in  PBS plus Tween 20 (PBST) followed by addition of ECL reagent (Chemiglow® -
Alpha Innotech or ChemiLucent™ -Millipore) to detect horseradish peroxidase (HRP) 
conjugated secondary antibodies. The membrane was then exposed to film (Hyperfilm, 
Amersham) in the dark for 1-10 minutes and developed using a Protec Optimax film 
processor. The film was scanned with a HP Scanjet G2410 (Hewlett Packard, Berkshire, 
UK). To create a digital image of the Western blot. See table 2.3 for the antibodies used. 
Membrane stripping of the antibodies was carried out using an IgG elution buffer 
(Pierce) for 2 hours at room temperature or overnight at 4°C. The membrane was washed 5 
times with Tris buffered saline plus Tween 20 (TBST) and then blocked as above and the 
second antibody of interest added, in the same way as the first. 
2.2.6 Site-directed Mutagenesis 
Site-directed mutagenesis was carried out using the Stratagene QuikChange® 
mutagenesis kit. Briefly primers were designed to contain the correct mutation (see table 
2.5 for further information) PCR was then carried out according to the manufacturer’s 
instructions. The template DNA was digested using the Dpn1 enzyme and transformed into 
XL1-Blue supercompetent cells and allowed to grow on antibiotic containing LB agar 
plates overnight at 37C. one to four colonies were selected, grown up overnight at 37C 
with shaking in antibiotic containing LB broth and then mini-prepped the following day 
and sent for sequencing. 
2.2.7 Preparation of Glutathione-S-transferase (GST)-tagged DNA Constructs 
GST tagged Par-1, GSK-3 and LGN were kindly donated by H. Piwinica-Worms, 
HK. Paudel and V. Slepak respectively. Dlg, Pals-1 and Rassf7 GST-tagged constructs 
were made using the Gateway® Cloning kit (Stratagene). The DNA was amplified using 
primers specific to the gene of interest (see table 2.6) with CACC added to the forward 
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primer, the PCR annealing and extension conditions varied between reactions and are 
listed in table 2.6. The general PCR conditions are listed below. 
1. 2 minutes at 95°C 
2. 20 Seconds at 95°C 
3. 30 Seconds at the annealing temperature 
4. X minutes at 72°C depending on the extension time 
5. Repeat steps 2- 4, 29 times 
6. 10 minutes at 72°C 
The integrity of the PCR was checked by running on a DNA gel. The TOPO® 
Cloning reaction was carried out according to the manufacturers instructions to create the 
TOPO® entry vector which was transformed into bacteria. A single bacterial colony was 
picked and grown up in 5ml Luria Bertani (LB) broth overnight at 37°C with shaking. This 
culture was mini-prepped (Sigma) to harvest the DNA. The amplified DNA was digested 
with the restriction enzyme BSRG1 attL1 and attL2 sites and there fore will excise the 
gene and allow conformation that it is present when the mix is run on a gel. The DNA 
which showed correct excision was sequenced (MWG operon). The TOPO® entry vector 
containing our gene of interest was then cloned into the destination vector pDEST™15 
Vector using the Gateway® LR Clonase™ Enzyme Mix according to the manufacturers 
instructions. The product was mini-prepped, run on a gel and then sequenced using the 
GST primer (see table 2.5). 
2.2.8 Transformation of E.coli 
E.coli were transformed with the appropriate plasmid using the heat shock method. 
The bacteria were defrosted on ice; approximately 10ng of plasmid DNA was added and 
allowed to bind to the outside of the bacteria, whilst on ice, for 30 minutes. The bacteria 
were then heat shocked at 42°C for 45 seconds and then put onto ice for 2 minutes. Warm 
LB broth (containing no antibiotic) was added to the mix at this stage and the bacteria are 
allowed to grow at 37°C and express the plasmid’s antibiotic resistance for at least 1 hour. 
The mix is then spread onto an LB agar plate containing the appropriate antibiotic and 
allowed to grow at 37°C overnight. 
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2.2.9 Expression of GST Fusion Proteins 
Par-1, Lgl and GSK-3 were in the pGEX-2T vector and were expressed in the 
BL21 strain of E.coli (gift from Dr. Paul Whitley), this strain uses isopropyl-1-thio-β-D-
galactopyranoside (IPTG) (Sigma) as the inducing agent. All other constructs were 
expressed in the BL21-A1 (Invitrogen) strain of E.coli, this strain uses L-arabinose 
(Sigma) as the inducing agent. 
Synthesis of the fusion protein was induced in the log phase of the 500ml bacterial 
cultures with 0.1 mM IPTG or 0.2% L-arabinose, diluted in dH2O, for three hours with 
shaking at 37C. Log phase was determined when the culture had an optical density of 0.5 
to 1 by taking a spectrophotometer reading at 600nm on a Helios Spectrophotometer 
(Unicam, Leeds, UK). 1ml samples were taken before and three hours after addition of the 
inducing agent. The cells were then pelleted and resuspended in 20ml PBS lysis buffer. 
The lysate was then sonificated for 3 30second bursts in a 150PW ultrasonic disintegrating 
(MSE Scientific Instruments, London, UK) and the lysate cleared by centrifugation at 
13200rpm for 20 minutes at 4°C. Glutathione-sepharose beads (Amersham) were washed 
in PBS lysis buffer and added to the supernatant to bind the GST fusion protein. The 
mixture was incubated with rotation for thirty minutes at 4C. The beads were then washed 
4 times with PBS containing protease inhibitors (Sigma) then poured into a disposable 
chromatography column (Quiagen). The fusion protein was eluted using cold 50mM Tris 
pH 8.0 (Fisher) containing 20mM reduced glutathione (Sigma). The reduced glutathione 
was removed using dialysis against PBS through a 3.5K molecular weight cut off 
SnakeSkin dialysis tubing (Pierce). The absorbance of the protein was then measured on a 
spectrophotometer and the concentration determined using the extinction coefficient. The 
concentration was adjusted to 1mg/ml where possible. The purified protein was stored at 
4C. 
The protein expression was analysed by SDS-PAGE followed by staining with 
Coomassie for one hour and then destaining for sixteen hours. The gel was then scanned. 
2.2.10 Kinase Assay 
100ng of purified recombinant GST-tagged PKC (Calbiochem) was mixed with 
10g of the fusion protein in kinase assay buffer along with 10-15Ci of 32P-labelled -
ATP (Perkin Elmer). The reactions were run at 30C for 30 minutes and then quenched 
with 4x sample buffer containing 5mM EDTA. 
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The reaction products were run on an SDS-PAGE gel (percentage composition 
varied depending on protein size) and analysed using autoradiography onto Amersham™ 
Hyperfilm™. The film was developed as before and digitally scanned. 
2.2.11 Bioinformatics 
DNA sequences were obtained from NCBI and the accession numbers are listed in 
table 2.7. The domain analysis was carried out using the simple modular architecture 
research tool (SMART). www.smart.embl-heidelberg.de. The phosphorylation prediction 
was carried out using scansite, www.scansite.mit.edu/motifscan.seq.phtml, PhosphoELM 
(http://phospho.elm.eu.org/), NetPhos (http://www.cbs.dtu.dk/services/NetPhos/) and 
Human protein Reference Database HPRD (http://www.hprd.org/). 
2.2.12 Cell Culture 
Cells in DMSO freezing media were revived from liquid nitrogen and allowed to 
grow at 37C with 5% carbon dioxide in growth media (see table 2.8 for different cell 
type’s growth medium). When cells reached near confluency they were passaged into 
experimental or maintenance, T25 flasks or 4 well plates (Iwaki). Passaging was carried 
out using 5ml trypsin (Lonza) to detach the cells from the flask. Cells were passaged at 
least twice following revival from liquid nitrogen and not more than 20 times for 
experimental use. 
2.2.13 Immunofluorescence 
Cells were plated onto coverslips (Fisher) in 4 well plates and left for two nights in 
growth media to adhere and make junctions. They were then washed twice with warm PBS 
then fixed using 4% Paraformaldehyde (PFA) and permeabilised using methanol cooled to 
-20C. Cells were then blocked with 10% foetal calf serum (FCS - Sigma) diluted in PBS 
followed by washing with 2% FCS and PBS. Primary antibodies, diluted in 2% FCS were 
incubated with the cells for at least 2 hours followed by extensive washing with 2% FCS 
and PBS. Secondary antibodies and the nuclear stain TOPRO-3 were incubated in the same 
manner except for the timing, which was reduced to at least 30 minutes followed by 
extensive washing as above. Cells were mounted onto coverslips using Mowiol and 
allowed to set at room temperature overnight. The antibodies used are listed in table 2.9. 
Imaging was carried out using a Zeiss LSM510 confocal microscope and images 
were processed using the Zeiss LSM image browser software (Thornwood, NY). 
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2.2.14 Transfection 
Transfection of MDCK cells in four well plates, plated 1/8 from confluency the day 
before, in growth media was carried out using Lipofectamine™ LTX (Invitrogen). 50l of 
DMEM with L-glutamine was added to 2g of DNA in one eppendorf and 50l of DMEM 
with L-glutamine was added to 8l of Lipofectamine™ LTX. The mixtures were incubated 
for 5 minutes and then combined and incubated for a further 20minutes. The cells were 
washed and the media changed to antibiotic free media. The mixture was then added to the 
cells in a drop wise fashion and gently mixed then left for at least 16 hours. The cells were 
then visualised using IF and the confocal microscope. 
2.2.15 Nocodazole Treatment 
Cells were plated onto coverslips allowed to stick for 24hrs and then the media was 
replaced by fresh media. 0.33M of Nocodazole was diluted in dimethyl sulfoxide 
(DMSO) and water and then added to the cells in a drop wise fashion. DMSO alone was 
used as a control. The cells were incubated for 4 hours and then fixed and stained as 
described previously. 
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Chapter 3 
Subcellular Localisation of Endogenous PKC and PKCζ 
3.1 Introduction 
There are a number of commercial PKC and PKCζ antibodies that can be used to 
look at the localisation of PKC and PKCζ. Many of them are raised against the C-terminal 
region of PKC/ζ proteins. This region is almost identical in the two proteins (Nakaya et 
al., 2000), so it is very likely that the antibodies will recognise both isoforms of PKC even 
if they specify one isoform, for example Santa Cruz produce a C20 PKC/ζ antibody that 
recognises both isoforms. There are antibodies available that are specific for each isoform 
however, for example BD Transduction produce a PKC antibody and Santa Cruz produce 
a PKCζ one. Finally there is an antibody available against a phosphorylated form of 
PKC/ζ, which is believed to be the active form (Akimoto et al., 1994). Throughout this 
report PKC/ζ will be used to describe staining that does not differentiate between the two 
isoforms and PKC or PKCζ, specifically when they do.
 The range of different antibodies means that although a number of sites of 
localisation have been described, the literature on PKC/ζ localisation is complicated and 
often incomplete. The aim of this chapter is to describe the localisation of PKC and PKCζ 
in MDCK cells which are commonly used to study cell polarity. 
3.1.1 PKC and PKCζ Localise Apically in Embryos 
The best characterised localisations of PKC/ζ are apically and at the tight 
junctions. In C elegans, there is only one PKC, PKC-3 and this localises apically in 
epithelial cells (Totong et al., 2007) including the gut epithelium (Bossinger et al., 2001). 
In Drosophila embryos, DaPKC localises apically in early epithelial development (Harris 
and Peifer, 2005; Sotillos et al., 2004). In Drosophila pupae dorsal thorax, DaPKC 
localises apically and at cell junctions (Georgiou et al., 2008). DaPKC also localises 
apically in the Drosophila ectodermal epithelium (Kim et al., 2009) and apically in 
neuroblasts (Atwood and Prehoda, 2009; Chabu and Doe, 2008; Krahn et al., 2010). In the 
developing Zebrafish embryo, PKC/ζ localise apically in the oesophagus, intestine and 
retinal neuroepithelium, but only PKC localises to the apical membrane in the Zebrafish 
swimbladder (Horne-Badovinac et al., 2001). In Xenopus embryos, PKC/ζ localises 
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apically (Chalmers et al., 2005; Chalmers, 2003). In Xenopus kidney epithelial A6 cells, 
PKC/ζ localises apically with some cytoplasmic staining (Nakaya et al., 2000). In chick 
embryos, PKC/ζ and active phospho-PKC/ζ localise to the apical luminal margin of the 
neuroepithelium (Ghosh et al., 2008). 
In mouse embroid bodies, PKCλ/ζ and active phospho-PKC/ζ localise to the 
apical membrane (Krishnamurthy et al., 2007) and in the mouse blastocyst PKCλ/ζ 
localises to the apical membrane of the epithelial trophectoderm (Eckert et al., 2005) and 
during preimplantation development, PKCλ/ζ becomes progressively apically and tight 
junctionally localised (Pauken and Capco, 2000; Plusa et al., 2005). During mouse 
embryogenesis, PKCλ is also found at the apical edge of the embryonic retina (Koike et al., 
2005). PKCλ/ζ is found at the apical junctions of lens epithelial cells in mice; PKCλ/ζ 
remains apical during elongation of the cells, but is gradually lost as the cells differentiate 
(Sugiyama et al., 2009). A similar effect is seen during mouse cortical neurogenesis, in 
which PKCλ/ζ localises strongly at the ventricular zone at E12, however, the intensity of 
the staining at this region decreases during development (Costa et al., 2008). Therefore, 
PKC/ζ has a well documented apical localisation which suggests a role in regulating 
polarity in the developing embryo. 
3.1.2 PKC and PKCζ Localise Apically in Cultured Cells 
Kidney derived MDCK cells show apical and tight junction PKC/ζ localisation in 
2D culture (Izumi et al., 1998; Nunbhakdi-Craig et al., 2002) and in 3D culture (Kim et al., 
2007). PKC/ζ are also found at the leading edge of migrating MDCK cells (Shin et al., 
2007) and on the primary cilia of MDCK cells (Fan et al., 2004). 
In colon derived, Caco-2 cells, PKC/ζ are localised apically (Mashukova et al., 
2009; Michel et al., 2005; Wald et al., 2008). In mouse epithelial MTD1-A cells PKC/ζ 
also localises to the apical membrane and tight junctions (Suzuki et al., 2002), as it does in 
the human keratinocyte cell line HaCaT (Aono and Hirai, 2008). Therefore PKC/ζ has 
apical and tight junctional localisation in cultured epithelial cells, but it is not clear if it is 
PKC, PKCζ or both as most of the antibodies used recognise both isoforms. 
3.1.3 PKC and PKCζ Localise to the Nucleus 
In addition to the tight junction localisation, PKCζ has been shown to localise to the 
peri-nuclear and nuclear region of PC12 cells (Neri et al., 1999; Zhou et al., 1997) and to 
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the nucleus, in 786-O cells growing at a low cell density, (Pal et al., 1998). PKC/λ also 
localises to the nucleus and shuttles continuously in and out in HeLa cells (Perander et al., 
2001); this was shown by treating the cells with Leptomycin B, a nuclear export inhibitor. 
When treated with Leptomycin B, there was rapid nuclear accumulation of PKC/λ, but 
there is only a fraction of the total cellular PKC/ζ in the nucleus normally. The antibody 
used in this experiment recognises both PKC/λ and PKCζ. Consistent with this, both 
PKCζ and PKC have nuclear localisation signals within their zinc finger region (Perander 
et al., 2001). White and colleagues showed that upon nerve growth factor stimulation, 
phosphorylation of tyrosine 256 in PKC occurs and that PKC accumulates in the nucleus 
of PC12 cells (White et al., 2002). They suggest that this tyrosine 256 phosphorylation 
exposes the nuclear localisation signal allowing PKC entry into the nucleus. Endogenous 
PKC/ζ has also been shown to localise to the nucleus in HeLa cells (Sabherwal et al., 
2009) and the authors suggest that PKC/ζ drives cell fate and proliferation in the nucleus 
of Xenopus embryos. Therefore nuclear proteins could be phosphorylation targets of 
PKC/ζ. 
3.1.4 PKC and PKCζ Localise to the Centrosomes during Mitosis 
It has previously been shown that PKCζ associated with the mitotic spindle in shark 
rectal gland and Chinese hamster ovary cells (Lehrich and Forrest, 1994). This work used 
an antibody described previously (Ono et al., 1989), which was raised against the C-
terminal region of PKCζ. However, this antibody was made before PKC was described 
and may therefore recognise both isoforms. The PKC isoform is not mentioned. 
More recently, Liu and colleagues showed PKC/ζ staining at the mitotic spindle in 
HeLa cells and phospho-PKC/ζ staining at the centrosomes in metaphase, but not 
anaphase or telophase. They also showed strong staining for both PKC/ζ and phospho-
PKC/ζ at the midbody in telophase (Liu et al., 2006). In their paper the antibody used for 
PKC/ζ is the same as the one used in this work for total atypical PKC/ζ and recognises 
both forms of atypical PKC, so the staining seen is for both isoforms. The phospho-PKCζ 
antibody is different to the one used in this work, but recognises both isoforms of atypical 
phospho-PKC/ζ. 
PKC/ζ is found at the centrosomes, colocalising with γ-tubulin in dorsal root 
ganglion neurones and granule neurones from mice (Mori et al., 2009; Solecki et al., 
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2004). Active phospho-PKC/ζ was also found at the centrosomes in the dorsal root 
ganglion neurones, but was not tested for in the granule neurones. 
Page Baluch and colleagues show PKCζ staining at the meiotic spindle in fertilised 
mouse eggs is meiosis II (Baluch and Capco, 2008; Page Baluch et al., 2004). The 
antibody used is the total atypical PKC antibody, which binds both PKC and PKCζ, 
therefore one or both of them are found at the meiotic spindle. In mouse meiosis I, 
phosphorylated PKCζ is found at the centrosomes (Na and Zernicka-Goetz, 2006). The 
antibody they used is no longer available, so whether it recognises iota and zeta is 
unknown. This suggests that PKC/ζ may have a role in meiosis and mitosis and that 
centrosomal proteins can be considered PKC candidate phosphorylation targets. 
3.2 Aims 
The current published PKC and PKCζ localisation data is widely detailed when it 
comes to tight junctions, but little has been published about the nuclear and centrosomal 
localisation of the two isoforms. There has been no data published indicating PKC/ζ at the 
centrosomes of MDCK cells, our model system. The aim of this chapter is to describe the 
localisation of total PKC/ζ, PKC, PKCζ as well as the active phospho-PKC/ζ within 
MDCK cells during all stages of the cell cycle. MDCK cells are being used as they are a 
well established polarised cell line that are relatively simple to image. 
3.3 Results 
To document the cellular localisation of PKC/ζ, antibodies for active phospho-
PKC/ζ, total PKC/ζ and PKC and PKCζ were purchased from commercial sources and 
the specificity of the PKC and PKCζ antibodies was tested using overexpressed PKC or 
PKCζ protein by our collaborators (Cancer Research Technologies). The antibodies only 
detected either PKC or PKCζ and did not cross-react. 
3.3.1 PKC and PKCζ Localise to the Tight Junctions in MDCK Cells 
The total PKC/ζ and phospho-PKC/ζ data in figure 3.1a and b confirm the 
published data (see section 3.1.2) that total and phospho-PKC/ζ localises to the tight 
junctions in MDCK cells. The results in figure 3.1 c and d, clearly show that the PKC/ζ 
antibodies bind the atypical or  and ζ isoforms directly and that they also localise to the 
58 
tight junctions. This confirms that both proteins localise to the tight junctions in MDCK 
cells. 
a Active P-PKC / ZO-1 / TOPRO-3 b Total-PKCι/ζ / ZO-1 / TOPRO-3 
c PKC Zeta / TOPRO-3 d PKC Iota / TOPRO-3 
Figure 3.1 PKC and PKCζ Localise to Tight Junctions in MDCK Cells 
Confluent MDCK cells were PFA fixed, stained with PKC/ζ (green) and ZO-1 (red) 
antibodies and imaged using confocal microscopy. The nucleus was stained with TOPRO-
3 (blue). Arrows indicate tight junctions. 
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(a) Active phospho-PKC/ζ colocalises with the tight junction marker ZO-1, (b) Total 
PKC/ζ colocalises with the tight junction marker ZO-1, (c) PKCζ localises at the same 
position as the phospho-PKC/ζ and total PKC/ζ antibodies, (d) PKC localises at the 
same position as the phospho-PKC/ζ and total PKC/ζ antibodies. 
3.3.2 Nuclear Localisation of PKC and PKCζ in MDCK Cells 
Previous research has indicated that PKC/ζ localises to the nucleus (see section 
3.1.3), but none of these studies have been undertaken in MDCK cells. To establish if 
MDCK cells had nuclear PKC or PKCζ, the MDCK cells were stained for each of the 
PKC/ζ antibodies and γ-tubulin. No clear nuclear localisation could be seen with any of 
the PKC/ζ antibodies (figure 3.2). There was also possible nuclear exclusion seen with the 
total PKC/ζ and phospho-PKC/ζ, but this was not clearly seen with the PKC and PKCζ 
antibodies. 
3.3.3 PKC and PKCζ Localisation Alters Dramatically during the Cell Cycle 
PKC/ζ has previously been shown to be on the mitotic apparatus in a few 
different cell types (see section 3.1.4). However, it has not been shown for MDCK cells so 
it was decided to stain MDCK cells during different stages of the cell cycle to clarify 
where, PKC, PKCζ and active phospho-PKC/ζ localise. A schematic diagram of the cell 
cycle is pictured in figure 3.2 to provide a visual representation of the cell cycle. 
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Figure 3.2 The Cell Cycle 
A schematic diagram of the cell cycle obtained from ‘Cell Biology’ 
www2.mbusd.org/staff/pware/cells on 16/01/11 
In the following images (figures 3.3-3.7) the PKC/ζ antibodies stain the tight 
junctions as in figure 3.1, but in many cases the tight junctions cannot be seen as the focal 
plane is at the level of the centrosomes not the tight junctions. 
During interphase and prophase all the PKC/ζ antibodies are localised throughout 
the cell including cytoplasm and were enriched at the tight junctions (figure 3.3 yellow 
arrows indicate interphase centrosomes and white arrows indicate prophase centrosomes. 
Data not shown for tight junctions). 
At metaphase the localisation of PKC and PKCζ changes dramatically (figure 3.4); 
active phospho-PKC/ζ staining is stronger and can be seen on the centrosomes from 
prometaphase onwards (figure 3.4a). The total PKC/ζ at metaphase has staining on the 
spindle microtubules and a small amount of staining on the centrosomes (figure 3.4b), 
however the total cell staining is not as bright as the phospho-PKC/ζ. The PKCζ staining 
does not locate directly to the centrosomes (figure 3.4c); however the antibody does stain 
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Phospho-PKCι/ζ γ-tubulin DNA merge a 
Total-PKCι/ζ γ-tubulin DNA merge b 
PKC Zeta pericentrin DNA merge c 
PKC Iota pericentrin DNA merge d 
Figure 3.3 PKC/ζ Localisation during Interphase and Prophase 
MDCK cells stained with PKC/ζ antibodies (green), and γ-tubulin (phospho-PKC/ζ and 
total PKC/ζ) or pericentrin (PKC and PKCζ) to show the centrosomes (red). The nucleus 
was stained with TOPRO-3 (blue). Cells were visualised using confocal microscopy. 
Yellow arrows indicate interphase centrosomes and white arrows indicate prophase 
centrosomes. 
At interphase and prophase there is no nuclear enrichment of PKC or PKCζ. There may be 
some nuclear exclusion of total  PKC/ζ. 
(a) Active phospho-PKC/ζ, (b) Total PKC/ζ, (c) PKCζ, (d) PKC 
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PKC Iota pericentrin DNA merge d 
Figure 3.4 PKC/ζ Localisation during Metaphase 
MDCK cells stained with PKC/ζ antibodies (green), and γ-tubulin (phospho-PKC/ζ and 
total PKC/ζ) or pericentrin (PKC and PKCζ) to show the centrosomes (red). The nucleus 
was stained with TOPRO-3 (blue). Cells were visualised using confocal microscopy. 
(a) Phospho-PKC/ζ staining is bright with a concentration on the centrosomes and spindle 
microtubules, (b) Total PKC/ζ staining is found on the spindle microtubules, (c) PKCζ 
staining is found on the spindle microtubules, (d) PKC staining is found on the 
centrosome and mitotic spindle. 
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the spindle microtubules. There is PKC staining at the centrosomes indicating that PKC 
locates to the centrosomes and combined with the phospho-PKC/ζ staining, is 
phosphorylated there (figure 3.4d). All the antibodies stain the mitotic spindle. Therefore, 
PKC and PKCζ are found on the spindle microtubules and active phosphorylated PKC on 
the centrosomes. 
During anaphase, the active phospho-PKC/ζ can still clearly be seen at the 
centrosomes and is now on the midbody microtubules (figure 3.5a). The total PKC/ζ 
antibody stains the midbody microtubules, but little staining is seen on the centrosomes 
(figure 3.5b). The PKCζ antibody shows strong midbody microtubule staining (figure 
3.5c). The PKC staining becomes much weaker, in comparison to the metaphase staining, 
although it is still brighter than the staining in the cells surrounding it which are not 
dividing, however there is not clear spindle or centrosomal staining (figure 3.5d). 
During telophase, active phospho-PKC/ζ retains its binding to the midbody 
microtubules and the centrosomes (figure 3.6a). The total PKC/ζ antibody shows midbody 
microtubule staining (figure 3.5b). The PKCζ antibodies also show midbody microtubule 
staining (figure 3.6c). The PKC staining returns to basal levels during telophase with no 
staining on the mitotic apparatus (figure 3.6d). So PKC/ζ is still active at the centrosomes 
at telophase, however, it is difficult to tell which of the two isoforms it is due to neither of 
the antibodies showing clear centrosomal staining. 
To summarise, active phosphorylated PKC/ζ is found at the centrosomes and 
spindle/midbody microtubules throughout metaphase, anaphase and telophase. From the 
metaphase staining it appears to be PKC on the centrosomes, however, no staining for 
PKC can be found on the centrosomes later on in mitosis. PKCζ locates to the spindle 
microtubules during metaphase and on the midbody microtubules later on in mitosis and 
could be phosphorylated at the centrosome. Therefore PKC and PKCζ may both have a 
role in regulating mitosis and could have centrosomal phosphorylation targets. 
64 
c 
Phospho-PKCι/ζ γ-tubulin DNA merge a 
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pericentrin PKC Iota merge DNA d 
Figure 3.5 PKC/ζ Localisation during Anaphase 
MDCK cells stained with PKC/ζ antibodies (green), and γ-tubulin (phospho-PKC/ζ and 
total PKC/ζ) or pericentrin (PKC and PKCζ) to show the centrosomes (red). The nucleus 
was stained with TOPRO-3 (blue). Cells were visualised using confocal microscopy. 
(a) Phospho-PKC/ζ staining is bright with a concentration on the centrosomes, spindle and 
midbody microtubules, (b) Total PKC/ζ staining is found on the spindle and midbody 
microtubules, (c) PKCζ staining is found on the spindle and midbody microtubules, 
(d) PKC staining is much weaker and stains no particular part of the mitotic apparatus, but 
is brighter in the cell in anaphase than the cells surrounding it. 
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Total-PKCι/ζ γ-tubulin DNA merge b 
PKC Zeta pericentrin DNA merge c 
PKC Iota pericentrin DNA merge d 
Figure 3.6 PKC/ζ Localisation during Telophase 
MDCK cells stained with PKC/ζ antibodies (green), and γ-tubulin (phospho-PKC/ζ and 
total PKC/ζ) or pericentrin (PKC and PKCζ) to show the centrosomes (red). The nucleus 
was stained with TOPRO-3 (blue). Cells were visualised using confocal microscopy. 
(a) Phospho-PKC/ζ staining is bright with a concentration on the centrosomes, spindle and 
midbody microtubules, (b) Total PKC/ζ staining is found on the midbody microtubules, 
(c) PKCζ staining is found on the midbody microtubules, (d) PKC staining is back to 
basal levels with no staining on the mitotic apparatus. 
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3.3.4 PKC and PKCζ Localisation during Metaphase in Caco2 Cells 
To ensure that the mitotic staining that had been seen was not an artefact of MDCK 
cells, the human colorectal adenocarcinoma epithelial cell line, Caco2 was stained in the 
same way as the MDCK cells (figure 3.7). The staining at metaphase was almost identical 
to the MDCK staining in figure 3.5, however, The PKC and PKCζ staining was a lot 
stronger at the centrosomes of Caco2 cells than on the centrosomes of MDCK cells. The 
active phospho-PKC/ζ antibody strongly stained the centrosomes and spindle 
microtubules (figure 3.7a). The total PKC/ζ antibody stains the spindle microtubules, but 
there is no clear centrosomal staining (figure 3.7b). The PKCζ antibody localises to the 
centrosomes and the spindle microtubules (figure 3.7c). The PKC antibody stains the 
centrosomes very strongly with weaker staining on the spindle microtubules (figure 3.7c). 
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Total-PKCι/ζ γ-tubulin DNA merge b 
PKC Zeta pericentrin DNA merge c 
PKC Iota pericentrin DNA merge d 
Figure 3.7 PKC Localisation during Metaphase in Caco2 Cells 
Caco2 cells stained with PKC/ζ antibodies (green) and γ-tubulin (phospho-PKC/ζ and 
total PKC/ζ) or pericentrin (PKC and PKCζ) to show the centrosomes (red). Nucleus 
stained with TOPRO-3 (blue). Cells were visualised using confocal microscopy. 
(a) Active phospho-PKC/ζ staining can be seen on the spindle microtubules and the 
centrosomes, (b) Total atypical PKC/ζ staining can be seen on the spindle microtubules, 
(c) PKCζ staining can be seen on the spindle microtubules and the centrosomes, 
(d) PKC staining can be seen on the spindle microtubules and the centrosomes. 
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3.3.5 Active Phosphorylated PKC/ζ is found at the Centrosomes in Metaphase in 
other Human Cell Lines 
The mitotic data from MDCK and Caco2 cells suggests that the localisation of 
PKC/ζ to the mitotic apparatus may be found in many different types of epithelial cells. 
To confirm the hypothesis the active phosphorylated PKC/ζ antibody was used. Ovcar-3, 
the human ovarian carcinoma cell line, HeLa, the human epithelial cervical cancer cell line 
and the A549 adenocarcinomic human alveolar basal epithelial cell line were stained for 
active phospho-PKC/ζ (figure 3.8). The cell lines all showed strong centrosomal staining 
with the A549 cells having particularly clear centrosomal staining. The Ovcar-3 and HeLa 
cells also had spindle microtubule staining, but the A549 cells did not. This confirms that 
phosphorylated PKC/ζ is found on the spindle and centrosome in a wide range of 
epithelial cells. 
3.3.6 Phosphorylation of PKC and PKCζ is Increased during Mitosis 
The immunofluorescence data in figures 3.4 to 3.7 predicts that phospho-PKC/ζ 
and perhaps the individual PKC and PKCζ proteins are upregulated during mitosis. To 
confirm if the PKC and/or PKCζ proteins or the phosphorylation was being up-regulated 
during mitosis, cells were treated with Nocodazole to produce large numbers of mitotic 
cells (Zieve et al., 1980) by depolymerising microtubules and causing the cells to arrest in 
mitosis. DMSO was used as a control because Nocodazole is dissolved in DMSO. The 
Nocodazole and DMSO treated cells were stained for active phospho-PKC/ζ and γ-tubulin 
to act as a positive control and confirm the increase in mitotic cells (figure 3.9 a and b). 
The Nocodazole and DMSO treated cells were lysed and subjected to Western 
blotting with each PKC/ζ antibody type and α-tubulin as a loading control (figure 3.9 c). 
The antibodies for total PKC/ζ, PKC and PKCζ show similar amounts of protein whether 
treated with Nocodazole or DMSO, so during mitosis the total amount of each atypical 
PKC isoform is kept constant. However, the active phospho-PKC/ζ antibody showed up-
regulation when treated with Nocodazole in comparison to DMSO. Therefore, the 
phosphorylation of either or both atypical PKC isoforms increases during mitosis, but the 
actual amount of protein is kept at similar levels. This suggests that the activity of PKC/ζ 
is increased during mitosis. 
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Ovcar-3 
Phospho-PKCι/ζ γ-tubulin DNA merge a 
HeLa 
Phospho-PKCι/ζ γ-tubulin DNA merge b 
A549 
Phospho-PKCι/ζ γ-tubulin DNA merge c 
Figure 3.8 Active Phosphorylated PKC/ζ is found at the Centrosomes in Diverse 
Epithelial Human Cell Lines 
Cell lines were stained with active phospho-PKC/ζ antibody (green) and γ-tubulin to show 
the centrosomes (red). The nucleus was stained with TOPRO-3 (blue). Cells were imaged 
using confocal microscopy. 
(a) Ovcar-3 cells show strong centrosomal and spindle microtubule phospho-PKC/ζ 
staining, (b) HeLa cells show strong centrosomal and spindle microtubule phospho-PKC/ζ 
staining, (c) A549 cells show strong centrosomal but little spindle microtubule phospho-
PKC/ζ staining. 
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Figure 3.9 Active Phosphorylated PKC/ζ is Upregulated during Mitosis 
MDCK cells were treated with Nocodazole or DMSO and stained with active phospho-
PKC/ζ antibodies (green) and γ-tubulin to show the centrosomes (red). Nucleus stained 
with TOPRO-3 (blue). Cells were visualised using confocal microscopy. Cell lysates from 
the Nocodazole and DMSO treated cells were subjected to Western blotting using the PKC 
antibodies and α-tubulin as a control. This experiment was repeated three times. 
(a) Cells treated with Nocodazole show high numbers of mitotic cells, (b) Cells treated 
with DMSO show few cells in mitosis, (c) The cells were lysed and subjected to Western 
blotting using the PKC antibodies and α-tubulin loading as a control. 
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3.4 Discussion 
3.4.1 Tight Junction Localisation 
In figure 3.1 it has been shown that the atypical PKC antibodies localise to the tight 
junctions, confirming previous data (Izumi et al., 1998; Nunbhakdi-Craig et al., 2002). The 
PKCζ antibody (figure 3.1 c) seems to bind the tight junctions more than the PKC 
antibody as the PKC (figure 3.1 d) staining is less pronounced or specific for the tight 
junctions. This could suggest that there is more PKCζ at the tight junctions or that the 
PKCζ is a better antibody in MDCK cells than the PKC antibody. To test this more PKC 
and PKCζ specific antibodies could be tested, especially those that have been raised 
against canine PKC and PKCζ. 
3.4.2 Nuclear Localisation 
The nuclear localisation of PKC/ζ was also investigated (figure 3.3). No clear 
nuclear staining was visualised, however, this is in resting cells. PKC/ζ has been reported 
to shuttle in and out of the nucleus (Perander et al., 2001), so the amount of PKC or PKCζ 
in the nucleus at any one time could be quite small and difficult to detect. To determine if 
either atypical PKC isoform localises to the nucleus, the MDCK cells could be treated with 
Leptomycin B, which prevents nuclear export. PKC or PKCζ would then accumulate in 
the nucleus and would be easily visualised using antibody staining. 
3.4.3 Cell Cycle Localisation 
There are a number of results that can be inferred from figures 3.3-3.6, firstly, 
active phospho-PKC/ζ localises to the centrosomes, spindle and midbody microtubules 
during metaphase, anaphase and telophase. The total PKC/ζ localises to the spindle and 
midbody microtubules during metaphase, anaphase and telophase. PKCζ also localises to 
the spindle and midbody microtubules during metaphase, anaphase and telophase, but little 
staining is seen on the centrosomes. PKC localises to the centrosomes and spindle 
microtubules during metaphase, however, in anaphase and telophase the staining is 
reduced. The PKC staining is in contrast to the Caco2 staining, which shows clear PKC 
at the centrosomes (figure 3.7d). The PKCζ staining in the Caco2 cells is also more 
pronounced at the centrosomes of the Caco2 cells than the MDCK cells (figure 3.7c). This 
discrepancy could be due to the antibodies not being raised against canine PKC and 
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PKCζ. The PKC and PKCζ antibodies may much more readily bind human PKC/ζ than 
canine. To confirm this, a Western blot with the same amount of PKC/ζ protein, from 
different species, could be utilised to demonstrate whether there is weaker binding to the 
canine PKC/ζ than other species of PKC/ζ. Future work would also include obtaining an 
antibody, specific for PKC that does recognise the canine PKC and using it to confirm 
that PKC does localise to the centrosomes during mitosis. Another possibility is that there 
is actually more PKC/ζ at the centrosomes in Caco2 cells as Caco2 cells are a cancer 
derived cell line and PKC/ζ is upregulated during cancer. To determine if this is the case, 
the study could be extended to look in more cell lines derived from both cancer cells and 
normal cells to determine if there are any differences in the amount of PKC or PKCζ at 
the centrosomes. 
Liu and colleagues showed PKC/ζ staining at the mitotic spindle in HeLa cells and 
phospho-PKC/ζ staining at the centrosomes in metaphase, but not anaphase or telophase 
(Liu et al., 2006). The slight differences seen in the staining at the centrosomes in anaphase 
and telophase may be due to different antibodies being used. In their paper the antibody 
used for PKC/ζ is the same as the one used in this work for total PKC/ζ however, the 
phospho-PKC/ζ antibody is different to the one used in this work, but does recognise both 
isoforms of phospho-PKC/ζ. The phospho-PKC/ζ antibody may not bind phospho-
PKC/ζ as well at the one we used. To test this HeLa cells could be stained with the 
phospho-PKC/ζ antibody used in this work and the phospho-PKC/ζ antibody used by Liu 
and colleagues, through all stages of the cell cycle. If only the phospho-PKC/ζ antibody 
used in this work binds the mitotic apparatus throughout cell division, it would confirm 
that the differences in staining are due to the specificity of the antibodies. 
Localisation and Western blotting data suggest that both PKC and PKCζ are likely 
to be activated during mitosis. To determine which PKC/ζ isoform is activated, cells can 
be arrested in metaphase using Nocodazole and the phospho-PKC/ζ used to 
immunoprecipitate the active PKC/ζ. This could then be subjected to Western blotting 
with the PKC and PKCζ antibodies to see which one is more prevalent in mitosis. From 
the immunofluorescence data, especially the Caco2 images (figure 3.8) it would be 
expected that both are found at the centrosomes, but PKC may be more prevalent as it is 
much brighter in the Caco2 images. 
73 
Active phospho-PKC/ζ is found at the centrosomes in metaphase in a variety of 
epithelial cells (figure 3.8) which suggests a key role in mitosis; however in this study only 
epithelial cells have been tested. It will be interesting to test non-epithelial cell lines such a 
blood cells or fibroblasts to determine whether PKC/ζ is active at the centrosomes in all 
cells. 
In figure 3.9 it was shown that it is the threonine 410 (T410) activating 
phosphorylation of the atypical PKCs that is increased in mitosis, not the protein levels. 
Phosphorylation of PKC/ζ on T410 is autophosphorylation and indicates that PKC/ζ is 
active. PKC and PKCζ are therefore they are likely to be translocated to the centrosomes 
and spindle microtubules early on in mitosis and phosphorylated there. T410 
phosphorylation indicates active atypical PKC therefore they are active on the centrosomes 
and the spindle microtubules. Further work is required to elucidate what activates PKC at 
the centrosomes and spindle microtubules. Cdc42 activates PKC/ζ by releasing the 
inhibitory affect on PKC/ζ by Par-6 and Cdc42 is found near the centrosomes in MDCK 
cells (Rodriguez-Fraticelli et al., 2010), so it is likely that PKC/ζ is being activated by 
Cdc42 at the centrosomes. To test this Cdc42 can be knocked down and if no PKC/ζ 
autophosphorylation at the centrosomes occurs, then Cdc42 is responsible for the PKC/ζ 
activation at the centrosomes and spindle microtubules. 
PKC/ζ can cause the phosphorylation of GSK3β on serine 9, inactivating GSK3β 
(Etienne-Manneville and Hall, 2003a). GSK3β is also found on the centrosomes and 
spindle microtubules during mitosis (Bobinnec et al., 2006; Wakefield et al., 2003) and is 
inactive at the centrosomes at this time (Wakefield et al., 2003). It is plausible that PKC/ζ 
is responsible for the GSK3β phosphorylation and inactivation at the centrosomes. To test 
this PKC/ζ can be knocked down and if no GSK3β phosphorylation occurs then it is very 
likely that PKC/ζ is responsible for the phosphorylation. 
In summary, there are two sites of PKC/ζ localisation and activation; the tight 
junctions and mitotic apparatus and potentially the nucleus. The following chapters will 
consider potential phosphorylation targets at these sites. 
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Chapter 4 
Establishing a Method to Identify Proteins Phosphorylated by PKC 
4.1 Introduction 
The aim of the project is to find novel PKC phosphorylation targets, so a method 
was needed to test potential candidates. There are many different ways of finding and 
verifying kinase targets (Johnson and Hunter, 2005). In this chapter the aim is to establish 
a method to determine whether a potential candidate is an actual PKC phosphorylation 
target. 
4.1.1 Phosphorylation Prediction Methods 
One way of identifying targets is to use computer based prediction programs. The 
four main web tools are Scansite (http://scansite.mit.edu/), PhosphoELM 
(http://phospho.elm.eu.org/), NetPhos (http://www.cbs.dtu.dk/services/NetPhos/) and 
Human protein Reference Database HPRD (http://www.hprd.org/). 
Scansite, PhosphoELM and NetPhos all use algorithms to predict kinase 
phosphorylation sites. However, publishers retain the copyright information about the 
algorithms, so exact details are not known, the details known are described below. 
Scansite uses an algorithm based on a Position Specific Scoring Matrix (PSSM) 
(Obenauer et al., 2003). A PSSM compares known phosphorylation sites from 
experimental data, for one kinase and scores which amino acids are strongly favoured or 
strongly disliked either side of the phosphorylation site. On the basis of this an algorithm 
can be written to scan a protein sequence to find predicted phosphorylation sites. 
PhosphoELM uses an algorithm based on a manual phospho-protein database, 
made up of high throughput data sets from the published literature (Diella et al., 2008). 
From these data sets they have written an algorithm to predict phosphorylation sites in a 
substrate for a given kinase. 
NetPhos uses an artificial neural network method to predict protein phosphorylation 
(Blom et al., 1999). Like PhosphoELM, the network is based on large data sets from the 
published literature. Within the network both the protein sequence and the structure are 
used, when available. The structural data should make the prediction more accurate as the 
protein folding around a phosphorylation site can be important for recognition by a kinase. 
75 
The HPRD is different from the other search method. It does not use an algorithm, 
instead it reports the presence of kinase motifs found in the literature (Amanchy et al., 
2007). The database is manually updated from the literature. 
The advantages of using the above online tools are that they are quick and easy to 
use and a large number of proteins can be rapidly tested. A disadvantage is that they are 
not completely accurate (see section 4.2). 
4.1.2 In vitro Methods for Determining PKC Phosphorylation 
An alternative to computer based prediction programs is to carry out in vitro kinase 
assays to test a potential kinase substrate. The main way of showing a protein is 
phosphorylated in vitro is to use the purified substrate mixed with the purified kinase and 
radio-labelled ATP32. The P32 is incorporated into the substrate and can be viewed via 
autoradiography. Lgl was shown to be phosphorylated by PKC using an Lgl-GST fusion 
protein, that had been expressed in bacteria, and commercially available purified PKC. 
(Betschinger et al., 2003). Par-1b was shown to be phosphorylated in a slightly different 
way, the Par-1b was a GST fusion protein, but the PKC was flag tagged and produced in 
Hek293 cells (Hurov et al., 2004). Both papers mentioned above went on to show in vivo 
PKC phosphorylation. The advantage with this method is that it is relatively quick, 
although slower than the prediction programs. However the disadvantages are that it 
requires radioactivity and that kinases may be able to phosphorylate a substrate in vitro, 
but the phosphorylation may not occur in vivo. This means that a phosphorylation site 
identified in vitro needs to be confirmed in vivo. 
Another in vitro method is KESTREL (kinase substrate tracking and elucidation) 
(Cohen and Knebel, 2006). Hela cell extracts are depleted of ATP, and a high 
concentration of kinase plus radio-labelled ATP added. The cell extract is then separated 
by electrophoresis and phosphorylation viewed using autoradiography. Phosphorylated 
proteins can then be purified and identified using mass spectrometry. This method was 
used to demonstrate the phosphorylation of PAPK4/p38δ by eEF2 kinase (Knebel et al., 
2001). The advantages of this method are that it tests all the proteins in a cell and is 
relatively quick to carry out. The disadvantages are that it requires radioactivity and that it 
may yield proteins that can be phosphorylated by a kinase, but are not normally as they are 
sequestered in different parts of the cell. 
76 
Another in vitro phosphorylation method is the screening of expression libraries. A 
cDNA library can be constructed with each cDNA tagged to GST. The GST-fusion 
proteins are then expressed in E.coli by bacteria phage and then transferred to a 
nitrocellulose membrane. The kinase of interest and radiolabelled ATP are added to the 
membrane and then removed by washing. Phosphorylation can be visualised by 
autoradiography to see which plaques were phosphorylated by the kinase. The cDNA in 
the phosphorylated plaque can then be sequenced to find which protein was expressed and 
phosphorylated by the kinase of interest. This method was used to determine the 
phosphorylation of MNK1 by ERK MAP kinase (Fukunaga and Hunter, 1997). The 
advantage of this method is that it is a random unbiased screen; however, the disadvantage 
with the approach is that you might identify a target in a biological process you are not 
interested in. 
4.1.3 In vivo Methods for Determining PKC Phosphorylation 
There are numerous ways of showing that a protein is phosphorylated in vivo. A 
kinase can be inhibited or knocked down using siRNA and a reduction in the amount of 
phosphorylation of the protein of interest can indicate phosphorylation by that particular 
kinase. The phosphorylation can be visualised using a phospho specific antibodies, 
particular for the substrate of interest, on a Western blot. This method was used to show 
PKC phosphorylation of GSK3 (Etienne-Manneville and Hall, 2003a) and Lgl 
(Betschinger et al., 2003). The advantages of this method are that it is in vivo and quick to 
carry out. The disadvantage is that it may not show direct phosphorylation, the kinase may 
phosphorylate another kinase causing it to phosphorylate the protein of interest. Another 
disadvantage is that you need phospho-specific antibodies which are expensive and time 
consuming to make. 
A more direct method of showing in vivo protein phosphorylation is to overexpress 
both proteins at the same time in the same cell and then assess for phosphorylation. This 
method was used to show the phosphorylation of FoxG1 by CKI (Regad et al., 2007). 
Xenopus embryos were co-injected with RNA for GFP tagged CKI and GFP-FoxG1, the 
embryos then expressed the proteins and phosphorylation occurred. The GFP-FoxG1 was 
immunoprecipitated and the phosphorylation visualised by Western blotting using a pan 
phosphoserine antibody. The advantages of this method are that it is quick to undertake, is 
in vivo and probably direct between the kinase and the substrate due to overexpression. 
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The disadvantage is that over expressing two proteins may not mimic the true situation and 
phosphorylation that would not normally occur due to spatial differences of the protein 
within the cell may occur with this method. 
Chen and colleagues showed the phosphorylation of adducin by transfecting cells 
with wild type (WT) and kinase dead (KD) novel PKC. The authors showed that adducin 
phosphorylation was increased in the cells transfected with WT but not those transfected 
with KD novel PKC the phosphorylation was visualised using a phospho-specific antibody 
(Chen et al., 2007). The advantages of this method are that it is in vivo and does not require 
radioactivity. The disadvantage is that the kinase is overexpressed and may cause the 
phosphorylation of proteins it would not normally have contact with and that it is may not 
be direct; the kinase may phosphorylate another kinase causing it to phosphorylate the 
protein of interest. 
A particularly clever in vivo phosphorylation assay involves mutation of the ATP 
binding pocket of the kinase so that it preferentially binds a radio-labelled analogue of 
ATP that cannot be bound by other kinases. The DNA for the mutated kinase is transfected 
into cells, expressed and the radiolabelled ATP analogue added. The cell extract is then 
separated by electrophoresis and visualised using autoradiography and the substrates 
identified using mass spectrometry.  This technique was used to discover phosphorylation 
of Cofilin and Dok-1 by v-Src (Shah and Shokat, 2002). The advantages of this method are 
that it is in vivo and quick once the kinase mutant has been made. However, the 
disadvantage can be that it may take a long time to make the kinase mutant. Another 
disadvantage is that the kinase is over expressed; therefore, it may phosphorylate proteins 
it wouldn’t usually have contact with. As with all the in vitro methods, to show that the 
phosphorylation seen in vivo is direct an in vitro kinase assay needs to be carried out. 
A candidate approach was chosen to enable the project to focus on proteins of 
interest rather than the many proteins that can be found using a screening program such as 
KESTREL. The project was started by testing phospho-prediction programs. 
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4.2 Results 
4.2.1 Testing Phosphorylation Prediction Methods 
The aim of the project was to test a large number of candidates that could be 
phosphorylated by PKC, the available phosphorylation prediction tools on the web were 
tested first. 
To test the reliability of these prediction methods four known PKC targets were 
chosen and assessed using the online tools. The four substrates chosen were Lgl, Par-1b, 
GSK3 and Numb. Mouse Lgl is phosphorylated by PKC on five serines, S654, 658, 662, 
669 and 672 (Plant et al., 2003). Human Par-1b is phosphorylated by PKC on one 
threonine, T595 (Hurov et al., 2004). Rat GSK3 is phosphorylated by PKC on one 
serine, S9 (Etienne-Manneville and Hall, 2003a). Human Numb is phosphorylated by 
PKC on two serines, S7 and 295 (Smith et al., 2007). The results of these proteins when 
inputted into the prediction tools are shown in table 3.1 
WEB BASED TOOLS 
Known Target Scansite ZETA Phospho ELM NetPhos HPRD 
Lgl A    
Par-1b     
GSK3     
Numb B    
Table 4.1 Results from the Four Phosphorylation Prediction Tools on Four Known 
PKC Substrates 
(A) denotes only four of the five known sites predicted. The accession numbers for the 
proteins are in the methods. (B) denotes only one of the two known sites predicted. 
When comparing the web based tools with known results Scansite correctly 
predicted some of the residues found in Lgl and Numb, but not all of them. It did not 
predict the correct sites for Par-1b or GSK3. PhosphoELM was unable to predict any of 
the known PKC phosphorylation sites even though they state that they use published data. 
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It is likely that they have used only limited data and not the data from the known targets we 
are using. NetPhos shows total PKC phosphorylation not the individual PKC family 
members, so the results are limited. Netphos correctly predicted all the known residues 
phosphorylated by PKC on Numb, but failed to predict any of the other residues in the 
other three known PKC targets; Lgl, Par-1b and GSK3β. The PhosphoELM was unable to 
predict the phosphorylation of Lgl, Par1b or GSK3, but it did correctly predict the 
phosphorylation of Numb. However, all of the tools incorrectly predicted other sites, apart 
from HPRD which only lists substrates known for the particular kinase. For Lgl and Par-1b 
the published data proves that the sites predicted are false positives. Plant and colleagues 
created recombinant fusion proteins that spanned the length of Lgl (Plant et al., 2003). 
Only two of these fusion proteins, corresponding to amino acids 418-1034 were 
phosphorylated by PKCζ, however, scansite predicts two sites which are not in this region 
and therefore not phosphorylated by PKCζ and are false positives. Netphos predicts thirty-
five other PKC sites that are false positives for PKC/ζ but may be positives for the other 
PKC subtypes. Similarly, Hurov and colleagues mutated the threonine 595 to alanine in 
Par-1b and abolished PKCζ phosphorylation (Hurov et al., 2004), however Scansite 
predicts three other Par-1b sites which are not phosphorylated by PKCζ and are therefore 
false positives. NetPhos predicts thirty-four other Par-1b PKC sites which are false 
positives for PKC/ζ but may be positive for other PKC subtypes. The HPRD only 
describes PKC phosphorylation sites; it does not specify which PKC. For each of the 
proteins many sites were predicted, indicating many false positives. This indicates that the 
parameters used by the algorithms are not specific and many false positives can be given 
and so the prediction tools alone are not sufficient to determine if PKC phosphorylates a 
protein. Scansite, as it predicts PKCζ substrates, might be a useful tool once 
phosphorylation has been established to help find the exact site phosphorylated by PKC. 
4.2.2 In vivo Xenopus Method 
The prediction programs were not suitable so another approach had to be found. 
The Xenopus method was tested because it is a relatively quick in vivo candidate approach. 
Two well established PKC targets are Lgl and Par-1b (Betschinger et al., 2003; Hurov et 
al., 2004; Plant et al., 2003), were chosen to test the in vivo Xenopus method. Lgl is 
phosphorylated on serines (Plant et al., 2003) and Par-1b is phosphorylated on a threonine 
(Hurov et al., 2004). 
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Figure 4.1 The in vivo Xenopus Method did Not Detect Phosphorylated Lgl or Par-1b. 
Proteins were expressed in Xenopus embryos and then IP using a GFP antibody and probed 
with pan phosphoserine and phosphothreonine antibodies. 
(a) Lgl is clearly expressed by the Xenopus embryos (top panel) however the 
phosphoserine antibody was unable to detect Lgl phosphorylation (lower panel), 
(b) Par-1b is clearly expressed by the Xenopus embryos (top panel) however the 
phosphothreonine antibody was unable to detect Par1b phosphorylation (lower panel). 
b 
RNA injected IP: GFP 
81 
Using these two proteins gives the opportunity to test the detection of both types of PKC 
phosphorylation. 
mRNA of each GFP fusion proteins were injected into 2 cell stage Xenopus 
embryos with and without a PKC construct. At approximately stage 9 the embryos were 
lysed and the GFP fusion proteins were immunoprecipitated using a GFP antibody. The 
presence of the fusion protein was determined by a Western blot using a GFP antibody and 
the presence of phosphorylation assessed using a phosphoserine antibody for Lgl and a 
phosphothreonine antibody for Par-1b. Both of the GFP fusion proteins were expressed 
highly even in the presence of PKC (figure 4.1 a top panel and b top panel). However, the 
phosphoserine and phosphothreonine antibodies could not detect any phosphorylation 
(figure 4.1 a and b, bottom panel). This is probably due to the phospho antibodies not 
being able to recognise all phosphorylated serines or threonines. As the antibodies do not 
recognise known PKC phosphorylation sites it is unlikely they will recognise any PKC 
phosphorylation sites, as the consensus sequence around the phosphorylation site is likely 
to be similar to that around the phosphorylation sites in Lgl and Par-1b. PKC was not 
blotted for, so it cannot be proven that it was present, but the embryos had cell 
apicalisation, so it is likely that it was present. 
4.2.3 Setting up an in vitro Kinase Assay 
Due to the in vivo Xenopus method not being suitable for established PKC targets 
and therefore not suitable for finding novel PKC phosphorylation targets an alternative 
method to measure phosphorylation was tested. The in vitro kinase assays were chosen as 
it is quick and shows direct phosphorylation. MBP is a known PKC substrate (Kishimoto 
et al., 1985) that can be purchased from Sigma. PKC can also be purchased from 
Calbiochem. Therefore, MBP was used to test the kinase assay conditions set out by 
Calbiochem and also act as a positive control. 
MBP was added to PKC and radiolabelled ATP, then incubated, the reaction was 
stopped using sample buffer and the mixture run on an SDS-Page gel and visualised using 
autoradiography. PKC can phosphorylate MBP (figure 4.2), showing that the kinase assay 
conditions are suitable for PKC substrate phosphorylation and MBP can be used as a 
positive control in future kinase assays. 
82 
MB
P +
AT
P3
2
MB
P +
PK
C
+ A
TP
32
PK
C
+A
TP
32
25kDa 
Figure 4.2 MBP is Phosphorylated by PKC 
An in vitro kinase assay was performed with MBP as the substrate and commercial PKC 
as the kinase, the kinase assay mixture was separated by electrophoresis and visualised 
using autoradiography. 
4.2.4 Testing an in vitro Kinase Assay Method which used GFP tagged Lgl and Par-1b 
Expressed in Xenopus Embryos. 
Xenopus embryos were used to make the proteins as that has already been 
successfully completed (figure 4.1) Par-1b and Lgl, known PKC phosphorylation targets 
were chosen as substrates to test the in vitro kinase assay using proteins expressed in 
Xenopus embryos. GFP tagged Lgl and Par-1b were expressed in Xenopus embryos and 
purified by immunoprecipitation using a GFP antibody (figure 4.3 a). The purified fusion 
proteins were then added to PKC and ATP32 , and the kinase assay carried out. Par-1b 
phosphorylation was not detected in this assay (figure 4.3 b). This may be due to not 
making enough Par-1b protein and a disadvantage with this approach is that it is not 
possible to quantitate the amount of protein because of the IgG protein from the IP. In 
contrast, Lgl was clearly phosphorylated (figure 4.3 b), however, this phosphorylation 
occurs with and without PKC. It was hypothesised that Lgl was being phosphorylated 
without PKC being added because PKC may have co-immunoprecipitated with the Lgl 
from the Xenopus extracts. To test this a Western blot for PKC was carried out. The 
results shown in figure 4.3 c show a strong band of PKC in the whole embryo extracts and 
a lighter band in the GFP IP for Lgl. This indicates that the phosphorylation seen in the 
kinase assay was due to the PKC co-immunoprecipitating with the Lgl. Due to this 
possibly happening with other candidate proteins and Par-1b phosphorylation not being 
detected it was decided to use an alternative method to express the proteins. 
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Figure 4.3 Testing the in vitro Kinase Assay using GFP tagged Lgl and Par-1b 
Expressed in Xenopus Embryos. 
GFP tagged Lgl and Par-1b were expressed in Xenopus embryos, purified by IP and either 
used for a Western blot or a kinase assay with commercial PKC. 
(a) A Western blot for GFP showing GFP tagged Lgl and Par-1b are expressed by the 
Xenopus embryos and are efficiently immunoprecipitated, (b) In the kinase assay Lgl is 
clearly phosphorylated; however, this occurs with and without the presence of PKC. Par-
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1b phosphorylation is not detected, (c) A Western blot for PKC shows that PKC co-
immunoprecipitates with Lgl from the Xenopus extracts. 
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Figure 4.4 Bacterially Produced Par-1b is Phosphorylated in an in vitro Kinase Assay 
GST-Par-1b was expressed in and purified from E.coli and subjected to a kinase assay and 
a Western blot. 
(a) GST-Par-1b is expressed after induction and purified successfully, (b) Par-1b is 
phosphorylated when mixed with PKC, however there is a small band of the same size 
present when PKC is mixed with ATP32 alone which is probably PKC 
autophosphorylation, (c) A Western blot for phospho-Par-1 clearly shows Par-1b is 
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phosphorylated by PKC. A western blot for GST shows PKC and Par-1b are the same 
size. 
4.2.5 Bacterially Produced GST-fusion Proteins are Phosphorylated in an in vitro 
Kinase Assay 
Due to PKC co-immunoprecipitating with fusion proteins produced in Xenopus it 
was decided that bacterially expressed GST fusion proteins would be used instead as these 
should not contain PKC when purified. This would prevent any PKC co-
immunoprecipitation and hopefully allow for a cleaner kinase assay. The GST fusion 
proteins would be purified using glutathione beads. Par-1b was chosen as a known PKC 
phosphorylation target to test the kinase assay and Par-1b tagged to GST was kindly 
donated by H.Piwnica-Worms (Hurov et al., 2004). There is clear induction of bacterial 
expression of GST-Par-1b and purification using glutathione coated sepharose beads 
(Figure 4.4 a). The purified fusion protein was added to PKC and ATP32 and the kinase 
assay carried out. The autoradiograph in figure 4.4 (b) shows Par-1b phosphorylation when 
PKC is added to the kinase assay. However, there is also a weaker band in the PKC and 
ATP32 lane. The commercial PKC is GST tagged and is the same size as Par-1b-GST. It is 
likely that the small band seen in the PKC and ATP32 lane is PKC autophosphorylation. 
To prove that Par-1b is being phosphorylated a Western blot for phospho-Par-1b on T595 
was carried out (figure 4.4 c left hand panel). The antibody recognises phosphorylation on 
threonine 595, the site phosphorylated by PKC (Hurov et al., 2004). Par-1b is 
phosphorylated by PKC. The right hand panel in figure 4.4 (c) shows a Western blot for 
GST. Par-1b-GST and PKC-GST are both present and are the same size. It can be 
concluded that a working method for testing whether a protein is phosphorylated by PKC 
has been established. 
4.3 Discussion 
The web based phosphorylation prediction methods were found to be unsuitable for 
predicting phosphorylation of suspected PKC substrates as many false positives were 
predicted. With NetPhos and HPRD, only predicted sites for all the PKC subtypes are 
shown. This limits the usefulness of these sites as the predicted phosphorylation could be 
due to any of the PKC subtypes, not just PKC. PhosphoELM lists predicted PKC 
substrates, however, if the substrate of interest is not in this list it is of little use. Scansite 
appears to be the best tool to because it predicts PKCζ phosphorylation sites specifically. 
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However, the results can only be used as a guide as Scansite, like the other programs, does 
predict false positives. In future the programs may be improved and therefore it will be 
worth keeping up to date with developments in this area. 
The in vivo Xenopus assay to determine PKC phosphorylation did not detect PKC 
phosphorylation of Lgl or Par-1b (Figure 4.1). This is probably due to the phospho 
antibodies not being able to recognise all phosphorylated serines or threonines. The 
antibodies are designed to recognise phosphorylated serines and threonines, but if the 
PKC consensus sequence for phosphorylation was not used when designing the antibodies 
they will not recognise substrates phosphorylated by PKC. Pan phosphoserine and 
phosphothreonine antibodies also tend to have a low affinity for their target, so may not 
bind with a high enough level to be detected (Johnson and Hunter, 2005). 
The in vitro kinase assay using GFP-tagged Lgl and Par-1b also failed to detect 
Par-1b phosphorylation, but did detect Lgl phosphorylation (figure 4.3). The lack of Par-1b 
phosphorylation may be due to it already being phosphorylated in the Xenopus embryo or 
that the band is too faint to be seen. Lgl is phosphorylated at least five times, and Par-1b 
only once, it may be that the Par-1b phosphorylation band is too faint in comparison to the 
Lgl phosphorylation band. Further exposure of the kinase assay resulted in over exposed 
film (data not shown). More Par-1b protein was needed than the amount that could be 
gained from the Xenopus embryos, hence using bacteria to produce the protein. Lgl was 
phosphorylated with and without PKC being added to the kinase assay. This has been 
shown before, Plant and colleagues showed that Lgl could be phosphorylated by PKC that 
associated with it before the 293T cells were lysed (Plant et al., 2003). This was an 
unexpected problem of making protein in embryos. It may also occur with candidate 
proteins and may not be PKC that is immunoprecipitated, leading to false positives. This 
would not occur if the protein were made in bacteria. 
The in vitro kinase assay using GST-fusion proteins was shown to be effective in 
showing Par-1b phosphorylation (figure 4.4). However, the disadvantage of using this 
method is that the proteins are made in bacteria and are not subjected to post-translational 
modifications that may occur when the proteins are expressed in mammalian cells. This 
problem will have to be considered when novel PKC phosphorylation targets are 
elucidated using this method. Once novel in vitro phosphorylation has been established it 
will have to be shown in vivo, but this in vitro kinase assay approach is a useful method as 
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the main aim of this thesis is to test candidate genes to see if they are phosphorylated by 
PKC. 
Chapter 5 
Investigating Novel PKC Phosphorylation Targets 
5.1 Introduction 
Cell polarity is the asymmetric distribution of constituents within a single cell that 
produces the asymmetry of cellular functions (Suzuki and Ohno, 2006). Epithelial cells are 
polarised along their apico-basal axis, the apical side of the cells is separated from the 
basal by tight junctions. The tight junctions have two functions; they provide a barrier 
between cells and they prevent the mixing of the transmembrane proteins between the 
apical and basal domains (Balda and Matter, 1998). 
There are four main polarity complexes that are required to maintain polarity: the 
apical PKC/ζ/Par-3/Par-6 complex, the apical Crumbs/Pals-1/Patj complex, the basolateral 
Lgl/Dlg/Scribbles group and the Yurt, Coracle, Neurexin IV and Na+, K+-ATPase group, 
as well as the basolateral protein Par-1. These complexes are evolutionarily conserved 
(Hurd et al., 2003; Izumi et al., 1998; Joberty et al., 2000; Laprise et al., 2009; Lin et al., 
2000; Plant et al., 2003; Yamanaka et al., 2003) and are required to establish and maintain 
epithelial polarity. 
Par-3 is known to be phosphorylated by PKC/ζ (Nagai-Tamai et al., 2002) and 
Par-6 has been reported as not being phosphorylated by PKC/ζ. Lgl is also known to be 
phosphorylated by PKC/ζ (Yamanaka et al., 2003). Drosophila Crumbs has also been 
shown to be a human PKC phosphorylation target in an in vitro kinase assay (Sotillos et 
al., 2004). Consequently these four proteins were not chosen as potential PKC 
phosphorylation targets to be tested in this project. The Yurt, Coracle, Neurexin IV and 
Na+, K+-ATPase group was not described as a polarity complex until later in this work, so 
unfortunately none of them were included. The proteins chosen for testing in an in vitro 
kinase assay were, Patj, Scribble, Pals-1 and Dlg. 
In addition to its role at tight junctions, PKC/ζ is active at the centrosomes (chapter 
3), which are cellular organelles that are composed of two centrioles surrounded by 
pericentriolar material (Alieva and Uzbekov, 2008; Schatten, 2008). This structure is a 
microtubule organising centre that plays a role in a wide variety of cellular functions 
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including, cell division, vesicle transport, cell motility and cell shape maintenance 
(Schatten, 2008). Defective centrosome function has also been linked to tumour 
progression (Nigg, 2002). Proteins associated with the centrosome can be split into three 
groups; the centriolar matrix, the pericentriolar matrix and centrosome associated proteins 
(Alieva and Uzbekov, 2008). Over 500 centrosomal proteins have been identified in a mass 
spectroscopy study (Andersen et al., 2003), however, these may not be present at all stages 
of the cell cycle and the role of many of these proteins is not understood. It would not be 
possible to test such a large number of proteins and it was decided to test two proteins 
which appeared to be particularly good candidates. Two proteins described below localise 
to the centrosome and are candidate PKC phosphorylation targets that will be tested in this 
project. 
5.1.1 LGN 
LGN was first cloned in 1996; it is a 76kDa protein with Leu-Gly-Asn repeats, and 
so was called LGN. The mRNA for LGN is expressed in a wide variety of tissues 
including kidney, lung and skeletal muscle (Mochizuki et al., 1996). LGN is the 
mammalian homologue of Drosophila Partner of Inscuteable (Pins) and they share a 63% 
similarity (Yu et al., 2000). In Drosophila neuroblasts Pins localises to a crescent in the 
apical cortex. It binds Inscuteable (Insc) and is required for the maintenance of Insc at the 
apical cortex. Insc links Baz and the Par-aPKC complex to Pins (Yu et al., 2000). Pins can 
localise asymmetrically in neuroblasts and lead to asymmetric spindle orientation by 
associating with microtubules and working in conjunction with DaPKC this leads to 
asymmetric neuroblast divisions (Bowman et al., 2006; Cai et al., 2003). 
In mammalian cells, the localisation of LGN seems to depend on the cell type. In 
MDCK cells, endogenous LGN is found throughout the cytoplasm in interphase, but 
during mitosis, LGN relocates to a crescent at each spindle pole and the mitotic apparatus 
(Du et al., 2001). In MDCK cells stably expressing YFP-LGN there is clear staining of the 
spindle poles during metaphase (Du and Macara, 2004). Overexpressed LGN localises to 
the cell cortex in mitotic: WISH, PC12 and NRK cells but not in Cos7 cells (Kaushik et al., 
2003). In HeLa cells, LGN protein levels increase during mitosis as shown by Western 
blotting (Du and Macara, 2004). In PC12 cells, loss of or overexpression of LGN causes 
cell cycle progression defects; the cells arrest at the G1/S phase checkpoint (Kaushik et al., 
2003). In MDCK cells, overexpression of LGN causes misorientated spindles during 
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metaphase and mis-segregation of chromosomes during anaphase. The same effect is 
observed in HeLa cells when LGN is knocked out using siRNA (Du et al., 2001), showing 
that LGN has a key role in mitosis. 
LGN has also been shown to bind PKC/ζ, Par-6 and Lgl during mitosis in HEK293 
cells (Yasumi et al., 2005). The Hek293 cells were synchronised using thymidine and 
Nocodazole, lysed and then subjected to an immunoprecipitation using an anti-LGN 
antibody and subsequent Western blotting using anti-PKC/ζ, Par-6 and Lgl antibodies. 
This revealed that LGN formed a complex with PKC/ζ, Par-6 and Lgl and when compared 
to the non-synchromised cells, the formation of this complex increased during mitosis. 
PKC/ζ, Lgl and LGN also colocalise at the cell periphery during metaphase in HEK293 
cells. 
LGN also binds NuMa and they colocalise at the centrosomes during mitosis in 
MDCK cells and the overexpression of LGN disrupts the localisation of NuMa at the 
centrosomes (Du et al., 2001). LGN and NuMa function together to regulate spindle 
formation and spindle pole organisation during mitosis. NuMa is required for the stability 
of microtubules; it prevents them from dissociating into tubulin subunits. LGN prevents 
NuMa from binding microtubules by binding the region of NuMa that binds microtubules. 
Therefore, LGN regulates the binding of NuMa to the microtubules at the spindle poles 
(Du et al., 2002). However, how LGN is regulated is unknown, although interestingly it 
does contain potential PKC phosphorylation sites according to Prosite (Mochizuki et al., 
1996) and may be regulated by PKC phosphorylation at the centrosomes. Therefore, it was 
decided to test if PKC could phosphorylate LGN. 
5.1.2 Glycogen Synthase Kinase 3β 
GSK3β was first described in 1992 as a component of a metabolic pathway (Plyte 
et al., 1992) but is now linked to many cellular processes, including, Wnt, NFκB and 
hedgehog signalling, cell fate and cell polarity (Kim and Kimmel, 2006). GSK3β localises 
to the centrosome and spindle microtubules during mitosis in mammalian HeLa cells 
(Fumoto et al., 2006; Izumi et al., 2008; Wakefield et al., 2003). GSK3β phosphorylates 
microtubule associated proteins, such as Tau, decreasing their ability to stabilise 
microtubules (Lovestone et al., 1996). During mitosis microtubule dynamics increase and 
microtubule nucleation at the centrosome occurs (Compton, 2000). GSK3β is 
phosphorylated on S9 during mitosis at the centrosome (Wakefield et al., 2003) and 
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inactivated (Harwood, 2001). GSK3β may also play a role in centrosomal protein 
transport, such as ninein, by interaction with Bicaudal-D. This requires GSK3β activity, 
again indicating that GSK3β is active on the spindle microtubules (Fumoto et al., 2006). 
GSK3β has also been shown to regulate microtubule dynamics through GCP5 (γ-tubulin 
complex protein-5) which is part of the centrosome. The inhibition of GSKβ at the 
centrosomes increases the recruitment of GCP5 and γ-tubulin to the centrosome leading to 
more microtubules at the centrosome (Izumi et al., 2008). If GSK3β is totally inhibited in 
synchronised HeLa cells during mitosis, there are defects in microtubule and chromosome 
alignment, therefore active GSK3β is needed for chromosome alignment. The GSK3β at 
the centrosomes is already phosphorylated and inactivated at the centrosomes, so it must be 
GSK3β on the spindle microtubules and elsewhere in the cytosol that is responsible for 
chromosome and microtubule alignment (Wakefield et al., 2003). There is temporal and 
spatial phosphorylation and therefore inhibition of GSK3β. 
Wakefield and colleagues suggest that it is PKB that is phosphorylating GSK3β, as 
PKB is active at the centrosomes. However, the staining is similar to the staining for 
phospho-PKC/ζ shown in chapter 3 of this work, so it is possible that is it PKC 
phosphorylating GSK3β. In support of this hypothesis, GSK3β has also been shown to be a 
phosphorylation target of PKCζ, however, not directly (Etienne-Manneville and Hall, 
2003a). GSK3β is phosphorylated at S9 at the leading edge of migrating astrocytes. The 
authors showed that GSK3β and PKCζ form a complex by IP and Western blotting. 
Phospho-GSK3β was not detected in the Western blot indicating that PKCζ cannot bind 
phospho-GSK3β. Inhibition of PKCζ prevented GSK3β phosphorylation and transfection 
of wild-type but not kinase dead PKCζ causes GSK3β phosphorylation. This suggests that 
GSK3β is a phosphorylation target of PKC, but it has not been shown to be direct. It was 
within this paper that the role of GSK3β in cell polarity was elucidated. GSK3β 
phosphorylation on serine 9 occurs at the leading edge of migrating astrocytes. A S9A 
mutant of GSK3β injected into the leading edge prevents centrosome reorientation and 
polarity establishment. GSK3β phosphorylation is needed to inactivate GSK3β allowing 
that accumulation of β-catenin at the leading edge and the association of adenomatous 
polyposis coli (APC) with the plus ends of microtubules. β-catenin is not necessary for cell 
polarisation, but APC is. However, how APC is involved in polarity remains unclear 
(Etienne-Manneville and Hall, 2003a). 
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5.2 Aims 
Due to the large number of polarity proteins that are involved in similar processes 
to the Par-PKC/ζ complex, but which have not been reported as positive PKC 
phosphorylation targets, the aim was to test some of these polarity proteins using the GST-
fusion protein kinase assay method developed in chapter four. The polarity proteins chosen 
were; Patj, Pals-1, Scribble and Dlg. To begin to understand the role of PKC at the 
centrosome, another aim was to test two known centrosomal proteins, LGN and GSK3β, to 
see if they are directly phosphorylated by PKC. 
5.3 Results 
Plasmids for each of the suspected polarity phosphorylation candidates were 
requested from other researchers. Patj was kindly provided by A Le Bivic (Lemmers et al., 
2002), Scribbles was kindly provided by I Macara (Qin et al., 2005), Dlg was kindly 
provided by L Banks (Massimi et al., 2006) and Pals-1 was kindly provided by B. Margolis 
(Kamberov et al., 2000). All the genes had different tags on them so had to be cloned into a 
GST vector using the Gateway® Cloning kit (stratagene), to allow expression in bacteria 
and purification. LGN-GST was kindly provided by V. Slepak (Nair et al., 2005) and 
GSK3β-GST was kindly provided by H. Paudel (Sun et al., 2002) and as they were already 
in GST expression vectors they could be used immediately. 
5.3.1 Patj and Scribble 
Patj contains one L27 domain and ten PDZ domains. The L27 is a protein-protein 
binding domain that binds to the L27 domain of Pals-1 (Li et al., 2004). PDZ domains are 
also protein-protein interaction domains (Ponting et al., 1997). No PKC/ζ phosphorylation 
sites were predicted by Scansite. Primers were designed for Patj as per manufacturers’ 
instructions. The Patj PCR was successful and a clear band at 4.7kb could be seen (figure 
5.1b). The TOPO® reaction was then carried out using the PCR product, amplified by 
E.coli, mini-prepped, and the products cut with the restriction enzyme BSRG1. The 
TOPO® vector has BSRG1 sites at the recombination sites, so using BSRG1 should excise 
the PCR product. This did not occur for Patj. The only band seen on cutting the plasmid 
was that of the self-ligated TOPO® vector (fig 5.1c). The TOPO® reaction was repeated 
six times altering the length of the TOPO® reaction and the temperature, but to no avail. 
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a Patj (196kDa) 
L27 PDZ PDZ 
b + - Template 
4.5kb 
c - + - + - + BRSG1 
2kb 
Figure 5.1 Unsuccessful Attempt to make a GST-fusion Protein of Patj 
(a) A schematic diagram of the domains in Patj. Scansite did not predict any PKCζ 
phosphorylation sites, (b) Patj PCR was successful. The Patj PCR product should be 4.7kb, 
(c) Patj TOPO™ reaction product, cut with the restriction enzyme BSRG1, should have 
produced a 4.7kb and a 2.5kb product, only the 2.5kb vector was present. This shows that 
there is no insert present. A few clones were also sequenced which contained no insert. 
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A few Patj TOPO® constructs were sent for sequencing and some returned showing the 
TOPO® linker sequence and around 100bp of the Patj gene indicating that a truncated 
piece of the Patj was being incorporated into the TOPO® vector and some contained no 
Patj at all. 
Scribble contains four PDZ domains, that are protein-protein interaction domains 
(Ponting et al., 1997). No PKC/ζ phosphorylation sites were predicted by Scansite. 
Primers were designed for Scribble as per manufacturers’ instructions. The Scribble PCR 
was not successful initially, only smears could be seen on the gel (figure 5.2b). DMSO can 
help break secondary structures in GC rich DNA allowing the polymerase easier access to 
the template DNA. On this basis 0%, 5% and 10% DMSO was added to each reaction and 
4.8kb PCR product of Scribble was achieved with 10% DMSO (figure 5.2c). The Scribble 
PCR product was then added to the TOPO® reaction, the reaction performed, the reaction 
product amplified by E.coli, mini-prepped, and the products cut with the restriction 
enzyme BSRG1. The TOPO® vector has BSRG1 sites at the recombination sites, so using 
BSRG1 should excise the whole 4.8kb PCR product. This did not occur for Scribble. The 
only band seen on cutting the plasmid was that of the self-ligated TOPO® vector (fig 
5.2d). The TOPO® reaction was repeated twice, altering the length of time the reaction 
took place for, but to no avail. No TOPO® reaction products were sent for sequencing as 
none of them contained any inserts. 
Due to the difficulties in cloning Patj and Scribble, it was decided to focus on other 
candidates. 
5.3.2 Pals-1 is not Phosphorylated by PKC in vitro. 
Pals-1 contains two L27 domains, one PDZ, one SH3 and one guanylate kinase-like 
domain. The L27 domain is a protein-protein binding domain that binds to the L27 domain 
of Patj (Li et al., 2004). The PDZ domain is also a protein-protein interaction domain 
(Ponting et al., 1997). The SH3 domain is also a protein-protein interaction domain 
(Pawson and Schlessingert, 1993). Primers were designed for Pals1 as per manufacturers’ 
instructions. The PCR was successful and the product the correct size. The product was 
ligated into the TOPO® vector and finally the GST vector via the Gateway® Cloning kit 
(Invitrogen) (data not shown). The schematic in figure 5.3a shows the domains of Pals-1 
fused to the GST tag. 
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a Scribble (175kDa)

PDZ 
b + - Template 
1kb 
4kb 
2kb 
c 0% 10% 5% DMSO 
5kb 
d - + - + - + - + BSRG1 
2kb 
Figure 5.2 Unsuccessful Attempt to Make a GST-fusion Protein of Scribble 
(a) A schematic diagram of the domains in Scribble. Scansite did not predict any PKCζ 
phosphorylation sites, (b) The initial Scribble PCR did not work, (c) Addition of DMSO to 
the PCR reaction mixture enabled Scribble PCR to work and a band of 4.8kb, the size of 
scribble was present, (d) Scribble TOPO™ reaction product, cut with the restriction 
enzyme BSRG1, should have produced a 4.8kb and a 2.5kb product, only the 2.5kb vector 
was present. This shows that there is no insert present. 
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a Pals-1-GST (89kDa)

GST Guanylate Kinase L27 L27 PDZ SH3 
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100 kDa 
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100 kDa 
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Figure 5.3 Pals-1 is not Phosphorylated by PKC in an in vitro Kinase Assay 
(a) A schematic diagram of the domains in Pals-1 tagged to GST. Scansite did not predict 
any PKCζ phosphorylation sites, (b) Pals-1 is expressed in E.coli following the addition of 
L-arabinose and successfully purified using glutathione sepharose beads, (c) The Pals-1-
GST fusion protein was used in a kinase assay with PKC, but no phosphorylation was 
detected by autoradiography (bottom panel). The purified Pals1 protein could be seen on 
the Coomassie stained kinase assay SDS-PAGE gel (top panel). 
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The finished GST-tagged Pals-1 plasmid was transformed into BL21-A1 E.coli, the 
bacteria grown to the log phase and then L-arabinose added to induce expression of the 
protein. Upon L-arabinose addition the protein was expressed and purified using 
glutathione sepharose beads (figure 5.3b) in the centre lane in figure 5.3b the induction of 
Pals-1 cannot be seen clearly; however, the purified protein is much clearer in the right 
hand lane. 
The purified GST-Pals-1 fusion protein was added to a kinase assay containing 
PKC and the reaction carried out. The reaction was quenched using sample buffer and the 
mixture separated by an SDS-PAGE gel and visualised using autoradiography. The top 
panel in figure 5.3c shows the Coomassie stained gel that contains the kinase assay mixture 
and the Pals-1 protein can clearly be seen. The bottom panel in figure 5.3c shows the 
autoradiograph, no phosphorylation band can be seen at the size of Pals-1. The 
autoradiograph was further exposed and no phosphorylation bands were seen (data not 
shown), so no phosphorylation of Pals-1 by PKC could be detected (figure 5.3c). MBP 
was used as a positive control and was phosphorylated (data not shown). 
5.3.3 Dlg is not Phosphorylated by PKC in vitro, but Increases PKC 
Autophosphorylation 
Dlg contains one L27 domain, three PDZ domains, one SH3 domain and a 
guanylate kinase domain that is inactive (Kistner et al., 1995). Primers were designed for 
Dlg as per manufacturers’ instructions. The PCR was successful and the product the 
correct size. The Dlg PCR product was ligated into the TOPO® vector and finally the GST 
vector via the Gateway® Cloning kit (Stratagene) (data not shown). The schematic in 
figure 5.4a shows the domains of Dlg fused to the GST tag. The finished GST-tagged Dlg 
plasmid was transformed into BL21-A1 E.coli, the bacteria grown to the log phase and 
then L-arabinose added to induce expression of the protein. Upon L-arabinose addition the 
protein was expressed and purified using glutathione sepharose beads (figure 5.4b). The 
purified GST-Dlg fusion protein was added to a kinase assay containing PKC and the 
reaction carried out. The reaction was quenched using sample buffer and the mixture 
separated by an SDS-PAGE gel and visualised using autoradiography. A band was seen by 
autoradiography, but Dlg phosphorylation by PKC was not detected (figure 5.4c), when 
the top and lower panels are overlaid the phosphorylation band is much lower than the Dlg 
protein band on the Coomassie stained gel. 
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Figure 5.4 Dlg is not Phosphorylated by PKC but Increases PKC 
Autophosphorylation 
(a) A schematic diagram of the domains in Dlg tagged to GST. Scansite did not predict any 
PKCζ phosphorylation sites, (b) Dlg was expressed in E.coli following the addition of L-
arabinose and successfully purified using glutathione sepharose beads, (c) The Dlg-GST 
fusion protein was used in a kinase assay with PKC, but no Dlg phosphorylation was 
visualised at the correct size (bottom panel). However there is a clear phosphorylation band 
at the same size as PKC. The purified Dlg protein can be seen on the Coomassie stained 
kinase assay SDS-PAGE gel (top panel) and is larger than the band seen by 
autoradiography. 
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This proves that it is not Dlg phosphorylation on the autoradiograph. The only other 
component within the mixture is PKC and the phosphorylation band on the 
autoradiograph is the same size as PKC (98 kDa), so it is highly likely that the band is 
PKC autophosphorylation. However lane 3 contains the same amount of PKC as lane 2 
and at this exposure time no autophosphorylation band is seen on the autoradiograph in this 
lane. This indicates that more PKC autophosphorylation is taking place when Dlg is added 
to the kinase assay mixture. However, Dlg does not contain an active kinase domain, so 
appears to be increasing the autophosphorylation of PKC. This experiment was repeated 
four times. 
5.3.4 LGN is not Phosphorylated by PKC in vitro 
LGN contains six tetratricopeptide repeat (TPR) domains and four Go-Loco motifs. 
The TPR motifs mediate the interaction of LGN with NUMA (Du et al., 2001), Lgl also 
binds the N-terminal region of LGN, but it is unclear if this is via the TPR motifs (Yasumi 
et al., 2005). Go-Loco motifs associate with the Gα subunits of heterotrimeric G-proteins 
and are responsible for the localisation of LGN (Kaushik et al., 2003). The schematic 
diagram in figure 6.1a shows the domains of LGN fused to the GST tag, including the 
potential PKCζ phosphorylation sites predicted by Scansite. The GST-tagged LGN plasmid 
was transformed into BL21-A1 E.coli, the bacteria grown to the log phase, and then L-
arabinose added to induce expression of the protein. Upon L-arabinose addition, the 
protein was expressed and then purified using glutathione sepharose beads (figure 6.1b). 
The purified protein is clear in the right hand lane of the Coomassie stained gel. The 
purified GST-LGN fusion protein was added to a kinase assay containing PKC and the 
reaction carried out. The reaction was quenched using sample buffer and the mixture 
separated by an SDS-PAGE gel and visualised using autoradiography. Phosphorylation of 
LGN could not be detected (figure 6.1c). The top panel in figure 6.1c shows the Coomassie 
stained gel that contains the kinase assay mixture, LGN-GST can clearly be seen. The 
bottom panel in figure 6.1c shows the autoradiograph, no phosphorylation band can be 
seen at the size of LGN-GST. The autoradiograph was further exposed and no 
phosphorylation bands were seen (data not shown). MBP was used as a positive control 
and was phosphorylated (data not shown). 
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Figure 5.5 LGN is not Phosphorylated by PKC in an in vitro Kinase Assay. 
(a) A schematic diagram of the domains in LGN tagged to GST including the potential 
phosphorylation sites predicted by Scansite, (b) LGN-GST is expressed in E.coli following 
the addition of L-arabinose and successfully purified using glutathione sepharose beads, 
(c) The LGN-GST fusion protein was used in a kinase assay with PKC, but no 
phosphorylation was detected by autoradiography (bottom panel). The purified LGN-GST 
protein can be seen on the Coomassie stained kinase assay SDS-PAGE gel (top panel). 
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5.3.5 GSK3β is not Phosphorylated by PKC in vitro 
The schematic diagram in figure 5.6a shows the domains of GSK3β fused to the 
GST tag, including the potential PKCζ phosphorylation sites predicted by Scansite. The 
GST-tagged GSK3β plasmid was transformed into BL21-A1 E.coli, the bacteria grown to 
the log phase and then L-arabinose added to induce expression of the protein. Upon L-
arabinose addition the protein was expressed and then purified using glutathione sepharose 
beads (figure 5.6b). The purified protein is clear in the right hand lane of the Coomassie 
stained gel. 
The purified GST- GSK3β fusion protein was added to a kinase assay containing 
PKC and the reaction carried out. The reaction was quenched using sample buffer and the 
mixture separated by an SDS-PAGE gel and visualised using autoradiography. 
Phosphorylation of GSK3β could not be detected (figure 5.6c). The top panel in figure 5.6c 
shows the Coomassie stained gel that contains the kinase assay mixture, GSK3β -GST can 
clearly be seen. The bottom panel in figure 5.6c shows the autoradiograph, no 
phosphorylation band can be seen at the size of GSK3β-GST. The autoradiograph was 
further exposed and no phosphorylation bands were seen (data not shown). MBP was used 
as a positive control and was phosphorylated by PKC (data not shown). 
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Figure 5.6 GSK3β is not Phosphorylated by PKC in an in vitro Kinase Assay 
(a) A schematic diagram of the domains in GSK3β tagged to GST including the potential 
phosphorylation sites predicted by Scansite, (b) GSK3β-GST is expressed in E.coli 
following the addition of L-arabinose and successfully purified using glutathione sepharose 
beads, (c) The GSK3β-GST fusion protein was used in a kinase assay with PKC, but no 
phosphorylation was detected by autoradiography (bottom panel). The purified GSK3β -
GST protein can be seen on the Coomassie stained kinase assay SDS-PAGE gel (top 
panel). 
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5.4 Discussion 
In this chapter the unsuccessful cloning of Scribble and Patj, into GST vectors has 
been described as well as the successful cloning of Pals-1 and Dlg. Pals-1, LGN and 
GSK3β kinase assays with PKC that could not detect phosphorylation have also been 
described. The results of these experiments are summarised in table 5.1. Also in this 
chapter it has been shown that Dlg unexpectedly increases the phosphorylation of PKC. 
DNA PCR TOPO® KA 
Patj   N/A 
Scribble   N/A 
Pals-1    
Dlg    
LGN N/A N/A  
GSK3β N/A N/A  
Table 5.1 A Summary of the Progress made with Cloning of the Genes into GST 
Vectors and the Following Kinase Assays. 
The unsuccessful attempts to make Patj and Scribble GST fusion proteins may have 
been due to the large size of the transcripts. Patj is 4.7 kb and Scribble is 4.8kb. Dlg and 
Pals-1 which were successful are 2.7kb and 2kb respectively. The TOPO® manufacturers 
indicate that the TOPO® vector will take sequences up to 10kb, however, they do say that 
longer ligation times may be required for larger plasmids. If more time was available, the 
Patj and Scribble could have been cut into two parts and put into the TOPO® vector 
separately. This would hopefully allow the incorporation of the smaller piece of DNA into 
the TOPO® vector. However, when the protein is expressed, only half of it would be there 
at any one time and this may affect the folding of the protein and possible phosphorylation 
by PKC. This could lead to false positives or missing PKC phosphorylation altogether. 
Another way round the problem of creating a GST fusion protein would be to use another 
method to incorporate the Scribble and Patj DNA into a GST vector. One such method is 
to cut the vector and the DNA of Scribble or Patj with different restriction enzymes, so that 
the vector cannot self ligate (because the sticky ends are different) but will ligate to the 
Scribble or Patj DNA as they will be cut to complement the sticky ends of the vector. This 
would allow incorporation of the whole Scribble or Patj DNA sequence into the GST 
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vector. DMSO was used in the Scribble PCR to help break down secondary structures in 
GC rich DNA. The DMSO was not removed and may have been a factor in the Scribbles 
TOPO® not working, even though it was at a low concentration in the final reaction 
(1.67%). In future, the PCR product should be gel extracted to remove the DMSO in case it 
is affecting the TOPO®. 
The results in figure 5.3 indicate that Pals-1 is not phosphorylated by PKC in an in 
vitro kinase assay. However, due to the limitations with an in vitro method, the situation in 
vivo cannot be determined. For example, Pals-1 may need a binding partner to be 
recognised by PKC. Pals-1 may also need a post-translational modification, which does 
not occur in bacteria, to be recognised and or phosphorylated by PKC. It is impossible to 
prove that Pals-1 is not phosphorylated by PKC, but this data suggests that it may not be 
the case and it is likely that as it is not phosphorylated in vitro, it is not phosphorylated in 
vivo either. This suggests that PKC is not regulating polarity by phosphorylating and 
controlling the function of Pals-1. 
The surprising result from this chapter was that Dlg increases the amount of PKC 
phosphorylation (figure 5.4). Dlg is a MAGUK protein, but its kinase domain is inactive 
(Kistner et al., 1995). Therefore it must be PKC autophosphorylation that is increased by 
Dlg. An assay to confirm that Dlg increases PKC autophosphorylation in vivo would be to 
see if the amount of Dlg protein in a cell alters the amount of PKC phosphorylation of its 
known targets such as Lgl or Par-1b. This could be achieved by overexpressing or 
knocking down Dlg. 
Dlg recruitment to the leading edge of migrating astrocytes is controlled by the Par-
PKC/ζ complex, knock down of PKCζ or PKCζ inhibition prevents the recruitment of Dlg 
to the leading edge. However, Dlg knockdown does not alter PKCζ localisation (Etienne-
Manneville et al., 2005). The Dlg recruitment to the leading edge could activate PKC 
further at the leading edge and drive migration. Dlg mutants do have abnormal cell polarity 
in Drosophila (Bilder et al., 2000; Wodarz, 2000). Dlg localises to the sites of cell-cell 
contact in polarised cells, but has not been reported to directly colocalise with PKC or 
PKCζ. However, Dlg may still activate PKC by interacting with it transiently. Dlg may 
transiently localise with and activate PKC during the establishment of polarity. Live cell 
imaging of Dlg and PKC during the establishment of polarity would reveal if this occurs. 
Dlg localises to the mitotic spindle in mitosis (Narayan et al., 2009) as does PKC/ζ 
(chapter 3). It is possible then that one of the roles of Dlg at the mitotic spindle is to 
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activate PKC/ζ by causing autophosphorylation. This would explain the increase in PKC 
autophosphorylation seen in the kinase assay containing Dlg in this work and the increase 
in active phospho-PKC/ζ seen in mitotic cells on the centrosomes and spindle (chapter 3). 
To test this, co localisation of Dlg with PKC needs to be established at the mitotic spindle. 
If this co localisation occurs then a knock down of Dlg in mitotic cells needs to be 
performed to see a decrease in PKC/ζ autophosphorylation. 
The results in figure 5.5 indicate that, although there are predicted phosphorylation 
sites within LGN, phosphorylation of LGN by PKC could not be detected using this assay. 
Due to the limitations with an in vitro method, the situation in vivo cannot be determined. 
For example, as with Pals-1, LGN may need a binding partner to be recognised by PKC. 
LGN may also need a post-translational modification that does not occur in bacteria to be 
recognised and or phosphorylated by PKC. However, Zheng and colleagues have very 
recently published data showing that LGN is apically excluded in MDCK cells, and that 
this exclusion is mediated by PKC/ζ and that kinase activity of PKC/ζ is important 
(Zheng et al., 2010). This indicates that PKC/ζ either phosphorylates LGN directly or that 
it phosphorylates another protein that mediates the exclusion effect on LGN. Interestingly 
the authors do not show an in vitro kinase assay for PKC/ζ and LGN. Further work will be 
required to elucidate the exact mechanism. As PKC/ζ and LGN colocalise in HEK293 
cells during mitosis (Yasumi et al., 2005), it will be interesting to see if this occurs in other 
polarised cell types, and whether this occurs during mitosis. LGN may still be 
phosphorylated by PKC, but may only bind to PKC in the complex with Par-6 and Lgl. 
Potentially this can be followed up with a kinase assay using more than just LGN and 
PKC, but include Lgl and or Par-6 proteins. 
The results in figure 5.6 show that phosphorylation of GSK3β by PKC could not 
be detected in an in vitro kinase assay. It has been shown that PKC/ζ activity causes the 
phosphorylation of GSK3β in vivo, however, direct phosphorylation has not been shown 
(Etienne-Manneville and Hall, 2003a). The authors of this paper make no mention of 
PKC, and the inhibitors and the antibodies they use are not proven in the paper to only 
inhibit/detect PKCζ. This makes it possible that they are presenting results that are relevant 
to PKCζ and PKC. Because of this it is unlikely that it is due to the use of PKC in the 
kinase assay instead of PKCζ that is responsible for the lack of phosphorylation visualised. 
So there are three possibilities, either GSK3β is not phosphorylated by PKC at all, that 
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GSK3β needs some sort of post translational modification or binding partner before it can 
be phosphorylated by PKC or that PKC is phosphorylating another kinase that goes on to 
phosphorylate GSK3β. This would explain the phosphorylation seen in vivo, but not in the 
in vitro kinase assay presented here. If it is a binding partner that is required, it may be 
bound to unphosphorylated GSK3β which could be immunoprecipitated from a cell lysate 
and the binding partner identified. If it is another kinase such as Par-1 that is 
phosphorylating GSK3β then an in vitro kinase assay with kinases that PKC 
phosphorylates could be set up. If one is found, this can be knocked down in vivo to see if 
there is a decrease in GSK3β phosphorylation. 
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Chapter 6 
The Hippo Pathway and PKC 
6.1 Introduction 
6.1.1 The Hippo Pathway 
The Hippo pathway controls proliferation and cell death in epithelial cells and is 
linked to the control of organ size and tumorigenesis. Activation of the Hippo pathway 
suppresses Yap and Taz, which are transcriptional co-activators. This results in repression 
of cell proliferation. As depicted in figure 6.1, the mammalian hippo pathway consists of 
Mst1/2 (Drosophila hippo) a Ste-20 family protein kinase, which interacts with Salvador, a 
scaffold protein (Callus et al., 2006) and phosphorylates Lats1/2 (Drosophila Warts), a 
serine threonine kinase (Chan et al., 2005). Lats1/2 then phosphorylates Yap (Drosophila 
Yorkie) and its paralog Taz (Hao et al., 2008; Lei et al., 2008; Zhao et al., 2007) 
sequestering Yap outside of the nucleus where it is unable to act as a transcriptional co-
activator (Basu et al., 2003) 
6.1.2 Mst1/2, Hippo and Salvador 
Mst1/2 and Hippo are serine/threonine kinases. In Drosophila eye discs, mutation 
of Hippo causes tissue overgrowth (Harvey et al., 2003). The C-terminal portion of Hippo 
binds the N-terminal of Salvador, which aids the binding of Hippo to Warts and the 
phosphorylation of Warts. Hippo is required for cell cycle exit as Hippo mutant cells 
continue dividing, creating overgrowth. There are also elevated protein levels of Cyclin E. 
DIAP1 protein levels are also elevated in Hippo mutant cells. Overexpression of Hippo 
decreases DIAP1 protein levels. Hippo can phosphorylate DIAP1 in vitro, but it has not 
been shown if this occurs in vivo and causes DIAP1 degradation. 
In mammals, MST1/2 binds to WW45 and phosphorylates Lats1/2 which then 
phosphorylates Yap, sequestering Yap out of the nucleus (Zeng and Hong, 2008). Yap is 
not phosphorylated by Lats1 in overexpression studies, unless Mst2 is also overexpressed 
(Oka et al., 2008). This indicates that Mst1/2 and Lats1/2 act in the same way in mammals 
as they do in Drosophila. 
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Figure 6.1 The Drosophila and Mammalian Hippo Pathways 
A comparison of the Drosophila and mammalian Hippo pathways. Mst1/2 (Hippo) binds 
to WW45 (Salvador), which promotes the phosphorylation of Lats1/2 (Liu et al.) by 
Mst1/2. Lats1/2 interacts with Mob1 (Mats) and phosphorylates Yap (Yorkie) causing its 
retention in the cytoplasm, out of the nucleus. 
6.1.3 Lats and Warts 
Lats1 and Lats2 are the mammalian orthologues of Drosophila Warts (Hori et al., 
2000). Lats1 and Lats2 interact with Yap in Hela cells (Hao et al., 2008; Zhang et al., 
2008) and in Cos7 cells (Hao et al., 2008). Lats1 interacts with Yap via the WW domains 
of Yap and the PPXY motif in Lats1 (Oka et al., 2008). When Yap is overexpressed in 
MCF10 cells there is an increase in anchorage independent growth and cell migration; 
however, when Lats1 is co-expressed with Yap the phenotype is cancelled, indicating that 
Lats1 represses Yap (Zhang et al., 2008). Yap is phosphorylated by Lats1 and Lats2 in vivo 
in Cos7 cells. There are five Lats phosphorylation sites in Yap: S61, S109, S127, S164 and 
S397, two of which are conserved in Drosophila Yorkie, S109 and S127 (S111 and S168 
in Drosophila). Lats1 phosphorylation of Yap sequesters it in the cytoplasm shown by a 
double transfection of Lats and Yap; however, Lats1 and Yap S5A (all five serines 
mutated) results in Yap nuclear accumulation. This indicates that Lats1 represses Yap via 
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phosphorylation (Hao et al., 2008). Lats binds to Mob1 which stimulates the kinase activity 
of Lats1/2 (Lai et al., 2005; Wei et al., 2007). 
6.1.4 Yap and Yorkie 
Yap was first characterised in 1995, Yap mRNA was found at high levels in the 
placenta, testis, ovary and small intestine and at lower levels elsewhere (Sudol et al., 
1995). Yap regulation is important for the control of organ size. Yap contains two WW 
domains which bind proline rich sequences in the TEAD family of transcription factors. 
Activation of Yap in the liver of adult mice results in a four fold increase in liver size, and 
in the intestine, Yap overexpression results in an expansion of progenitor cells (Camargo et 
al., 2007). Yap activating mutations phenocopy the Mst1/2, Lats and Salvador loss-of-
function mutations. The Drosophila homologue of Yap is Yorkie and Yap can functionally 
replace Yorkie in Drosophila (Huang et al., 2005). Yorkie co-immunoprecipitates from 
Drosophila S2 cells with Warts and the WW domains of Yorkie are required for this 
interaction. Warts phosphorylates Yorkie in vitro (Huang et al., 2005). Phosphorylation of 
Yorkie at serine 168 increases when Yorkie and Hippo, Salvador or Warts are 
overexpressed together in S2 cells. This phosphorylation causes Yorkie to bind 14-3-3 
proteins and sequesters Yorkie in the cytoplasm, out of the nucleus. Conversely, loss of 
Hippo signalling causes Yorkie nuclear accumulation (Dong et al., 2007). Yorkie is 
phosphorylated by Warts in vivo and there appear to be multiple phospho-isoforms. A 
Yorkie mutant that has a serine to alanine mutation at serine 168 (S168A), which prevents 
the serine phosphorylation, cannot bind 14-3-3 proteins and accumulates in the nucleus; 
however there is still some cytoplasmically located Yorkie. This indicates that there might 
be another mechanism that either puts more Yorkie in the nucleus or sequesters it out of 
the nucleus. The Yorkie S168A mutant is hyperactivated, indicated by a severe overgrowth 
phenotype, which resembles the Hippo mutant (Oh and Irvine, 2008). 
Another mode of Yorkie regulation is mediated via its WW domains. Yorkie binds 
Expanded at the apical domain of cells via the WW domains in Yorkie and the PPXY 
motif within Expanded. This binding does not require Yorkie phosphorylation. Yorkie 
binding to Expanded inhibits Yorkie, presumably by keeping it out of the nucleus (Badouel 
et al., 2009). If the Yorkie WW domains are mutated Yorkie no longer localises to the 
apical domain (Zhang et al., 2009). Yorkie also binds Hippo via its WW domain and the 
PPXY motif in Hippo, which also represses Yorkie activity (Oh et al., 2009), so Yorkie 
signalling can be attenuated by direct binding to members of the Hippo pathway as well as 
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phosphorylation by Warts. However, this direct binding regulation has yet to be shown for 
mammalian Yap. 
6.1.5 Downstream of Yap and Yorkie 
Downstream of Yorkie is a transcription factor called Scalloped (Goulev et al., 
2008). Downstream of Yap is the TEAD family of transcription factors and targets of these 
include connective tissue growth factor (CTGF) (Zhao et al., 2008) DIAP1, CyclinE 
(Kango-Singh et al., 2002; Tapon et al., 2002) and Expanded (Badouel et al., 2009). CTGF 
promotes cell migration and proliferation in fibroblasts and is also involved in extracellular 
matrix remodelling (Moussad and Brigstock, 2000). DIAP1 is a caspase inhibitor and 
therefore prevents caspase-dependent cell death (Wang et al., 1999). Cyclin E is involved 
in the G1-S phase transition of the cell cycle (Ohtsubo et al., 1995). Anti-Cyclin E 
antibodies prevent fibroblasts going into S-phase when microinjected into them. 
6.1.6 The Hippo Pathway and Cancer 
Hippo pathway misregulation leads to tissue overgrowth and Yap is thought to be 
an oncogene. Overexpression of Yap in MCF10A breast cells induces EMT, anchorage 
independent growth and inhibition of apoptosis (Overholtzer et al., 2006). Therefore, Yap 
can transform MCF10A cells. High levels of Yap and nuclear accumulation of Yap have 
also been found in colonic adenocarcinoma, lung adenocarcinoma and ovarian serous 
cystadenocarcinoma (Steinhardt et al., 2008). There is also strong nuclear Yap staining in 
hepatocellular carcinoma (Zhao et al., 2007) and the presence of high levels of Yap 
correlate with a poor patient prognosis (Xu et al., 2009). 
6.1.7 Upstream of the Hippo Pathway 
Upstream of the Hippo pathway in Drosophila, there are multiple mechanisms of 
regulation. One protein upstream of the Hippo pathway is the transmembrane cadherin Fat, 
which binds to Dachsous, another transmembrane cadherin. These two proteins recruit 
each other to the membrane (Willecke et al., 2008). Phosphorylation of Fat and Dachsous 
by the kinases, Four-jointed and Discs overgrown regulates their binding (Feng and Irvine, 
2009; Ishikawa et al., 2008). Fat and Dachsous signal through the unconventional myosin 
Dachs, which stabilises Warts (Cho et al., 2006) allowing Hippo pathway activation; 
however, how this stabilisation occurs is unknown. Fat and Dachsous are also regulated by 
Lowfat, which stabilises them (Mao et al., 2009), though again, how this stabilisation is 
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achieved is unknown. Another protein, Approximated, a palmitoyltransferase, also 
regulates Fat signalling by regulating the localisation and levels of Dachs (Matakatsu and 
Blair, 2008). High levels of Approximated lead to low levels of Dachs and therefore Hippo 
pathway suppression. A direct Hippo inhibitor is Drosophila RASSF (dRASSF). dRASSF 
binds directly to Hippo which prevents Hippo from binding to Salvador (Polesello et al., 
2006). This prevents the activation of Warts and consequently represses the Hippo 
pathway. 
Yorkie can also be directly inhibited by direct association with Expanded; this 
inhibition is possibly mediated by Expanded sequestering Yorkie out of the nucleus 
(Badouel et al., 2009). This sequestration would prevent Yorkie from acting as a 
transcriptional co-activator. 
Another mode of Hippo regulation is through the Kibra-Expanded-Merlin complex. 
Expanded and the cytoskeletal protein, Merlin bind the WW-domain containing protein, 
Kibra at the apical membrane and this results in the core Hippo pathway components being 
localised to the apical membrane for activation (Baumgartner et al., 2010; Genevet et al., 
2010; Yu et al., 2010). How the Kibra-Expanded-Merlin complex activates the core Hippo 
pathway components is unknown. 
Crumbs also regulates the Hippo pathway by binding to Expanded and localising it 
to the apical membrane (Ling et al., 2010). This localisation would allow Expanded to bind 
Merlin and Kibra. Kibra is also phosphorylated by PKCζ (Buther et al., 2004), however, 
whether this phosphorylation has any effect on the binding of Kibra to Expanded and 
Merlin and therefore any effect on the Hippo pathway is unknown. 
PKC/ζ and Lgl also regulate the Hippo pathway. Lgl inhibits PKC/ζ which 
activates the Hippo pathway. So if PKC/ζ is not inhibited the Hippo pathway is inhibited 
by PKC/ζ leading to Yorkie activation. PKC/ζ inhibits the Hippo pathway by 
mislocalising Hippo and dRASSF, therefore preventing the interaction of Hippo with 
Salvador (Grzeschik et al., 2010). However, how this affect by PKC/ζ is mediated is 
unknown. This links polarity complexes directly to Hippo pathway regulation 
6.1.8 The Hippo Pathway and Polarity 
In Drosophila it has also been shown that Warts mutant cells have larger apical 
domains (Justice et al., 1995). Two papers have been recently published that link polarity 
and the hippo pathway, both used Drosophila as a model organism. Genevet and 
111 
colleagues created a null Hippo mutant and showed that in imaginal discs there is an 
increase in the apical domain and an increase in the amount of PKC protein present at the 
apical membrane (Genevet et al., 2009). They also showed that the adherens junctions are 
larger. The authors suggest that either Yorkie activates an apical determinant or that there 
maybe an imbalance between apical and basal endocytosis. Hamaratoglu and colleagues 
showed that in Hippo and Warts mutants, membrane levels of DaPKC, Patj and Crumbs 
are increased in the wing, antenna and eye imaginal discs (Hamaratoglu et al., 2009). The 
authors suggest that the Hippo pathway regulates the amount of apical complexes at the 
membrane. 
On the basis of the polarity and Hippo pathway links and that PKC is often 
upregulated in cancer, as is Yap; Yap became a possible target of PKC. The following 
work was done in collaboration with Dr. Makoto Furutani-Seiki and Dr. Stefan Bagby 
(University of Bath). As this is a collaboration, Medaka Yap and Taz were used. The Yap 
and Taz only contain about first 250 amino acids, they are missing about 200 aminoacids 
from the C-terminal, which contains a PDZ motif and SH3 domain. 
6.2 Results 
6.2.1 PKC Phosphorylates Yap and Taz 
As the Hippo pathway appears to interact with polarity proteins it was hypothesised 
that PKC may directly phosphorylate members of the Hippo pathway. Yap and Taz were 
scanned using Scansite which showed they have predicted PKC phosphorylation sites and 
Figure 6.2a depicts the domains of the proteins with the predicted scansite phosphorylation 
sites in black and the Lats sites in red. The S397 is not shown as this is a small piece of 
Yap that does not contain this site. Purified Yap and Taz were kindly donated by Claire 
Webb and Stefan Bagby (University of Bath). The Coomassie stain of the purified proteins 
is shown in figure 6.2b. These proteins were put into a kinase assay with PKC, run on an 
SDS-PAGE gel and visualised using autoradiography. Clear phosphorylation of Yap and 
Taz by PKC can be seen in figure 6.2c; therefore, Yap and Taz are in vitro PKC targets. 
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Figure 6.2 Yap and Taz are Phosphorylated by PKC in vitro 
(a) A schematic diagram of the domains of Yap and Taz tagged to His including the 
phosphorylation sites predicted by Scansite in black (S54 and S45 respectively) and the 
known Lats phosphorylation sites for Yap in red, (b) His column purified Taz and Yap, 
(c) The purified His-tagged Taz and Yap were used in a kinase assay with PKC. Clear 
phosphorylation of Taz and Yap can be seen on the autoradiograph. 
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6.2.2 A Truncated Version of Yap and Taz, Missing the Potential PKC 
Phosphorylation Sites Predicted by Scansite is Not Phosphorylated by PKC 
The predicted PKC phosphorylation sites for Yap and Taz were at S54 and S45 
respectively. Claire Webb and Stefan Bagby kindly donated purified Yap and Taz that was 
truncated so didn’t contain the predicted PKC phosphorylation sites; however, it does still 
contain the three of the five serines phosphorylated by Lats1. 
The schematic diagrams for the truncated Yap and Taz are depicted in figure 6.3a. 
The truncated proteins were put into a kinase assay with PKC, run on an SDS-PAGE gel 
and visualised by autoradiography. The truncated Yap and Taz proteins were not 
phosphorylated by PKC in an in vitro kinase assay (figure 6.3b). This experiment was 
repeated three times and the same result was achieved each time, so it can be concluded 
that PKC phosphorylates the N-terminal part of Yap and Taz. MBP was used as a positive 
control, to ensure the PKC was functional. MBP was phosphorylated by PKC (figure 
6.3c) indicating that the in vitro kinase assay worked correctly. 
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Figure 6.3 A Truncated Version of Yap and Taz, Missing the Potential PKC 
Phosphorylation Sites Predicted by Scansite is not Phosphorylated by PKC 
(a) A schematic diagram of the domains of truncated Yap and Taz tagged to His which are 
missing the potential PKC phosphorylation site predicted by Scansite, but still contain 
three of the Lats sites (in red), (b) The purified, truncated Yap and Taz were used in a 
kinase assay with PKC. No phosphorylation could be visualised on the autoradiograph, (c) 
MBP was used as a positive control for the kinase assay; clear phosphorylation of MBP 
can be seen on the autoradiograph. 
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6.2.3 Mutated Yap and Taz are still Phosphorylated by PKC 
Plasmid DNA coding for Yap and Taz was kindly donated by Makoto Furutani-
Seiki. To determine if Yap and Taz are phosphorylated on S54 and S45 respectively, they 
were mutated to alanines. The sequences surrounding the predicted phosphorylation sites 
are identical, so the same primers were used for both Yap and Taz. The sequences are 
depicted in figure 6.4. 
Yap - VVPQSVPMRMRKLPDSFFKPPEPKSHSRQASTDAG 
Taz - RQPSSVPMRMRKLPDSFFKPPEPRGHSRQASSDGG 
Figure 6.4 Sequence Comparisons Between Taz and Yap 
A sequence comparison of the amino acids surrounding the predicted serine 
phosphorylated by PKC (in red). The amino acids either side of the predicted serine are 
almost identical although they differ more as you get further upstream or downstream of 
the serine. 
The mutations were made using site directed mutagenesis and confirmed by 
sequencing. The schematics in figure 6.5a depict the domains of Yap and Taz with their 
mutations. 
The Yap and Taz proteins were made in E.coli and purified. The mutant proteins 
along side the wild type were then put into a kinase assay with PKC as before. The kinase 
assay products were then run on an SDS-PAGE gel and visualised using autoradiography. 
The top panels in figures 6.5b and c show the Coomassie stained gel and therefore the 
proteins in the kinase assay. The lower panels in figure 6.5b and c shows the 
autoradiograph. Yap and Taz S54A and S45A mutants are still phosphorylated by PKC. 
This result indicates that this site is either not phosphorylated by PKC or that it is and is 
one of multiple PKC phosphorylation sites in Yap and Taz. It is likely that there are 
multiple sites as the phosphorylation of the mutants appeared to be less than that of the 
wild type protein. However, this has not been quantified. 
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Figure 6.5 Yap and Taz, when Mutated at the Scansite Predicted Serine are still 
Phosphorylated by PKC in an in vitro Kinase Assay 
(a) A schematic of the domains of Taz and Yap tagged to His including the serine 
phosphorylation sites predicted by Scansite mutated to alanine, (b) The purified His-tagged 
S54A Yap was used in a kinase assay with PKC. Clear phosphorylation of S54A Yap can 
be seen on the autoradiograph (lower panel). The purified S54A Yap protein can be seen 
on the Coomassie stained kinase assay SDS-PAGE gel (top panel), (c) The purified His-
tagged S45A Taz was used in a kinase assay with PKC. Clear phosphorylation of S45A 
Taz can be seen on the autoradiograph. The purified S45A Taz protein can be seen on the 
Coomassie stained kinase assay SDS-PAGE gel (top panel). 
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6.2.4 Overexpression of Yap and PKC causes Nuclear Accumulation of Yap 
The data shown in figures 6.2, 6.3 and 6.5 show that PKC phosphorylates Yap and 
Taz. To begin to establish the functional relevance of this it was decided to overexpress 
human Yap and human constitutively active PKC together in MDCK cells and see if there 
was any movement of Yap within the cell. 
The consitutively active PKC has an alanine to glutamate substitution at residue 
120. this is within the pseudosubstrate domain and has been shown to be active using an 
invitro kinase assay (Spitaler et al., 2000). When Yap is overexpressed in MDCK cells 
alone it shows uniform cytoplasmic staining (figure 6.6a). However, when PKC and Yap 
were overexpressed together in MDCK cells strong nuclear staining of Yap could be seen 
(figure 6.6b). Therefore, PKC causes Yap nuclear translocation. The in vitro studies were 
carried out with Medaka Yap, however, in the expression studies Human Yap was used. 
The two proteins are similar and the predicted PKC phosphorylation site is conserved. 
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a 
Yap-Flag Active PKCι TOPRO-3 Combined 
b 
Yap-Flag Active PKCι TOPRO-3 Combined 
Figure 6.6 PKC Causes Yap to Move into the Nucleus when they are Overexpressed 
in MDCK Cells 
(a) When Flag tagged Yap is overexpressed in MDCK cells it shows uniform cytoplasmic 
staining,  two representative images containing transfected cells are shown (upper and 
lower panels) (b) When Flag tagged Yap is overexpressed with PKC in MDCK cells, 
there is clear nuclear accumulation of Yap, but not PKC, two representative images 
containing transfected cells are shown. The antibody used can detect PKC and PKCζ. 
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6.3 Discussion 
Yap and Taz act at the end of the Hippo signalling pathway. The data presented 
here shows that PKC phosphorylates Yap and Taz in vitro on the N-terminal part of the 
protein (figure 6.3) and PKC can promote the nuclear localisation of Yap (figure 6.4). 
It appears that S54 and S45 are not the only phosphorylation targets for Yap and 
Taz respectively. When these sites were mutated to alanine phosphorylation of Yap and 
Taz by PKC still occurs (figure 6.4). Therefore, these serines may be a PKC 
phosphorylation targets, but cannot be the only phosphorylation site. The slight reduction 
in phosphorylation of the mutant Yap and Taz is consistent with this idea. This needs to be 
investigated further. The Yap and Taz protein sequences will have to be examined 
manually using the PSSM for PKC (Fujii et al., 2004). There are thirteen serines and two 
threonines in the N-terminal half of Yap and Taz. This will allow a screen of the sequence 
and will hopefully identify candidate serine or threonine PKC phosphorylation sites that 
can be mutated to alanine and used in an in vitro kinase assay to identify the PKC 
phosphorylation site(s). The C-terminal half of Yap and Taz also needs to be checked 
using the in vitro kinase assay for PKC phosphorylation. This phosphorylation also needs 
to be investigated in vivo. Once the phosphorylation sites have been elucidated a phospho-
specific antibody could be generated and applied to cells overexpressing Yap and PKC to 
see if it is the phosphorylation that causes nuclear localisation. The phospho-specific 
antibody could also be used to look for endogenous Yap phosphorylation. If PKC 
phosphorylation causes Yap to move into the nucleus then only phospho-Yap will be seen 
in the nucleus. Another use for this antibody could be to see whether knocking down 
PKC/ζ stops the Yap phosphorylation, to show that PKC/ζ is the only kinase that 
phosphorylates Yap on those site(s). 
When PKC and Yap are overexpressed together, a significant portion of the Yap 
protein relocalises to the nucleus (figure 6.5). The phosphorylation of Yap by PKC is 
likely to be the signal for Yap to move into the nucleus. This will have to be proven once 
the site(s) of Yap phosphorylation by PKC are found. These site(s) can be mutated to 
alanine and if when overexpressed with PKC the serine-alanine mutant does not go into 
the nucleus, the PKC phosphorylation is the signal. This can be achieved using a Yap 
antibody or tagging the mutated Yap and using an antibody against the Tag. It will also be 
interesting to see if PKC overexpression has the same effect on endogenous Yap as it does 
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on overexpressed Yap. A PKC/ζ inhibitor could also be used to test whether endogenous 
Yap becomes less phosphorylated or moves out of the nucleus upon PKC/ζ inhibition. 
The phosphorylation of Taz by PKC also needs to be investigated as little is 
known about the targets or regulation of Taz. To see if the same effect of PKC on Yap 
occurs with Taz, it will be interesting to overexpress Taz with PKC and see if nuclear 
accumulation of Taz occurs. If it does, the same experiments described for Yap can be 
carried out. 
As high nuclear levels of Yap are found in many cancers (Steinhardt et al., 2008; 
Zhao et al., 2007), as is PKC (Eder et al., 2005; Kojima et al., 2008; Li et al., 2008; Patel 
et al., 2008; Regala et al., 2005b; Scotti et al., 2010; Takagawa et al., 2010; Wang et al., 
2009; Yang et al., 2008; Zhang et al., 2006) and the overexpression phenotype of Yap is 
tissue overgrowth and transformation (Overholtzer et al., 2006), it is possible that one of 
the effects of PKC overexpression in cancer is to cause Yap to move into the nucleus and 
act as a transcriptional co-activator leading to transformation and overgrowth. This theory 
can be tested by knocking down Yap in a PKC high expression setting such as a cancer 
cell line with high PKC levels, such as A549, and see if transformation and proliferation 
still occur. 
In a normal non-cancerous setting, the Hippo signal may override the PKC signal 
as PKC is mainly localised to the apical junctions not the nucleus (chapter 3). This may 
prevent PKC from binding to and phosphorylating Yap, and therefore giving it a nuclear 
signal. However, PKC may also phosphorylate Yap in the cytoplasm. PKC/ζ also 
regulates the Hippo pathway by mislocalising Hippo, so there are two modes of Hippo 
regulation by PKC/ζ (see introduction and depicted in figure 6.6). The two complexes, 
Hippo and polarity, may negatively regulate each other as Hippo signalling suppresses the 
amount of apical complexes (Hamaratoglu et al., 2009) and PKC suppresses the Hippo 
pathway by phosphorylating and activating Yap as well as regulating Hippo localisation. 
Although this interaction needs to be investigated further, it has potential to help explain 
the function of these two oncogenic pathways. 
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Figure 6.6 PKC and the Hippo Pathway 
PKC inhibits the Hippo pathway by mislocalising Hippo, preventing the phosphorylation 
and activation of Warts. PKC also directly phosphorylates Yap causing Yap nuclear 
accumulation. 
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Chapter 7 
Final Summary and Future Directions 
The aim of the work described here was to discover new substrates of PKC with 
the aim of elucidating how PKC functions in cancer. 
Chapter 3 demonstrates the localisation of the atypical PKC proteins. Antibody 
staining revealed that both PKC and PKCζ localise to the tight junctions. Further staining 
revealed that both isoforms also localise to the centrosomes during mitosis. The staining 
using the active phospho-PKC antibody indicated that PKC/ζ was active at the 
centrosomes. Further work is required to determine which aPKC isoform is active at the 
centrosomes, or whether they are both active there. 
To elucidate novel PKC phosphorylation targets a kinase assay was developed 
(Chapter 4). Initially PKC was overexpressed in Xenopus embryos with the known 
phosphorylation targets, Lgl and Par-1. These were then immunoprecipitated and subjected 
to a Western blot with pan phospho-serine and threonine antibodies. Unfortunately the 
antibodies did not recognise the phospho-Lgl or Phospho-Par-1. An in vitro kinase assay 
using commercially obtained PKC, Lgl and Par-1b purified from Xenopus embryos and 
radiolabelled ATP was then tried. Par-1b phosphorylation could not be detected. The Lgl 
phosphorylation could be detected, but unfortunately PKC immunoprecipitated with the 
Lgl, resulting in phosphorylation of Lgl, with and without the addition of PKC to the 
kinase assay. Due to these difficulties it was decided to express the proteins in bacteria so 
that PKC would not be immunoprecipitated with the candidate phosphorylation target. 
This was successfully achieved using GST-Par-1 and an in vitro kinase assay successfully 
carried out. 
The establishment of the in vitro kinase assay allowed the testing of potential PKC 
phosphorylation targets. As PKC/ζ is a crucial regulator of cell polarity, possible polarity 
phosphorylation targets were tested using the in vitro kinase assay (Chapter 5). Patj and 
Scribbles were not successfully cloned into the GST vector and will require further work to 
be able to test these in a kinase assay. The cloning of Pals-1 and Dlg was successful and 
these were used in the kinase assay.  Pals-1 displayed no detectable phosphorylation by 
PKC, indicating that it is not a substrate of PKC. Dlg also showed no detectable 
phosphorylation by PKC, but interestingly increased the amount of PKC 
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autophosphorylation. The phosphorylation cannot be Dlg phosphorylating PKC as Dlg has 
no functional kinase domain. This indicates that Dlg, by binding to PKC causes it to 
autophosphorylate and activate itself further. This result demonstrates a new method of 
PKC activation and it will be interesting to see if this activation occurs in vivo. Dlg is 
found at the centrosomes, during metaphase, as is PKC, so Dlg could cause the activation 
of PKC at the centrosomes during mitosis. Testing this hypothesis will require further 
investigation, possibly by overexpression of Dlg in cultured cells, and seeing if the 
phosphorylation of PKC substrates increases or if the autophosphorylation of PKC itself 
increases. It will also be interesting to see if the Dlg induced autophosphorylation occurs 
during metaphase when PKC is active at the centrosomes. The cells could be arrested in 
metaphase and then PKC/ζ can be immunoprecipitated out and Western blotting used to 
see if Dlg is bound to PKC during mitosis. 
Yurt is another polarity protein that is regulated by phosphorylation in Drosophila, 
however, the kinase responsible is currently unknown. Yurt was not investigated in this 
project but future work could examine if Yurt is regulated by phosphorylation in 
mammalian cells and if this phosphorylation is carried out by PKC. This can be achieved 
initially using the kinase assay described here with mammalian Yurt. If Yurt is 
phosphorylated by PKC, further studies can be carried out to see if this phosphorylation 
occurs in vivo and the effects of the phosphorylation. 
The staining in Chapter 3 also led to the testing of centrosomal proteins as potential 
PKC phosphorylation targets (Chapter 5). Unfortunately, the two proteins tested, LGN 
and GSK3β displayed no detectable phosphorylation by PKC, indicating that they are not 
direct phosphorylation substrates of PKC. Further candidates will have to be tested to find 
the phosphorylation target(s) of PKC at the centrosomes. One of these could be Rassf7, 
which localises to the centrosomes (Sherwood et al., 2008) and has predicted PKC/ζ 
phosphorylation sites. Another centrosomal and spindle localised protein is the GEF Ect2 
(Oceguera-Yanez et al., 2005), at the centrosomes, Ect2 activates Cdc42 by regulating the 
amount of GTP bound to it. Ect2 has been linked to the Par-PKC complex in NSCLC and 
has been shown to bind the complex (Justilien and Fields, 2009). In early mitosis Ect2 is 
phosphorylated by an unknown kinase, PKC/ζ could phosphorylate Ect2, at the 
centrosomes, leading to Cdc42 activation and further PKC/ζ activation, creating a positive 
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feedback loop. This needs to be investigated starting with the in vitro kinase assay 
described here. 
The final chapter demonstrates that PKC can phosphorylate and cause nuclear 
accumulation of the Hippo pathway members Yap and Taz. The site(s) phosphorylated by 
PKC, remain unknown, but they are in the N-terminal half of the protein. The 
phosphorylation of Yap and Taz and the nuclear accumulation of Yap upon overexpression 
with PKC is particularly exciting as it may help to explain the mechanism by which PKC 
functions in tumorigenesis. PKC is upregulated in cancer and this upregulation may cause 
Yap phosphorylation and nuclear entry. Overexpression of Yap causes tissue overgrowth, 
so the regulation of Yap by PKC may explain how PKC functions in cancer. It will be 
interesting to test it if is the phosphorylation by PKC that causes Yap to go into the 
nucleus when they are overexpressed together. It will also be interesting to test whether 
PKC phosphorylates Yap in a normal cell setting or just during growth. 
A summary of the published phosphorylation substrates, substrates identified in this 
work and substrates that have been shown to not be phosphorylated in vitro including 
published data and data from this project by PKC are listed in table 7.1. 
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Proteins Phosphorylated by PKC/ζ 
Protein Reference 
Lgl (Betschinger et al., 2003) 
Par-1 (Hurov et al., 2004) 
Par-3 (Nagai-Tamai et al., 2002) 
Crumbs (Sotillos et al., 2004) 
X-GAP (Hyodo-Miura et al., 2006) 
p70 S6 Kinase (Akimoto et al., 1998) 
IKKβ (Win and Acevedo-Duncan, 2008) 
Numb (Smith et al., 2007) 
ZO-2 (Avila-Flores et al., 2001) 
Nucleolin (Zhou et al., 1997) 
Ezrin (Wald et al., 2008) 
Miranda (Atwood and Prehoda, 2009) 
Bad (Jin et al., 2005) 
Src-3 (Garabedian and Logan, 2008; Yi et al., 2008) 
IRS-1 (Weyrich et al., 2007) 
Yap This work 
Taz This work 
Proteins Not Directly Phosphorylated by PKC/ζ 
Par-6 (Lin et al., 2000) 
GSK3β This work 
LGN This work 
Pals-1 This work 
Dlg This work 
Table 7.1 A list of the known positive and negative phosphorylation substrates of 
PKC 
Overall these results provide an interesting platform for further research to 
elucidate the mechanisms of PKC regulation and the mechanisms by which PKC carries 
out its normal functions and promotes tumour growth 
126 
References 
Akimoto, K., Mizuno, K., Osada, S., Hirai, S., Tanuma, S., Suzuki, K., Ohno, S., 1994. A 
new member of the third class in the protein kinase C family, PKC lambda, 
expressed dominantly in an undifferentiated mouse embryonal carcinoma cell line 
and also in many tissues and cells. J Biol Chem. 269, 12677-83. 
Akimoto, K., Nakaya, M., Yamanaka, T., Tanaka, J., Matsuda, S., Weng, Q. P., Avruch, J., 
Ohno, S., 1998. Atypical protein kinase Clambda binds and regulates p70 S6 
kinase. Biochem J. 335 ( Pt 2), 417-24. 
Alieva, I. B., Uzbekov, R. E., 2008. The centrosome is a polyfunctional multiprotein cell 
complex. Biochemistry (Mosc). 73, 626-43. 
Amanchy, R., Periaswamy, B., Mathivanan, S., Reddy, R., Tattikota, S. G., Pandey, A., 
2007. A curated compendium of phosphorylation motifs. Nat Biotechnol. 25, 285-
6. 
Andersen, J. S., Wilkinson, C. J., Mayor, T., Mortensen, P., Nigg, E. A., Mann, M., 2003. 
Proteomic characterization of the human centrosome by protein correlation 
profiling. Nature. 426, 570-4. 
Aono, S., Hirai, Y., 2008. Phosphorylation of claudin-4 is required for tight junction 
formation in a human keratinocyte cell line. Exp Cell Res. 314, 3326-39. 
Atwood, S. X., Prehoda, K. E., 2009. aPKC phosphorylates Miranda to polarize fate 
determinants during neuroblast asymmetric cell division. Curr Biol. 19, 723-9. 
Avila-Flores, A., Rendon-Huerta, E., Moreno, J., Islas, S., Betanzos, A., Robles-Flores, 
M., Gonzalez-Mariscal, L., 2001. Tight-junction protein zonula occludens 2 is a 
target of phosphorylation by protein kinase C. Biochem J. 360, 295-304. 
Bachmann, A., Schneider, M., Theilenberg, E., Grawe, F., Knust, E., 2001. Drosophila 
Stardust is a partner of Crumbs in the control of epithelial cell polarity. Nature. 
414, 638-43. 
Badouel, C., Gardano, L., Amin, N., Garg, A., Rosenfeld, R., Le Bihan, T., McNeill, H., 
2009. The FERM-domain protein Expanded regulates Hippo pathway activity via 
direct interactions with the transcriptional activator Yorkie. Dev Cell. 16, 411-20. 
Balda, M. S., Matter, K., 1998. Tight junctions. J Cell Sci. 111 ( Pt 5), 541-7. 
Balklava, Z., Pant, S., Fares, H., Grant, B. D., 2007. Genome-wide analysis identifies a 
general requirement for polarity proteins in endocytic traffic. Nat Cell Biol. 9, 
1066-73. 
Baluch, D. P., Capco, D. G., 2008. GSK3 beta mediates acentromeric spindle stabilization 
by activated PKC zeta. Dev Biol. 317, 46-58. 
Bandyopadhyay, G., Standaert, M. L., Sajan, M. P., Kanoh, Y., Miura, A., Braun, U., 
Kruse, F., Leitges, M., Farese, R. V., 2004. Protein kinase C-lambda knockout in 
embryonic stem cells and adipocytes impairs insulin-stimulated glucose transport. 
Mol Endocrinol. 18, 373-83. 
Basu, S., Totty, N. F., Irwin, M. S., Sudol, M., Downward, J., 2003. Akt phosphorylates 
the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation 
of p73-mediated apoptosis. Mol Cell. 11, 11-23. 
Baumgartner, R., Poernbacher, I., Buser, N., Hafen, E., Stocker, H., 2010. The WW 
domain protein Kibra acts upstream of Hippo in Drosophila. Dev Cell. 18, 309-16. 
Benton, R., St Johnston, D., 2003. Drosophila PAR-1 and 14-3-3 inhibit Bazooka/PAR-3 
to establish complementary cortical domains in polarized cells. Cell. 115, 691-704. 
Betschinger, J., Mechtler, K., Knoblich, J. A., 2003. The Par complex directs asymmetric 
cell division by phosphorylating the cytoskeletal protein Lgl. Nature. 422, 326-30. 
127 
Bhat, M. A., Izaddoost, S., Lu, Y., Cho, K. O., Choi, K. W., Bellen, H. J., 1999. Discs 
Lost, a novel multi-PDZ domain protein, establishes and maintains epithelial 
polarity. Cell. 96, 833-45. 
Bilder, D., Li, M., Perrimon, N., 2000. Cooperative regulation of cell polarity and growth 
by Drosophila tumor suppressors. Science. 289, 113-6. 
Blom, N., Gammeltoft, S., Brunak, S., 1999. Sequence and structure-based prediction of 
eukaryotic protein phosphorylation sites. J Mol Biol. 294, 1351-62. 
Bobinnec, Y., Morin, X., Debec, A., 2006. Shaggy/GSK-3beta kinase localizes to the 
centrosome and to specialized cytoskeletal structures in Drosophila. Cell Motil 
Cytoskeleton. 63, 313-20. 
Bossinger, O., Klebes, A., Segbert, C., Theres, C., Knust, E., 2001. Zonula adherens 
formation in Caenorhabditis elegans requires dlg-1, the homologue of the 
Drosophila gene discs large. Dev Biol. 230, 29-42. 
Bowman, S. K., Neumuller, R. A., Novatchkova, M., Du, Q., Knoblich, J. A., 2006. The 
Drosophila NuMA Homolog Mud regulates spindle orientation in asymmetric cell 
division. Dev Cell. 10, 731-42. 
Buther, K., Plaas, C., Barnekow, A., Kremerskothen, J., 2004. KIBRA is a novel substrate 
for protein kinase Czeta. Biochem Biophys Res Commun. 317, 703-7. 
Cai, Y., Yu, F., Lin, S., Chia, W., Yang, X., 2003. Apical complex genes control mitotic 
spindle geometry and relative size of daughter cells in Drosophila neuroblast and pI 
asymmetric divisions. Cell. 112, 51-62. 
Callus, B. A., Verhagen, A. M., Vaux, D. L., 2006. Association of mammalian sterile 
twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, 
leads to its stabilization and phosphorylation. FEBS J. 273, 4264-76. 
Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R., 
Brummelkamp, T. R., 2007. YAP1 increases organ size and expands 
undifferentiated progenitor cells. Curr Biol. 17, 2054-60. 
Caruana, G., Bernstein, A., 2001. Craniofacial dysmorphogenesis including cleft palate in 
mice with an insertional mutation in the discs large gene. Mol Cell Biol. 21, 1475-
83. 
Chabu, C., Doe, C. Q., 2008. Dap160/intersectin binds and activates aPKC to regulate cell 
polarity and cell cycle progression. Development. 135, 2739-46. 
Chalmers, A. D., Pambos, M., Mason, J., Lang, S., Wylie, C., Papalopulu, N., 2005. aPKC, 
Crumbs3 and Lgl2 control apicobasal polarity in early vertebrate development. 
Development. 132, 977-86. 
Chalmers, A. D., Strauss, B., Papalopulu, N, 2003. Oriented cell divisions assymetrically 
segregate aPKC and generate cell fate diversity in the early Xenopus embryo. . 
Development. 2657-2668. 
Chan, E. H., Nousiainen, M., Chalamalasetty, R. B., Schafer, A., Nigg, E. A., Sillje, H. H., 
2005. The Ste20-like kinase Mst2 activates the human large tumor suppressor 
kinase Lats1. Oncogene. 24, 2076-86. 
Chen, C. L., Hsieh, Y. T., Chen, H. C., 2007. Phosphorylation of adducin by protein kinase 
Cdelta promotes cell motility. J Cell Sci. 120, 1157-67. 
Chen, X., Macara, I. G., 2005. Par-3 controls tight junction assembly through the Rac 
exchange factor Tiam1. Nat Cell Biol. 7, 262-9. 
Chishti, A. H., Kim, A. C., Marfatia, S. M., Lutchman, M., Hanspal, M., Jindal, H., Liu, S. 
C., Low, P. S., Rouleau, G. A., Mohandas, N., Chasis, J. A., Conboy, J. G., 
Gascard, P., Takakuwa, Y., Huang, S. C., Benz, E. J., Jr., Bretscher, A., Fehon, R. 
G., Gusella, J. F., Ramesh, V., Solomon, F., Marchesi, V. T., Tsukita, S., Hoover, 
128 
K. B., et al., 1998. The FERM domain: a unique module involved in the linkage of 
cytoplasmic proteins to the membrane. Trends Biochem Sci. 23, 281-2. 
Cho, E., Feng, Y., Rauskolb, C., Maitra, S., Fehon, R., Irvine, K. D., 2006. Delineation of a 
Fat tumor suppressor pathway. Nat Genet. 38, 1142-50. 
Cohen, D., Brennwald, P. J., Rodriguez-Boulan, E., Musch, A., 2004. Mammalian PAR-1 
determines epithelial lumen polarity by organizing the microtubule cytoskeleton. J 
Cell Biol. 164, 717-27. 
Cohen, D., Musch, A., 2003. Apical surface formation in MDCK cells: regulation by the 
serine/threonine kinase EMK1. Methods. 30, 269-76. 
Cohen, P., Knebel, A., 2006. KESTREL: a powerful method for identifying the 
physiological substrates of protein kinases. Biochem J. 393, 1-6. 
Compton, D. A., 2000. Spindle assembly in animal cells. Annu Rev Biochem. 69, 95-114. 
Costa, M. R., Wen, G., Lepier, A., Schroeder, T., Gotz, M., 2008. Par-complex proteins 
promote proliferative progenitor divisions in the developing mouse cerebral cortex. 
Development. 135, 11-22. 
Cowan, C. R., Hyman, A. A., 2007. Acto-myosin reorganization and PAR polarity in C. 
elegans. Development. 134, 1035-43. 
Cox, D. N., Lu, B., Sun, T. Q., Williams, L. T., Jan, Y. N., 2001. Drosophila par-1 is 
required for oocyte differentiation and microtubule organization. Curr Biol. 11, 75-
87. 
den Hollander, A. I., Ghiani, M., de Kok, Y. J., Wijnholds, J., Ballabio, A., Cremers, F. P., 
Broccoli, V., 2002. Isolation of Crb1, a mouse homologue of Drosophila crumbs, 
and analysis of its expression pattern in eye and brain. Mech Dev. 110, 203-7. 
den Hollander, A. I., ten Brink, J. B., de Kok, Y. J., van Soest, S., van den Born, L. I., van 
Driel, M. A., van de Pol, D. J., Payne, A. M., Bhattacharya, S. S., Kellner, U., 
Hoyng, C. B., Westerveld, A., Brunner, H. G., Bleeker-Wagemakers, E. M., 
Deutman, A. F., Heckenlively, J. R., Cremers, F. P., Bergen, A. A., 1999. 
Mutations in a human homologue of Drosophila crumbs cause retinitis pigmentosa 
(RP12). Nat Genet. 23, 217-21. 
Denning, M. F., 2007. Tightening the epidermal barrier with atypical PKCs. J Invest 
Dermatol. 127, 742-4. 
Diaz-Meco, M. T., Lozano, J., Municio, M. M., Berra, E., Frutos, S., Sanz, L., Moscat, J., 
1994. Evidence for the in vitro and in vivo interaction of Ras with protein kinase C 
zeta. J Biol Chem. 269, 31706-10. 
Diaz-Meco, M. T., Municio, M. M., Frutos, S., Sanchez, P., Lozano, J., Sanz, L., Moscat, 
J., 1996a. The product of par-4, a gene induced during apoptosis, interacts 
selectively with the atypical isoforms of protein kinase C. Cell. 86, 777-86. 
Diaz-Meco, M. T., Municio, M. M., Sanchez, P., Lozano, J., Moscat, J., 1996b. Lambda-
interacting protein, a novel protein that specifically interacts with the zinc finger 
domain of the atypical protein kinase C isotype lambda/iota and stimulates its 
kinase activity in vitro and in vivo. Mol Cell Biol. 16, 105-14. 
Diella, F., Gould, C. M., Chica, C., Via, A., Gibson, T. J., 2008. Phospho.ELM: a database 
of phosphorylation sites--update 2008. Nucleic Acids Res. 36, D240-4. 
Doerflinger, H., Benton, R., Shulman, J. M., St Johnston, D., 2003. The role of PAR-1 in 
regulating the polarised microtubule cytoskeleton in the Drosophila follicular 
epithelium. Development. 130, 3965-75. 
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., 
Anders, R. A., Maitra, A., Pan, D., 2007. Elucidation of a universal size-control 
mechanism in Drosophila and mammals. Cell. 130, 1120-33. 
129 
Dow, L. E., Brumby, A. M., Muratore, R., Coombe, M. L., Sedelies, K. A., Trapani, J. A., 
Russell, S. M., Richardson, H. E., Humbert, P. O., 2003. hScrib is a functional 
homologue of the Drosophila tumour suppressor Scribble. Oncogene. 22, 9225-30. 
Dow, L. E., Humbert, P. O., 2007. Polarity regulators and the control of epithelial 
architecture, cell migration, and tumorigenesis. Int Rev Cytol. 262, 253-302. 
Du, Q., Macara, I. G., 2004. Mammalian Pins is a conformational switch that links NuMA 
to heterotrimeric G proteins. Cell. 119, 503-16. 
Du, Q., Stukenberg, P. T., Macara, I. G., 2001. A mammalian Partner of inscuteable binds 
NuMA and regulates mitotic spindle organization. Nat Cell Biol. 3, 1069-75. 
Du, Q., Taylor, L., Compton, D. A., Macara, I. G., 2002. LGN blocks the ability of NuMA 
to bind and stabilize microtubules. A mechanism for mitotic spindle assembly 
regulation. Curr Biol. 12, 1928-33. 
Ebnet, K., Suzuki, A., Ohno, S., Vestweber, D., 2004. Junctional adhesion molecules 
(JAMs): more molecules with dual functions? J Cell Sci. 117, 19-29. 
Eckert, J. J., McCallum, A., Mears, A., Rumsby, M. G., Cameron, I. T., Fleming, T. P., 
2005. Relative contribution of cell contact pattern, specific PKC isoforms and gap 
junctional communication in tight junction assembly in the mouse early embryo. 
Dev Biol. 288, 234-47. 
Eder, A. M., Sui, X., Rosen, D. G., Nolden, L. K., Cheng, K. W., Lahad, J. P., Kango-
Singh, M., Lu, K. H., Warneke, C. L., Atkinson, E. N., Bedrosian, I., Keyomarsi, 
K., Kuo, W. L., Gray, J. W., Yin, J. C., Liu, J., Halder, G., Mills, G. B., 2005. 
Atypical PKCiota contributes to poor prognosis through loss of apical-basal 
polarity and cyclin E overexpression in ovarian cancer. Proc Natl Acad Sci U S A. 
102, 12519-24. 
Elbert, M., Cohen, D., Musch, A., 2006. PAR1b promotes cell-cell adhesion and inhibits 
dishevelled-mediated transformation of Madin-Darby canine kidney cells. Mol Biol 
Cell. 17, 3345-55. 
Etemad-Moghadam, B., Guo, S., Kemphues, K. J., 1995. Asymmetrically distributed PAR-
3 protein contributes to cell polarity and spindle alignment in early C. elegans 
embryos. Cell. 83, 743-52. 
Etienne-Manneville, S., Hall, A., 2003a. Cdc42 regulates GSK-3beta and adenomatous 
polyposis coli to control cell polarity. Nature. 421, 753-6. 
Etienne-Manneville, S., Hall, A., 2003b. Cell polarity: Par6, aPKC and cytoskeletal 
crosstalk. Curr Opin Cell Biol. 15, 67-72. 
Etienne-Manneville, S., Manneville, J. B., Nicholls, S., Ferenczi, M. A., Hall, A., 2005. 
Cdc42 and Par6-PKCzeta regulate the spatially localized association of Dlg1 and 
APC to control cell polarization. J Cell Biol. 170, 895-901. 
Fan, S., Hurd, T. W., Liu, C. J., Straight, S. W., Weimbs, T., Hurd, E. A., Domino, S. E., 
Margolis, B., 2004. Polarity proteins control ciliogenesis via kinesin motor 
interactions. Curr Biol. 14, 1451-61. 
Farese, R. V., Sajan, M. P., Yang, H., Li, P., Mastorides, S., Gower, W. R., Jr., Nimal, S., 
Choi, C. S., Kim, S., Shulman, G. I., Kahn, C. R., Braun, U., Leitges, M., 2007. 
Muscle-specific knockout of PKC-lambda impairs glucose transport and induces 
metabolic and diabetic syndromes. J Clin Invest. 117, 2289-301. 
Farquhar, M. G., Palade, G. E., 1963. Junctional complexes in various epithelia. J Cell 
Biol. 17, 375-412. 
Feng, Y., Irvine, K. D., 2009. Processing and phosphorylation of the Fat receptor. Proc 
Natl Acad Sci U S A. 106, 11989-94. 
130 
Fields, A. P., Frederick, L. A., Regala, R. P., 2007. Targeting the oncogenic protein kinase 
Ciota signalling pathway for the treatment of cancer. Biochem Soc Trans. 35, 996-
1000. 
Fields, A. P., Regala, R. P., 2007. Protein kinase C iota: human oncogene, prognostic 
marker and therapeutic target. Pharmacol Res. 55, 487-97. 
Fujii, K., Zhu, G., Liu, Y., Hallam, J., Chen, L., Herrero, J., Shaw, S., 2004. Kinase peptide 
specificity: improved determination and relevance to protein phosphorylation. Proc 
Natl Acad Sci U S A. 101, 13744-9. 
Fukunaga, R., Hunter, T., 1997. MNK1, a new MAP kinase-activated protein kinase, 
isolated by a novel expression screening method for identifying protein kinase 
substrates. Embo J. 16, 1921-33. 
Fumoto, K., Hoogenraad, C. C., Kikuchi, A., 2006. GSK-3beta-regulated interaction of 
BICD with dynein is involved in microtubule anchorage at centrosome. Embo J. 
25, 5670-82. 
Garabedian, M. J., Logan, S. K., 2008. Atypical regulation of SRC-3. Trends Biochem Sci. 
33, 301-4. 
Genevet, A., Polesello, C., Blight, K., Robertson, F., Collinson, L. M., Pichaud, F., Tapon, 
N., 2009. The Hippo pathway regulates apical-domain size independently of its 
growth-control function. J Cell Sci. 122, 2360-70. 
Genevet, A., Wehr, M. C., Brain, R., Thompson, B. J., Tapon, N., 2010. Kibra is a 
regulator of the Salvador/Warts/Hippo signaling network. Dev Cell. 18, 300-8. 
Georgiou, M., Marinari, E., Burden, J., Baum, B., 2008. Cdc42, Par6, and aPKC regulate 
Arp2/3-mediated endocytosis to control local adherens junction stability. Curr Biol. 
18, 1631-8. 
Ghosh, S., Marquardt, T., Thaler, J. P., Carter, N., Andrews, S. E., Pfaff, S. L., Hunter, T., 
2008. Instructive role of aPKCzeta subcellular localization in the assembly of 
adherens junctions in neural progenitors. Proc Natl Acad Sci U S A. 105, 335-40. 
Goulev, Y., Fauny, J. D., Gonzalez-Marti, B., Flagiello, D., Silber, J., Zider, A., 2008. 
SCALLOPED interacts with YORKIE, the nuclear effector of the hippo tumor-
suppressor pathway in Drosophila. Curr Biol. 18, 435-41. 
Grawe, F., Wodarz, A., Lee, B., Knust, E., Skaer, H., 1996. The Drosophila genes crumbs 
and stardust are involved in the biogenesis of adherens junctions. Development. 
122, 951-9. 
Green, K. J., Jones, J. C., 1996. Desmosomes and hemidesmosomes: structure and function 
of molecular components. Faseb J. 10, 871-81. 
Grifoni, D., Garoia, F., Bellosta, P., Parisi, F., De Biase, D., Collina, G., Strand, D., 
Cavicchi, S., Pession, A., 2007. aPKCzeta cortical loading is associated with Lgl 
cytoplasmic release and tumor growth in Drosophila and human epithelia. 
Oncogene. 26, 5960-5. 
Grunicke, H. H., Spitaler, M., Mwanjewe, J., Schwaiger, W., Jenny, M., Ueberall, F., 
2003. Regulation of cell survival by atypical protein kinase C isozymes. Adv 
Enzyme Regul. 43, 213-28. 
Grzeschik, N. A., Parsons, L. M., Allott, M. L., Harvey, K. F., Richardson, H. E., 2010. 
Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two 
distinct mechanisms. Curr Biol. 20, 573-81. 
Guo, S., Kemphues, K. J., 1995. par-1, a gene required for establishing polarity in C. 
elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically 
distributed. Cell. 81, 611-20. 
131 
Gustafson, W. C., Ray, S., Jamieson, L., Thompson, E. A., Brasier, A. R., Fields, A. P., 
2004. Bcr-Abl regulates protein kinase Ciota (PKCiota) transcription via an Elk1 
site in the PKCiota promoter. J Biol Chem. 279, 9400-8. 
Hamaratoglu, F., Gajewski, K., Sansores-Garcia, L., Morrison, C., Tao, C., Halder, G., 
2009. The Hippo tumor-suppressor pathway regulates apical-domain size in parallel 
to tissue growth. J Cell Sci. 122, 2351-9. 
Hao, Y., Chun, A., Cheung, K., Rashidi, B., Yang, X., 2008. Tumor suppressor LATS1 is a 
negative regulator of oncogene YAP. J Biol Chem. 283, 5496-509. 
Harris, T. J., Peifer, M., 2005. The positioning and segregation of apical cues during 
epithelial polarity establishment in Drosophila. J Cell Biol. 170, 813-23. 
Harvey, K. F., Pfleger, C. M., Hariharan, I. K., 2003. The Drosophila Mst ortholog, hippo, 
restricts growth and cell proliferation and promotes apoptosis. Cell. 114, 457-67. 
Harwood, A. J., 2001. Regulation of GSK-3: a cellular multiprocessor. Cell. 105, 821-4. 
Hashimoto, N., Kido, Y., Uchida, T., Matsuda, T., Suzuki, K., Inoue, H., Matsumoto, M., 
Ogawa, W., Maeda, S., Fujihara, H., Ueta, Y., Uchiyama, Y., Akimoto, K., Ohno, 
S., Noda, T., Kasuga, M., 2005. PKClambda regulates glucose-induced insulin 
secretion through modulation of gene expression in pancreatic beta cells. J Clin 
Invest. 115, 138-45. 
Hernandez, A. I., Blace, N., Crary, J. F., Serrano, P. A., Leitges, M., Libien, J. M., 
Weinstein, G., Tcherapanov, A., Sacktor, T. C., 2003. Protein kinase M zeta 
synthesis from a brain mRNA encoding an independent protein kinase C zeta 
catalytic domain. Implications for the molecular mechanism of memory. J Biol 
Chem. 278, 40305-16. 
Hirose, T., Izumi, Y., Nagashima, Y., Tamai-Nagai, Y., Kurihara, H., Sakai, T., Suzuki, 
Y., Yamanaka, T., Suzuki, A., Mizuno, K., Ohno, S., 2002. Involvement of 
ASIP/PAR-3 in the promotion of epithelial tight junction formation. J Cell Sci. 115, 
2485-95. 
Hirose, T., Karasawa, M., Sugitani, Y., Fujisawa, M., Akimoto, K., Ohno, S., Noda, T., 
2006. PAR3 is essential for cyst-mediated epicardial development by establishing 
apical cortical domains. Development. 133, 1389-98. 
Hong, Y., Stronach, B., Perrimon, N., Jan, L. Y., Jan, Y. N., 2001. Drosophila Stardust 
interacts with Crumbs to control polarity of epithelia but not neuroblasts. Nature. 
414, 634-8. 
Hori, T., Takaori-Kondo, A., Kamikubo, Y., Uchiyama, T., 2000. Molecular cloning of a 
novel human protein kinase, kpm, that is homologous to warts/lats, a Drosophila 
tumor suppressor. Oncogene. 19, 3101-9. 
Horikoshi, Y., Suzuki, A., Yamanaka, T., Sasaki, K., Mizuno, K., Sawada, H., Yonemura, 
S., Ohno, S., 2009. Interaction between PAR-3 and the aPKC-PAR-6 complex is 
indispensable for apical domain development of epithelial cells. J Cell Sci. 122, 
1595-606. 
Horne-Badovinac, S., Lin, D., Waldron, S., Schwarz, M., Mbamalu, G., Pawson, T., Jan, 
Y., Stainier, D. Y., Abdelilah-Seyfried, S., 2001. Positional cloning of heart and 
soul reveals multiple roles for PKC lambda in zebrafish organogenesis. Curr Biol. 
11, 1492-502. 
Hsu, Y. C., Willoughby, J. J., Christensen, A. K., Jensen, A. M., 2006. Mosaic Eyes is a 
novel component of the Crumbs complex and negatively regulates photoreceptor 
apical size. Development. 133, 4849-59. 
Huang, J., Wu, S., Barrera, J., Matthews, K., Pan, D., 2005. The Hippo signaling pathway 
coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the 
Drosophila Homolog of YAP. Cell. 122, 421-34. 
132 
Huang, L., Muthuswamy, S. K., 2010. Polarity protein alterations in carcinoma: a focus on 
emerging roles for polarity regulators. Curr Opin Genet Dev. 20, 41-50. 
Hurd, T. W., Gao, L., Roh, M. H., Macara, I. G., Margolis, B., 2003. Direct interaction of 
two polarity complexes implicated in epithelial tight junction assembly. Nat Cell 
Biol. 5, 137-42. 
Hurov, J. B., Watkins, J. L., Piwnica-Worms, H., 2004. Atypical PKC phosphorylates 
PAR-1 kinases to regulate localization and activity. Curr Biol. 14, 736-41. 
Hutterer, A., Betschinger, J., Petronczki, M., Knoblich, J. A., 2004. Sequential roles of 
Cdc42, Par-6, aPKC, and Lgl in the establishment of epithelial polarity during 
Drosophila embryogenesis. Dev Cell. 6, 845-54. 
Hyodo-Miura, J., Yamamoto, T. S., Hyodo, A. C., Iemura, S., Kusakabe, M., Nishida, E., 
Natsume, T., Ueno, N., 2006. XGAP, an ArfGAP, is required for polarized 
localization of PAR proteins and cell polarity in Xenopus gastrulation. Dev Cell. 
11, 69-79. 
Imai, F., Hirai, S., Akimoto, K., Koyama, H., Miyata, T., Ogawa, M., Noguchi, S., 
Sasaoka, T., Noda, T., Ohno, S., 2006. Inactivation of aPKClambda results in the 
loss of adherens junctions in neuroepithelial cells without affecting neurogenesis in 
mouse neocortex. Development. 133, 1735-44. 
Ishidate, T., Matsumine, A., Toyoshima, K., Akiyama, T., 2000. The APC-hDLG complex 
negatively regulates cell cycle progression from the G0/G1 to S phase. Oncogene. 
19, 365-72. 
Ishiguro, H., Akimoto, K., Nagashima, Y., Kojima, Y., Sasaki, T., Ishiguro-Imagawa, Y., 
Nakaigawa, N., Ohno, S., Kubota, Y., Uemura, H., 2009. aPKClambda/iota 
promotes growth of prostate cancer cells in an autocrine manner through 
transcriptional activation of interleukin-6. Proc Natl Acad Sci U S A. 106, 16369-
74. 
Ishikawa, H. O., Takeuchi, H., Haltiwanger, R. S., Irvine, K. D., 2008. Four-jointed is a 
Golgi kinase that phosphorylates a subset of cadherin domains. Science. 321, 401-
4. 
Izumi, N., Fumoto, K., Izumi, S., Kikuchi, A., 2008. GSK-3beta regulates proper mitotic 
spindle formation in cooperation with a component of the gamma-tubulin ring 
complex, GCP5. J Biol Chem. 283, 12981-91. 
Izumi, Y., Hirose, T., Tamai, Y., Hirai, S., Nagashima, Y., Fujimoto, T., Tabuse, Y., 
Kemphues, K. J., Ohno, S., 1998. An atypical PKC directly associates and 
colocalizes at the epithelial tight junction with ASIP, a mammalian homologue of 
Caenorhabditis elegans polarity protein PAR-3. J Cell Biol. 143, 95-106. 
Jaken, S., Parker, P. J., 2000. Protein kinase C binding partners. Bioessays. 22, 245-54. 
Jin, Z., Xin, M., Deng, X., 2005. Survival function of protein kinase C{iota} as a novel 
nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-activated bad kinase. 
J Biol Chem. 280, 16045-52. 
Joberty, G., Petersen, C., Gao, L., Macara, I. G., 2000. The cell-polarity protein Par6 links 
Par3 and atypical protein kinase C to Cdc42. Nat Cell Biol. 2, 531-9. 
Johnson, S. A., Hunter, T., 2005. Kinomics: methods for deciphering the kinome. Nat 
Methods. 2, 17-25. 
Justice, R. W., Zilian, O., Woods, D. F., Noll, M., Bryant, P. J., 1995. The Drosophila 
tumor suppressor gene warts encodes a homolog of human myotonic dystrophy 
kinase and is required for the control of cell shape and proliferation. Genes Dev. 9, 
534-46. 
Justilien, V., Fields, A. P., 2009. Ect2 links the PKCiota-Par6alpha complex to Rac1 
activation and cellular transformation. Oncogene. 28, 3597-607. 
133 
Kamberov, E., Makarova, O., Roh, M., Liu, A., Karnak, D., Straight, S., Margolis, B., 
2000. Molecular cloning and characterization of Pals, proteins associated with 
mLin-7. J Biol Chem. 275, 11425-31. 
Kango-Singh, M., Nolo, R., Tao, C., Verstreken, P., Hiesinger, P. R., Bellen, H. J., Halder, 
G., 2002. Shar-pei mediates cell proliferation arrest during imaginal disc growth in 
Drosophila. Development. 129, 5719-30. 
Karp, C. M., Tan, T. T., Mathew, R., Nelson, D., Mukherjee, C., Degenhardt, K., 
Karantza-Wadsworth, V., White, E., 2008. Role of the polarity determinant crumbs 
in suppressing mammalian epithelial tumor progression. Cancer Res. 68, 4105-15. 
Kaushik, R., Yu, F., Chia, W., Yang, X., Bahri, S., 2003. Subcellular localization of LGN 
during mitosis: evidence for its cortical localization in mitotic cell culture systems 
and its requirement for normal cell cycle progression. Mol Biol Cell. 14, 3144-55. 
Kim, L., Kimmel, A. R., 2006. GSK3 at the edge: regulation of developmental 
specification and cell polarization. Curr Drug Targets. 7, 1411-9. 
Kim, M., Datta, A., Brakeman, P., Yu, W., Mostov, K. E., 2007. Polarity proteins PAR6 
and aPKC regulate cell death through GSK-3beta in 3D epithelial morphogenesis. J 
Cell Sci. 120, 2309-17. 
Kim, S., Gailite, I., Moussian, B., Luschnig, S., Goette, M., Fricke, K., Honemann-Capito, 
M., Grubmuller, H., Wodarz, A., 2009. Kinase-activity-independent functions of 
atypical protein kinase C in Drosophila. J Cell Sci. 122, 3759-71. 
Kishimoto, A., Nishiyama, K., Nakanishi, H., Uratsuji, Y., Nomura, H., Takeyama, Y., 
Nishizuka, Y., 1985. Studies on the phosphorylation of myelin basic protein by 
protein kinase C and adenosine 3':5'-monophosphate-dependent protein kinase. J 
Biol Chem. 260, 12492-9. 
Kistner, U., Garner, C. C., Linial, M., 1995. Nucleotide binding by the synapse associated 
protein SAP90. FEBS Lett. 359, 159-63. 
Klezovitch, O., Fernandez, T. E., Tapscott, S. J., Vasioukhin, V., 2004. Loss of cell 
polarity causes severe brain dysplasia in Lgl1 knockout mice. Genes Dev. 18, 559-
71. 
Knebel, A., Morrice, N., Cohen, P., 2001. A novel method to identify protein kinase 
substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38delta. Embo 
J. 20, 4360-9. 
Knoblich, J. A., 2008. Mechanisms of asymmetric stem cell division. Cell. 132, 583-97. 
Koike, C., Nishida, A., Akimoto, K., Nakaya, M. A., Noda, T., Ohno, S., Furukawa, T., 
2005. Function of atypical protein kinase C lambda in differentiating 
photoreceptors is required for proper lamination of mouse retina. J Neurosci. 25, 
10290-8. 
Kojima, Y., Akimoto, K., Nagashima, Y., Ishiguro, H., Shirai, S., Chishima, T., Ichikawa, 
Y., Ishikawa, T., Sasaki, T., Kubota, Y., Inayama, Y., Aoki, I., Ohno, S., Shimada, 
H., 2008. The overexpression and altered localization of the atypical protein kinase 
C lambda/iota in breast cancer correlates with the pathologic type of these tumors. 
Hum Pathol. 39, 824-31. 
Kovac, J., Oster, H., Leitges, M., 2007. Expression of the atypical protein kinase C (aPKC) 
isoforms iota/lambda and zeta during mouse embryogenesis. Gene Expr Patterns. 7, 
187-196. 
Krahn, M. P., Klopfenstein, D. R., Fischer, N., Wodarz, A., 2010. Membrane targeting of 
Bazooka/PAR-3 is mediated by direct binding to phosphoinositide lipids. Curr Biol. 
20, 636-42. 
Krishnamurthy, K., Wang, G., Silva, J., Condie, B. G., Bieberich, E., 2007. Ceramide 
regulates atypical PKCzeta/lambda-mediated cell polarity in primitive ectoderm 
134 
cells. A novel function of sphingolipids in morphogenesis. J Biol Chem. 282, 3379-
90. 
Lai, Z. C., Wei, X., Shimizu, T., Ramos, E., Rohrbaugh, M., Nikolaidis, N., Ho, L. L., Li, 
Y., 2005. Control of cell proliferation and apoptosis by mob as tumor suppressor, 
mats. Cell. 120, 675-85. 
Lamb, R. S., Ward, R. E., Schweizer, L., Fehon, R. G., 1998. Drosophila coracle, a 
member of the protein 4.1 superfamily, has essential structural functions in the 
septate junctions and developmental functions in embryonic and adult epithelial 
cells. Mol Biol Cell. 9, 3505-19. 
Laprise, P., Beronja, S., Silva-Gagliardi, N. F., Pellikka, M., Jensen, A. M., McGlade, C. 
J., Tepass, U., 2006. The FERM protein Yurt is a negative regulatory component of 
the Crumbs complex that controls epithelial polarity and apical membrane size. 
Dev Cell. 11, 363-74. 
Laprise, P., Lau, K. M., Harris, K. P., Silva-Gagliardi, N. F., Paul, S. M., Beronja, S., 
Beitel, G. J., McGlade, C. J., Tepass, U., 2009. Yurt, Coracle, Neurexin IV and the 
Na(+),K(+)-ATPase form a novel group of epithelial polarity proteins. Nature. 459, 
1141-5. 
Lee, C. Y., Robinson, K. J., Doe, C. Q., 2006. Lgl, Pins and aPKC regulate neuroblast self-
renewal versus differentiation. Nature. 439, 594-8. 
Lee, S. S., Weiss, R. S., Javier, R. T., 1997. Binding of human virus oncoproteins to 
hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor 
suppressor protein. Proc Natl Acad Sci U S A. 94, 6670-5. 
Lehrich, R. W., Forrest, J. N., Jr., 1994. Protein kinase C zeta is associated with the mitotic 
apparatus in primary cell cultures of the shark rectal gland. J Biol Chem. 269, 
32446-50. 
Lei, Q. Y., Zhang, H., Zhao, B., Zha, Z. Y., Bai, F., Pei, X. H., Zhao, S., Xiong, Y., Guan, 
K. L., 2008. TAZ promotes cell proliferation and epithelial-mesenchymal transition 
and is inhibited by the hippo pathway. Mol Cell Biol. 28, 2426-36. 
Leitges, M., Sanz, L., Martin, P., Duran, A., Braun, U., Garcia, J. F., Camacho, F., Diaz-
Meco, M. T., Rennert, P. D., Moscat, J., 2001. Targeted disruption of the zetaPKC 
gene results in the impairment of the NF-kappaB pathway. Mol Cell. 8, 771-80. 
Lemmers, C., Medina, E., Delgrossi, M. H., Michel, D., Arsanto, J. P., Le Bivic, A., 2002. 
hINADl/PATJ, a homolog of discs lost, interacts with crumbs and localizes to tight 
junctions in human epithelial cells. J Biol Chem. 277, 25408-15. 
Lemmers, C., Michel, D., Lane-Guermonprez, L., Delgrossi, M. H., Medina, E., Arsanto, J. 
P., Le Bivic, A., 2004. CRB3 binds directly to Par6 and regulates the 
morphogenesis of the tight junctions in mammalian epithelial cells. Mol Biol Cell. 
15, 1324-33. 
Li, Q., Wang, J. M., Liu, C., Xiao, B. L., Lu, J. X., Zou, S. Q., 2008. Correlation of aPKC-
iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma. 
Hepatobiliary Pancreat Dis Int. 7, 70-5. 
Li, Y., Karnak, D., Demeler, B., Margolis, B., Lavie, A., 2004. Structural basis for L27 
domain-mediated assembly of signaling and cell polarity complexes. Embo J. 23, 
2723-33. 
Lin, D., Edwards, A. S., Fawcett, J. P., Mbamalu, G., Scott, J. D., Pawson, T., 2000. A 
mammalian PAR-3-PAR-6 complex implicated in Cdc42/Rac1 and aPKC 
signalling and cell polarity. Nat Cell Biol. 2, 540-7. 
Lin, D., Gish, G. D., Songyang, Z., Pawson, T., 1999. The carboxyl terminus of B class 
ephrins constitutes a PDZ domain binding motif. J Biol Chem. 274, 3726-33. 
135 
Ling, C., Zheng, Y., Yin, F., Yu, J., Huang, J., Hong, Y., Wu, S., Pan, D., 2010. The apical 
transmembrane protein Crumbs functions as a tumor suppressor that regulates 
Hippo signaling by binding to Expanded. Proc Natl Acad Sci U S A. 107, 10532-7. 
Liu, J. W., Shen, J. J., Tanzillo-Swarts, A., Bhatia, B., Maldonado, C. M., Person, M. D., 
Lau, S. S., Tang, D. G., 2003. Annexin II expression is reduced or lost in prostate 
cancer cells and its re-expression inhibits prostate cancer cell migration. Oncogene. 
22, 1475-85. 
Liu, X. F., Xie, X., Miki, T., 2006. Inhibition of protein kinase C zeta blocks the 
attachment of stable microtubules to kinetochores leading to abnormal chromosome 
alignment. Cell Signal. 18, 2314-23. 
Liu, Y., Wang, B., Wang, J., Wan, W., Sun, R., Zhao, Y., Zhang, N., 2009. Down-
regulation of PKCzeta expression inhibits chemotaxis signal transduction in human 
lung cancer cells. Lung Cancer. 63, 210-8. 
Liu, Y. F., Paz, K., Herschkovitz, A., Alt, A., Tennenbaum, T., Sampson, S. R., Ohba, M., 
Kuroki, T., LeRoith, D., Zick, Y., 2001. Insulin stimulates PKCzeta -mediated 
phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated 
mechanism to negatively regulate the function of IRS proteins. J Biol Chem. 276, 
14459-65. 
Lovestone, S., Hartley, C. L., Pearce, J., Anderton, B. H., 1996. Phosphorylation of tau by 
glycogen synthase kinase-3 beta in intact mammalian cells: the effects on the 
organization and stability of microtubules. Neuroscience. 73, 1145-57. 
Lu, Y., Jamieson, L., Brasier, A. R., Fields, A. P., 2001. NF-kappaB/RelA transactivation 
is required for atypical protein kinase C iota-mediated cell survival. Oncogene. 20, 
4777-92. 
Lue, R. A., Marfatia, S. M., Branton, D., Chishti, A. H., 1994. Cloning and 
characterization of hdlg: the human homologue of the Drosophila discs large tumor 
suppressor binds to protein 4.1. Proc Natl Acad Sci U S A. 91, 9818-22. 
Makarova, O., Roh, M. H., Liu, C. J., Laurinec, S., Margolis, B., 2003. Mammalian 
Crumbs3 is a small transmembrane protein linked to protein associated with Lin-7 
(Pals1). Gene. 302, 21-9. 
Mantovani, F., Massimi, P., Banks, L., 2001. Proteasome-mediated regulation of the hDlg 
tumour suppressor protein. J Cell Sci. 114, 4285-92. 
Mao, Y., Kucuk, B., Irvine, K. D., 2009. Drosophila lowfat, a novel modulator of Fat 
signaling. Development. 136, 3223-33. 
Martin-Belmonte, F., Gassama, A., Datta, A., Yu, W., Rescher, U., Gerke, V., Mostov, K., 
2007. PTEN-mediated apical segregation of phosphoinositides controls epithelial 
morphogenesis through Cdc42. Cell. 128, 383-97. 
Mashukova, A., Oriolo, A. S., Wald, F. A., Casanova, M. L., Kroger, C., Magin, T. M., 
Omary, M. B., Salas, P. J., 2009. Rescue of atypical protein kinase C in epithelia by 
the cytoskeleton and Hsp70 family chaperones. J Cell Sci. 122, 2491-503. 
Massimi, P., Narayan, N., Cuenda, A., Banks, L., 2006. Phosphorylation of the discs large 
tumour suppressor protein controls its membrane localisation and enhances its 
susceptibility to HPV E6-induced degradation. Oncogene. 25, 4276-85. 
Matakatsu, H., Blair, S. S., 2008. The DHHC palmitoyltransferase approximated regulates 
Fat signaling and Dachs localization and activity. Curr Biol. 18, 1390-5. 
Matsumine, A., Ogai, A., Senda, T., Okumura, N., Satoh, K., Baeg, G. H., Kawahara, T., 
Kobayashi, S., Okada, M., Toyoshima, K., Akiyama, T., 1996. Binding of APC to 
the human homolog of the Drosophila discs large tumor suppressor protein. 
Science. 272, 1020-3. 
136 
Matsumoto, M., Ogawa, W., Akimoto, K., Inoue, H., Miyake, K., Furukawa, K., Hayashi, 
Y., Iguchi, H., Matsuki, Y., Hiramatsu, R., Shimano, H., Yamada, N., Ohno, S., 
Kasuga, M., Noda, T., 2003. PKClambda in liver mediates insulin-induced SREBP-
1c expression and determines both hepatic lipid content and overall insulin 
sensitivity. J Clin Invest. 112, 935-44. 
McLaughlin, M., Hale, R., Ellston, D., Gaudet, S., Lue, R. A., Viel, A., 2002. The 
distribution and function of alternatively spliced insertions in hDlg. J Biol Chem. 
277, 6406-12. 
Michel, D., Arsanto, J. P., Massey-Harroche, D., Beclin, C., Wijnholds, J., Le Bivic, A., 
2005. PATJ connects and stabilizes apical and lateral components of tight junctions 
in human intestinal cells. J Cell Sci. 118, 4049-57. 
Mitic, L. L., Anderson, J. M., 1998. Molecular architecture of tight junctions. Annu Rev 
Physiol. 60, 121-42. 
Mochizuki, N., Cho, G., Wen, B., Insel, P. A., 1996. Identification and cDNA cloning of a 
novel human mosaic protein, LGN, based on interaction with G alpha i2. Gene. 
181, 39-43. 
Mori, D., Yamada, M., Mimori-Kiyosue, Y., Shirai, Y., Suzuki, A., Ohno, S., Saya, H., 
Wynshaw-Boris, A., Hirotsune, S., 2009. An essential role of the aPKC-Aurora A-
NDEL1 pathway in neurite elongation by modulation of microtubule dynamics. Nat 
Cell Biol. 11, 1057-68. 
Moussad, E. E., Brigstock, D. R., 2000. Connective tissue growth factor: what's in a name? 
Mol Genet Metab. 71, 276-92. 
Muller, B. M., Kistner, U., Veh, R. W., Cases-Langhoff, C., Becker, B., Gundelfinger, E. 
D., Garner, C. C., 1995. Molecular characterization and spatial distribution of 
SAP97, a novel presynaptic protein homologous to SAP90 and the Drosophila 
discs-large tumor suppressor protein. J Neurosci. 15, 2354-66. 
Muller, H. A., Wieschaus, E., 1996. armadillo, bazooka, and stardust are critical for early 
stages in formation of the zonula adherens and maintenance of the polarized 
blastoderm epithelium in Drosophila. J Cell Biol. 134, 149-63. 
Murdoch, J. N., Henderson, D. J., Doudney, K., Gaston-Massuet, C., Phillips, H. M., 
Paternotte, C., Arkell, R., Stanier, P., Copp, A. J., 2003. Disruption of scribble 
(Scrb1) causes severe neural tube defects in the circletail mouse. Hum Mol Genet. 
12, 87-98. 
Murray, N. R., Jamieson, L., Yu, W., Zhang, J., Gokmen-Polar, Y., Sier, D., Anastasiadis, 
P., Gatalica, Z., Thompson, E. A., Fields, A. P., 2004. Protein kinase Ciota is 
required for Ras transformation and colon carcinogenesis in vivo. J Cell Biol. 164, 
797-802. 
Musch, A., Cohen, D., Yeaman, C., Nelson, W. J., Rodriguez-Boulan, E., Brennwald, P. J., 
2002. Mammalian homolog of Drosophila tumor suppressor lethal (2) giant larvae 
interacts with basolateral exocytic machinery in Madin-Darby canine kidney cells. 
Mol Biol Cell. 13, 158-68. 
Na, J., Zernicka-Goetz, M., 2006. Asymmetric positioning and organization of the meiotic 
spindle of mouse oocytes requires CDC42 function. Curr Biol. 16, 1249-54. 
Nagafuchi, A., 2001. Molecular architecture of adherens junctions. Curr Opin Cell Biol. 
13, 600-3. 
Nagai-Tamai, Y., Mizuno, K., Hirose, T., Suzuki, A., Ohno, S., 2002. Regulated protein-
protein interaction between aPKC and PAR-3 plays an essential role in the 
polarization of epithelial cells. Genes Cells. 7, 1161-71. 
Nagasaka, K., Nakagawa, S., Yano, T., Takizawa, S., Matsumoto, Y., Tsuruga, T., 
Nakagawa, K., Minaguchi, T., Oda, K., Hiraike-Wada, O., Ooishi, H., Yasugi, T., 
137 
Taketani, Y., 2006. Human homolog of Drosophila tumor suppressor Scribble 
negatively regulates cell-cycle progression from G1 to S phase by localizing at the 
basolateral membrane in epithelial cells. Cancer Sci. 97, 1217-25. 
Nair, K. S., Mendez, A., Blumer, J. B., Rosenzweig, D. H., Slepak, V. Z., 2005. The 
presence of a Leu-Gly-Asn repeat-enriched protein (LGN), a putative binding 
partner of transducin, in ROD photoreceptors. Invest Ophthalmol Vis Sci. 46, 383-
9. 
Nakagawa, S., Huibregtse, J. M., 2000. Human scribble (Vartul) is targeted for ubiquitin-
mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP 
ubiquitin-protein ligase. Mol Cell Biol. 20, 8244-53. 
Nakanishi, H., Exton, J. H., 1992. Purification and characterization of the zeta isoform of 
protein kinase C from bovine kidney. J Biol Chem. 267, 16347-54. 
Nakaya, M., Fukui, A., Izumi, Y., Akimoto, K., Asashima, M., Ohno, S., 2000. Meiotic 
maturation induces animal-vegetal asymmetric distribution of aPKC and 
ASIP/PAR-3 in Xenopus oocytes. Development. 127, 5021-31. 
Narayan, N., Massimi, P., Banks, L., 2009. CDK phosphorylation of the discs large tumour 
suppressor controls its localisation and stability. J Cell Sci. 122, 65-74. 
Navarro, C., Nola, S., Audebert, S., Santoni, M. J., Arsanto, J. P., Ginestier, C., Marchetto, 
S., Jacquemier, J., Isnardon, D., Le Bivic, A., Birnbaum, D., Borg, J. P., 2005. 
Junctional recruitment of mammalian Scribble relies on E-cadherin engagement. 
Oncogene. 24, 4330-9. 
Neri, L. M., Martelli, A. M., Borgatti, P., Colamussi, M. L., Marchisio, M., Capitani, S., 
1999. Increase in nuclear phosphatidylinositol 3-kinase activity and 
phosphatidylinositol (3,4,5) trisphosphate synthesis precede PKC-zeta translocation 
to the nucleus of NGF-treated PC12 cells. Faseb J. 13, 2299-310. 
Newton, A. C., 1995. Protein kinase C: structure, function, and regulation. J Biol Chem. 
270, 28495-8. 
Nigg, E. A., 2002. Centrosome aberrations: cause or consequence of cancer progression? 
Nat Rev Cancer. 2, 815-25. 
Nishimura, T., Kaibuchi, K., 2007. Numb controls integrin endocytosis for directional cell 
migration with aPKC and PAR-3. Dev Cell. 13, 15-28. 
Noda, Y., Takeya, R., Ohno, S., Naito, S., Ito, T., Sumimoto, H., 2001. Human 
homologues of the Caenorhabditis elegans cell polarity protein PAR6 as an adaptor 
that links the small GTPases Rac and Cdc42 to atypical protein kinase C. Genes 
Cells. 6, 107-19. 
Nunbhakdi-Craig, V., Machleidt, T., Ogris, E., Bellotto, D., White, C. L., 3rd, Sontag, E., 
2002. Protein phosphatase 2A associates with and regulates atypical PKC and the 
epithelial tight junction complex. J Cell Biol. 158, 967-78. 
Obenauer, J. C., Cantley, L. C., Yaffe, M. B., 2003. Scansite 2.0: Proteome-wide 
prediction of cell signaling interactions using short sequence motifs. Nucleic Acids 
Res. 31, 3635-41. 
Oceguera-Yanez, F., Kimura, K., Yasuda, S., Higashida, C., Kitamura, T., Hiraoka, Y., 
Haraguchi, T., Narumiya, S., 2005. Ect2 and MgcRacGAP regulate the activation 
and function of Cdc42 in mitosis. J Cell Biol. 168, 221-32. 
Oh, H., Irvine, K. D., 2008. In vivo regulation of Yorkie phosphorylation and localization. 
Development. 135, 1081-8. 
Oh, H., Reddy, B. V., Irvine, K. D., 2009. Phosphorylation-independent repression of 
Yorkie in Fat-Hippo signaling. Dev Biol. 335, 188-97. 
138 
Ohno, S., 2001. Intercellular junctions and cellular polarity: the PAR-aPKC complex, a 
conserved core cassette playing fundamental roles in cell polarity. Curr Opin Cell 
Biol. 13, 641-8. 
Ohtsubo, M., Theodoras, A. M., Schumacher, J., Roberts, J. M., Pagano, M., 1995. Human 
cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol. 
15, 2612-24. 
Oka, T., Mazack, V., Sudol, M., 2008. Mst2 and Lats kinases regulate apoptotic function 
of Yes kinase-associated protein (YAP). J Biol Chem. 283, 27534-46. 
Ono, Y., Fujii, T., Ogita, K., Kikkawa, U., Igarashi, K., Nishizuka, Y., 1989. Protein 
kinase C zeta subspecies from rat brain: its structure, expression, and properties. 
Proc Natl Acad Sci U S A. 86, 3099-103. 
Osmani, N., Vitale, N., Borg, J. P., Etienne-Manneville, S., 2006. Scrib controls Cdc42 
localization and activity to promote cell polarization during astrocyte migration. 
Curr Biol. 16, 2395-405. 
Overholtzer, M., Zhang, J., Smolen, G. A., Muir, B., Li, W., Sgroi, D. C., Deng, C. X., 
Brugge, J. S., Haber, D. A., 2006. Transforming properties of YAP, a candidate 
oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci U S A. 103, 
12405-10. 
Page Baluch, D., Koeneman, B. A., Hatch, K. R., McGaughey, R. W., Capco, D. G., 2004. 
PKC isotypes in post-activated and fertilized mouse eggs: association with the 
meiotic spindle. Dev Biol. 274, 45-55. 
Pal, S., Claffey, K. P., Cohen, H. T., Mukhopadhyay, D., 1998. Activation of Sp1-
mediated vascular permeability factor/vascular endothelial growth factor 
transcription requires specific interaction with protein kinase C zeta. J Biol Chem. 
273, 26277-80. 
Parkinson, S. J., Le Good, J. A., Whelan, R. D., Whitehead, P., Parker, P. J., 2004. 
Identification of PKCzetaII: an endogenous inhibitor of cell polarity. Embo J. 23, 
77-88. 
Patel, R., Win, H., Desai, S., Patel, K., Matthews, J. A., Acevedo-Duncan, M., 2008. 
Involvement of PKC-iota in glioma proliferation. Cell Prolif. 41, 122-35. 
Pauken, C. M., Capco, D. G., 2000. The expression and stage-specific localization of 
protein kinase C isotypes during mouse preimplantation development. Dev Biol. 
223, 411-21. 
Pawson, T., Schlessingert, J., 1993. SH2 and SH3 domains. Curr Biol. 3, 434-42. 
Peng, C. Y., Manning, L., Albertson, R., Doe, C. Q., 2000. The tumour-suppressor genes 
lgl and dlg regulate basal protein targeting in Drosophila neuroblasts. Nature. 408, 
596-600. 
Perander, M., Bjorkoy, G., Johansen, T., 2001. Nuclear import and export signals enable 
rapid nucleocytoplasmic shuttling of the atypical protein kinase C lambda. J Biol 
Chem. 276, 13015-24. 
Petronczki, M., Knoblich, J. A., 2001. DmPAR-6 directs epithelial polarity and 
asymmetric cell division of neuroblasts in Drosophila. Nat Cell Biol. 3, 43-9. 
Pinheiro, E. M., Montell, D. J., 2004. Requirement for Par-6 and Bazooka in Drosophila 
border cell migration. Development. 131, 5243-51. 
Plant, P. J., Fawcett, J. P., Lin, D. C., Holdorf, A. D., Binns, K., Kulkarni, S., Pawson, T., 
2003. A polarity complex of mPar-6 and atypical PKC binds, phosphorylates and 
regulates mammalian Lgl. Nat Cell Biol. 5, 301-8. 
Plusa, B., Frankenberg, S., Chalmers, A., Hadjantonakis, A. K., Moore, C. A., Papalopulu, 
N., Papaioannou, V. E., Glover, D. M., Zernicka-Goetz, M., 2005. Downregulation 
139 
of Par3 and aPKC function directs cells towards the ICM in the preimplantation 
mouse embryo. J Cell Sci. 118, 505-15. 
Plyte, S. E., Hughes, K., Nikolakaki, E., Pulverer, B. J., Woodgett, J. R., 1992. Glycogen 
synthase kinase-3: functions in oncogenesis and development. Biochim Biophys 
Acta. 1114, 147-62. 
Polesello, C., Huelsmann, S., Brown, N. H., Tapon, N., 2006. The Drosophila RASSF 
homolog antagonizes the hippo pathway. Curr Biol. 16, 2459-65. 
Ponting, C. P., Phillips, C., Davies, K. E., Blake, D. J., 1997. PDZ domains: targeting 
signalling molecules to sub-membranous sites. Bioessays. 19, 469-79. 
Qin, Y., Capaldo, C., Gumbiner, B. M., Macara, I. G., 2005. The mammalian Scribble 
polarity protein regulates epithelial cell adhesion and migration through E-cadherin. 
J Cell Biol. 171, 1061-71. 
Qin, Y., Meisen, W. H., Hao, Y., Macara, I. G., 2010. Tuba, a Cdc42 GEF, is required for 
polarized spindle orientation during epithelial cyst formation. J Cell Biol. 189, 661-
9. 
Qiu, R. G., Abo, A., Steven Martin, G., 2000. A human homolog of the C. elegans polarity 
determinant Par-6 links Rac and Cdc42 to PKCzeta signaling and cell 
transformation. Curr Biol. 10, 697-707. 
Regad, T., Roth, M., Bredenkamp, N., Illing, N., Papalopulu, N., 2007. The neural 
progenitor-specifying activity of FoxG1 is antagonistically regulated by CKI and 
FGF. Nat Cell Biol. 9, 531-40. 
Regala, R. P., Thompson, E. A., Fields, A. P., 2008. Atypical protein kinase C iota 
expression and aurothiomalate sensitivity in human lung cancer cells. Cancer Res. 
68, 5888-95. 
Regala, R. P., Weems, C., Jamieson, L., Copland, J. A., Thompson, E. A., Fields, A. P., 
2005a. Atypical protein kinase Ciota plays a critical role in human lung cancer cell 
growth and tumorigenicity. J Biol Chem. 280, 31109-15. 
Regala, R. P., Weems, C., Jamieson, L., Khoor, A., Edell, E. S., Lohse, C. M., Fields, A. 
P., 2005b. Atypical protein kinase C iota is an oncogene in human non-small cell 
lung cancer. Cancer Res. 65, 8905-11. 
Rodriguez-Fraticelli, A. E., Vergarajauregui, S., Eastburn, D. J., Datta, A., Alonso, M. A., 
Mostov, K., Martin-Belmonte, F., 2010. The Cdc42 GEF Intersectin 2 controls 
mitotic spindle orientation to form the lumen during epithelial morphogenesis. J 
Cell Biol. 189, 725-38. 
Rodriguez, E. M., Dunham, E. E., Martin, G. S., 2009. Atypical protein kinase C activity is 
required for extracellular matrix degradation and invasion by Src-transformed cells. 
J Cell Physiol. 221, 171-82. 
Roh, M. H., Makarova, O., Liu, C. J., Shin, K., Lee, S., Laurinec, S., Goyal, M., Wiggins, 
R., Margolis, B., 2002. The Maguk protein, Pals1, functions as an adapter, linking 
mammalian homologues of Crumbs and Discs Lost. J Cell Biol. 157, 161-72. 
Rolls, M. M., Albertson, R., Shih, H. P., Lee, C. Y., Doe, C. Q., 2003. Drosophila aPKC 
regulates cell polarity and cell proliferation in neuroblasts and epithelia. J Cell Biol. 
163, 1089-98. 
Sabherwal, N., Tsutsui, A., Hodge, S., Wei, J., Chalmers, A. D., Papalopulu, N., 2009. The 
apicobasal polarity kinase aPKC functions as a nuclear determinant and regulates 
cell proliferation and fate during Xenopus primary neurogenesis. Development. 
136, 2767-77. 
Schatten, H., 2008. The mammalian centrosome and its functional significance. Histochem 
Cell Biol. 129, 667-86. 
140 
Schimanski, C. C., Schmitz, G., Kashyap, A., Bosserhoff, A. K., Bataille, F., Schafer, S. 
C., Lehr, H. A., Berger, M. R., Galle, P. R., Strand, S., Strand, D., 2005. Reduced 
expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene 
lgl, contributes to progression of colorectal cancer. Oncogene. 24, 3100-9. 
Scotti, M. L., Bamlet, W. R., Smyrk, T. C., Fields, A. P., Murray, N. R., 2010. Protein 
kinase Ciota is required for pancreatic cancer cell transformed growth and 
tumorigenesis. Cancer Res. 70, 2064-74. 
Selbie, L. A., Schmitz-Peiffer, C., Sheng, Y., Biden, T. J., 1993. Molecular cloning and 
characterization of PKC iota, an atypical isoform of protein kinase C derived from 
insulin-secreting cells. J Biol Chem. 268, 24296-302. 
Shah, K., Shokat, K. M., 2002. A chemical genetic screen for direct v-Src substrates 
reveals ordered assembly of a retrograde signaling pathway. Chem Biol. 9, 35-47. 
Sherwood, V., Manbodh, R., Sheppard, C., Chalmers, A. D., 2008. RASSF7 is a member 
of a new family of RAS association domain-containing proteins and is required for 
completing mitosis. Mol Biol Cell. 19, 1772-82. 
Shi, S. H., Jan, L. Y., Jan, Y. N., 2003. Hippocampal neuronal polarity specified by 
spatially localized mPar3/mPar6 and PI 3-kinase activity. Cell. 112, 63-75. 
Shin, K., Straight, S., Margolis, B., 2005. PATJ regulates tight junction formation and 
polarity in mammalian epithelial cells. J Cell Biol. 168, 705-11. 
Shin, K., Wang, Q., Margolis, B., 2007. PATJ regulates directional migration of 
mammalian epithelial cells. EMBO Rep. 8, 158-64. 
Smith, C. A., Lau, K. M., Rahmani, Z., Dho, S. E., Brothers, G., She, Y. M., Berry, D. M., 
Bonneil, E., Thibault, P., Schweisguth, F., Le Borgne, R., McGlade, C. J., 2007. 
aPKC-mediated phosphorylation regulates asymmetric membrane localization of 
the cell fate determinant Numb. Embo J. 26, 468-80. 
Solecki, D. J., Model, L., Gaetz, J., Kapoor, T. M., Hatten, M. E., 2004. Par6alpha 
signaling controls glial-guided neuronal migration. Nat Neurosci. 7, 1195-203. 
Soloff, R. S., Katayama, C., Lin, M. Y., Feramisco, J. R., Hedrick, S. M., 2004. Targeted 
deletion of protein kinase C lambda reveals a distribution of functions between the 
two atypical protein kinase C isoforms. J Immunol. 173, 3250-60. 
Sotillos, S., Diaz-Meco, M. T., Caminero, E., Moscat, J., Campuzano, S., 2004. DaPKC-
dependent phosphorylation of Crumbs is required for epithelial cell polarity in 
Drosophila. J Cell Biol. 166, 549-57. 
Spitaler, M., Villunger, A., Grunicke, H., Uberall, F., 2000. Unique structural and 
functional properties of the ATP-binding domain of atypical protein kinase C-iota. 
J Biol Chem. 275, 33289-96. 
St Johnston, D., Ahringer, J., 2010. Cell polarity in eggs and epithelia: parallels and 
diversity. Cell. 141, 757-74. 
Stallings-Mann, M., Jamieson, L., Regala, R. P., Weems, C., Murray, N. R., Fields, A. P., 
2006. A novel small-molecule inhibitor of protein kinase Ciota blocks transformed 
growth of non-small-cell lung cancer cells. Cancer Res. 66, 1767-74. 
Steinhardt, A. A., Gayyed, M. F., Klein, A. P., Dong, J., Maitra, A., Pan, D., Montgomery, 
E. A., Anders, R. A., 2008. Expression of Yes-associated protein in common solid 
tumors. Hum Pathol. 39, 1582-9. 
Storrs, C. H., Silverstein, S. J., 2007. PATJ, a tight junction-associated PDZ protein, is a 
novel degradation target of high-risk human papillomavirus E6 and the 
alternatively spliced isoform 18 E6. J Virol. 81, 4080-90. 
Straight, S. W., Shin, K., Fogg, V. C., Fan, S., Liu, C. J., Roh, M., Margolis, B., 2004. 
Loss of PALS1 expression leads to tight junction and polarity defects. Mol Biol 
Cell. 15, 1981-90. 
141 
Sudol, M., Bork, P., Einbond, A., Kastury, K., Druck, T., Negrini, M., Huebner, K., 
Lehman, D., 1995. Characterization of the mammalian YAP (Yes-associated 
protein) gene and its role in defining a novel protein module, the WW domain. J 
Biol Chem. 270, 14733-41. 
Sugiyama, Y., Akimoto, K., Robinson, M. L., Ohno, S., Quinlan, R. A., 2009. A cell 
polarity protein aPKClambda is required for eye lens formation and growth. Dev 
Biol. 336, 246-56. 
Sun, R., Gao, P., Chen, L., Ma, D., Wang, J., Oppenheim, J. J., Zhang, N., 2005. Protein 
kinase C zeta is required for epidermal growth factor-induced chemotaxis of human 
breast cancer cells. Cancer Res. 65, 1433-41. 
Sun, W., Qureshi, H. Y., Cafferty, P. W., Sobue, K., Agarwal-Mawal, A., Neufield, K. D., 
Paudel, H. K., 2002. Glycogen synthase kinase-3beta is complexed with tau protein 
in brain microtubules. J Biol Chem. 277, 11933-40. 
Suzuki, A., Ishiyama, C., Hashiba, K., Shimizu, M., Ebnet, K., Ohno, S., 2002. aPKC 
kinase activity is required for the asymmetric differentiation of the premature 
junctional complex during epithelial cell polarization. J Cell Sci. 115, 3565-73. 
Suzuki, A., Ohno, S., 2006. The PAR-aPKC system: lessons in polarity. J Cell Sci. 119, 
979-87. 
Suzuki, A., Yamanaka, T., Hirose, T., Manabe, N., Mizuno, K., Shimizu, M., Akimoto, K., 
Izumi, Y., Ohnishi, T., Ohno, S., 2001. Atypical protein kinase C is involved in the 
evolutionarily conserved par protein complex and plays a critical role in 
establishing epithelia-specific junctional structures. J Cell Biol. 152, 1183-96. 
Takagawa, R., Akimoto, K., Ichikawa, Y., Akiyama, H., Kojima, Y., Ishiguro, H., 
Inayama, Y., Aoki, I., Kunisaki, C., Endo, I., Nagashima, Y., Ohno, S., 2010. High 
expression of atypical protein kinase C lambda/iota in gastric cancer as a prognostic 
factor for recurrence. Ann Surg Oncol. 17, 81-8. 
Tanentzapf, G., Tepass, U., 2003. Interactions between the crumbs, lethal giant larvae and 
bazooka pathways in epithelial polarization. Nat Cell Biol. 5, 46-52. 
Tapon, N., Harvey, K. F., Bell, D. W., Wahrer, D. C., Schiripo, T. A., Haber, D. A., 
Hariharan, I. K., 2002. salvador Promotes both cell cycle exit and apoptosis in 
Drosophila and is mutated in human cancer cell lines. Cell. 110, 467-78. 
Tepass, U., 1996. Crumbs, a component of the apical membrane, is required for zonula 
adherens formation in primary epithelia of Drosophila. Dev Biol. 177, 217-25. 
Tepass, U., Knust, E., 1993. Crumbs and stardust act in a genetic pathway that controls the 
organization of epithelia in Drosophila melanogaster. Dev Biol. 159, 311-26. 
Thiery, J. P., 2002. Epithelial-mesenchymal transitions in tumour progression. Nat Rev 
Cancer. 2, 442-54. 
Totong, R., Achilleos, A., Nance, J., 2007. PAR-6 is required for junction formation but 
not apicobasal polarization in C. elegans embryonic epithelial cells. Development. 
134, 1259-68. 
Traweger, A., Wiggin, G., Taylor, L., Tate, S. A., Metalnikov, P., Pawson, T., 2008. 
Protein phosphatase 1 regulates the phosphorylation state of the polarity scaffold 
Par-3. Proc Natl Acad Sci U S A. 105, 10402-7. 
Wakefield, J. G., Stephens, D. J., Tavare, J. M., 2003. A role for glycogen synthase kinase-
3 in mitotic spindle dynamics and chromosome alignment. J Cell Sci. 116, 637-46. 
Wald, F. A., Oriolo, A. S., Mashukova, A., Fregien, N. L., Langshaw, A. H., Salas, P. J., 
2008. Atypical protein kinase C (iota) activates ezrin in the apical domain of 
intestinal epithelial cells. J Cell Sci. 121, 644-54. 
Wallingford, J. B., 2005. Vertebrate gastrulation: polarity genes control the matrix. Curr 
Biol. 15, R414-6. 
142 
Wang, J. M., Li, Q., Du, G. S., Lu, J. X., Zou, S. Q., 2009. Significance and expression of 
atypical protein kinase C-iota in human hepatocellular carcinoma. J Surg Res. 154, 
143-9. 
Wang, Q., Chen, X. W., Margolis, B., 2007. PALS1 regulates E-cadherin trafficking in 
mammalian epithelial cells. Mol Biol Cell. 18, 874-85. 
Wang, Q., Hurd, T. W., Margolis, B., 2004. Tight junction protein Par6 interacts with an 
evolutionarily conserved region in the amino terminus of PALS1/stardust. J Biol 
Chem. 279, 30715-21. 
Wang, S. L., Hawkins, C. J., Yoo, S. J., Muller, H. A., Hay, B. A., 1999. The Drosophila 
caspase inhibitor DIAP1 is essential for cell survival and is negatively regulated by 
HID. Cell. 98, 453-63. 
Watts, J. L., Etemad-Moghadam, B., Guo, S., Boyd, L., Draper, B. W., Mello, C. C., 
Priess, J. R., Kemphues, K. J., 1996. par-6, a gene involved in the establishment of 
asymmetry in early C. elegans embryos, mediates the asymmetric localization of 
PAR-3. Development. 122, 3133-40. 
Wei, X., Shimizu, T., Lai, Z. C., 2007. Mob as tumor suppressor is activated by Hippo 
kinase for growth inhibition in Drosophila. Embo J. 26, 1772-81. 
Weyrich, P., Neuscheler, D., Melzer, M., Hennige, A. M., Haring, H. U., Lammers, R., 
2007. The Par6alpha/aPKC complex regulates Akt1 activity by phosphorylating 
Thr34 in the PH-domain. Mol Cell Endocrinol. 268, 30-6. 
White, W. O., Seibenhener, M. L., Wooten, M. W., 2002. Phosphorylation of tyrosine 256 
facilitates nuclear import of atypical protein kinase C. J Cell Biochem. 85, 42-53. 
Willecke, M., Hamaratoglu, F., Sansores-Garcia, L., Tao, C., Halder, G., 2008. Boundaries 
of Dachsous Cadherin activity modulate the Hippo signaling pathway to induce cell 
proliferation. Proc Natl Acad Sci U S A. 105, 14897-902. 
Win, H. Y., Acevedo-Duncan, M., 2008. Atypical protein kinase C phosphorylates 
IKKalphabeta in transformed non-malignant and malignant prostate cell survival. 
Cancer Lett. 
Win, H. Y., Acevedo-Duncan, M., 2009. Role of protein kinase C-iota in transformed non-
malignant RWPE-1 cells and androgen-independent prostate carcinoma DU-145 
cells. Cell Prolif. 42, 182-94. 
Wissler, F., Labouesse, M., 2007. PARtners for endocytosis. Nat Cell Biol. 9, 1027-9. 
Wodarz, A., 2000. Tumor suppressors: linking cell polarity and growth control. Curr Biol. 
10, R624-6. 
Wodarz, A., Hinz, U., Engelbert, M., Knust, E., 1995. Expression of crumbs confers apical 
character on plasma membrane domains of ectodermal epithelia of Drosophila. 
Cell. 82, 67-76. 
Wodarz, A., Ramrath, A., Kuchinke, U., Knust, E., 1999. Bazooka provides an apical cue 
for Inscuteable localization in Drosophila neuroblasts. Nature. 402, 544-7. 
Woods, D. F., Bryant, P. J., 1994. Tumor suppressor genes and signal transduction in 
Drosophila. Princess Takamatsu Symp. 24, 1-13. 
Woods, D. F., Hough, C., Peel, D., Callaini, G., Bryant, P. J., 1996. Dlg protein is required 
for junction structure, cell polarity, and proliferation control in Drosophila 
epithelia. J Cell Biol. 134, 1469-82. 
Xu, M. Z., Yao, T. J., Lee, N. P., Ng, I. O., Chan, Y. T., Zender, L., Lowe, S. W., Poon, R. 
T., Luk, J. M., 2009. Yes-associated protein is an independent prognostic marker in 
hepatocellular carcinoma. Cancer. 115, 4576-85. 
Yamanaka, T., Horikoshi, Y., Sugiyama, Y., Ishiyama, C., Suzuki, A., Hirose, T., 
Iwamatsu, A., Shinohara, A., Ohno, S., 2003. Mammalian Lgl forms a protein 
143 
complex with PAR-6 and aPKC independently of PAR-3 to regulate epithelial cell 
polarity. Curr Biol. 13, 734-43. 
Yamanaka, T., Horikoshi, Y., Suzuki, A., Sugiyama, Y., Kitamura, K., Maniwa, R., Nagai, 
Y., Yamashita, A., Hirose, T., Ishikawa, H., Ohno, S., 2001. PAR-6 regulates 
aPKC activity in a novel way and mediates cell-cell contact-induced formation of 
the epithelial junctional complex. Genes Cells. 6, 721-31. 
Yang, Y. L., Chu, J. Y., Luo, M. L., Wu, Y. P., Zhang, Y., Feng, Y. B., Shi, Z. Z., Xu, X., 
Han, Y. L., Cai, Y., Dong, J. T., Zhan, Q. M., Wu, M., Wang, M. R., 2008. 
Amplification of PRKCI, located in 3q26, is associated with lymph node metastasis 
in esophageal squamous cell carcinoma. Genes Chromosomes Cancer. 47, 127-36. 
Yasumi, M., Sakisaka, T., Hoshino, T., Kimura, T., Sakamoto, Y., Yamanaka, T., Ohno, 
S., Takai, Y., 2005. Direct binding of Lgl2 to LGN during mitosis and its 
requirement for normal cell division. J Biol Chem. 280, 6761-5. 
Yi, P., Feng, Q., Amazit, L., Lonard, D. M., Tsai, S. Y., Tsai, M. J., O'Malley, B. W., 
2008. Atypical protein kinase C regulates dual pathways for degradation of the 
oncogenic coactivator SRC-3/AIB1. Mol Cell. 29, 465-76. 
Yu, F., Morin, X., Cai, Y., Yang, X., Chia, W., 2000. Analysis of partner of inscuteable, a 
novel player of Drosophila asymmetric divisions, reveals two distinct steps in 
inscuteable apical localization. Cell. 100, 399-409. 
Yu, J., Zheng, Y., Dong, J., Klusza, S., Deng, W. M., Pan, D., 2010. Kibra functions as a 
tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin 
and Expanded. Dev Cell. 18, 288-99. 
Zeng, Q., Hong, W., 2008. The emerging role of the hippo pathway in cell contact 
inhibition, organ size control, and cancer development in mammals. Cancer Cell. 
13, 188-92. 
Zhan, L., Rosenberg, A., Bergami, K. C., Yu, M., Xuan, Z., Jaffe, A. B., Allred, C., 
Muthuswamy, S. K., 2008. Deregulation of scribble promotes mammary 
tumorigenesis and reveals a role for cell polarity in carcinoma. Cell. 135, 865-78. 
Zhang, J., Smolen, G. A., Haber, D. A., 2008. Negative regulation of YAP by LATS1 
underscores evolutionary conservation of the Drosophila Hippo pathway. Cancer 
Res. 68, 2789-94. 
Zhang, L., Huang, J., Yang, N., Liang, S., Barchetti, A., Giannakakis, A., Cadungog, M. 
G., O'Brien-Jenkins, A., Massobrio, M., Roby, K. F., Katsaros, D., Gimotty, P., 
Butzow, R., Weber, B. L., Coukos, G., 2006. Integrative genomic analysis of 
protein kinase C (PKC) family identifies PKCiota as a biomarker and potential 
oncogene in ovarian carcinoma. Cancer Res. 66, 4627-35. 
Zhang, X., Milton, C. C., Humbert, P. O., Harvey, K. F., 2009. Transcriptional output of 
the Salvador/warts/hippo pathway is controlled in distinct fashions in Drosophila 
melanogaster and mammalian cell lines. Cancer Res. 69, 6033-41. 
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, 
L., Zheng, P., Ye, K., Chinnaiyan, A., Halder, G., Lai, Z. C., Guan, K. L., 2007. 
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact 
inhibition and tissue growth control. Genes Dev. 21, 2747-61. 
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Lin, J. D., Wang, C. Y., Chinnaiyan, A. M., 
Lai, Z. C., Guan, K. L., 2008. TEAD mediates YAP-dependent gene induction and 
growth control. Genes Dev. 22, 1962-71. 
Zheng, Z., Zhu, H., Wan, Q., Liu, J., Xiao, Z., Siderovski, D. P., Du, Q., 2010. LGN 
regulates mitotic spindle orientation during epithelial morphogenesis. J Cell Biol. 
189, 275-88. 
144 
Zhou, G., Seibenhener, M. L., Wooten, M. W., 1997. Nucleolin is a protein kinase C-zeta 
substrate. Connection between cell surface signaling and nucleus in PC12 cells. J 
Biol Chem. 272, 31130-7. 
Zieve, G. W., Turnbull, D., Mullins, J. M., McIntosh, J. R., 1980. Production of large 
numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor 
nocodazole. Nocodazole accumulated mitotic cells. Exp Cell Res. 126, 397-405. 
145 
